Page last updated: 2024-08-24

imiquimod and Skin Neoplasms

imiquimod has been researched along with Skin Neoplasms in 779 studies

Research

Studies (779)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (0.39)	18.2507
2000's	350 (44.93)	29.6817
2010's	316 (40.56)	24.3611
2020's	110 (14.12)	2.80

Authors

Authors	Studies
Das, M; Jarrett, P; Kim, TY; Poppito, N	1
Cho, KH; Choi, CW; Jo, SJ; Lee, JW	1
Fogarty, GB; Guitera, P; Hong, A; O'Donnell, BA; Paton, E; Pellacani, G; Scolyer, RA; Stretch, JR; Waddell, A	2
Aasi, SZ; Alam, M; Arai, N; Aung, PP; Barker, CA; Bolotin, D; Bordeaux, JS; Brackett, A; Cartee, TV; Chandra, S; Cho, NL; Choi, JN; Chung, KY; Cliby, WA; Dorigo, O; Downing, MB; Eisen, DB; Fujisawa, Y; Golda, N; Halfdanarson, TR; Harikumar, V; Iavazzo, C; Ibrahim, SA; Jiang, SIB; Kang, BY; Kanitakis, J; Khan, A; Kibbi, N; Kim, JYS; Kuzel, TM; Lawrence, N; Leitao, MM; MacLean, AB; Maher, IA; Mittal, BB; Nehal, KS; Owen, JL; Ozog, DM; Pettaway, CA; Poon, E; Ross, JS; Rossi, AM; Servaes, S; Solomon, MJ; Thomas, VD; Tolia, M; Voelzke, BB; Waldman, A; Wang, JX; Wong, MK; Worley, B; Zhou, Y	1
Avallone, G; Conforti, C; Dell'Aquila, C; Merli, M; Quaglino, P; Ribero, S; Zalaudek, I	1
Arits, AHMM; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Oostewechel, LCF; Sinx, KAE; Verkouteren, BJA; Vernemmen, AIP; Winnepenninckx, VJL	1
Bassukas, ID; Dounousi, E; Gaitanis, G; Koutlas, V; Pappas, C; Tsironi, T	1
Bailie, JE; Burke, B	1
Brown, H; De'Ambrosis, B; Kennedy, D; Louie, B; McCormack, C; Muir, J; Smithers, BM	1
Álvarez-Chinchilla, P; Bañuls-Roca, J; Hispán-Ocete, P; Poveda-Montoyo, I; Schneller-Pavelescu, L	2
Ahmady, S; Arits, AHMM; de Rooij, MJM; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF	1
Cheng, B; Etzkorn, JR; Giordano, CN; Higgins, HW; Miller, CJ; Shin, TM; Sobanko, JF; Veerabagu, S	1
Borsky, K; Chicco, M; Goodall, R; Harrison, C; Rodrigues, J; Wietek, N	1
Bevilacqua, F; Bleeker, MCG; Bornstein, J; Carcopino, X; Chargari, C; Cruickshank, ME; Erzeneoglu, BE; Esat Temiz, B; Gallio, N; Gultekin, M; Heller, D; Joura, E; Kesic, V; Planchamp, F; Preti, M; Querleu, D; Reich, O; Stockdale, CK; Van Beurden, M; Vieira-Baptista, P; Woelber, L; Zodzika, J	1
Di Bartolomeo, L; Guarneri, F; Moretti, G	1
Bevilacqua, F; Bleeker, MCG; Bornstein, J; Carcopino, X; Chargari, C; Cruickshank, ME; Erzeneoglu, BE; Gallio, N; Gultekin, M; Heller, D; Joura, E; Kesic, V; Planchamp, F; Preti, M; Querleu, D; Reich, O; Stockdale, CK; Temiz, BE; Van Beurden, M; Vieira-Baptista, P; Woelber, L; Zodzika, J	1
Daniel, C; Kaushik, M; Neumann, I; Patalay, R; Timlin, H	1
Borroni, RG; Bressan, A; Cortese, A; Costanzo, A; Fiorillo, G; Toso, F; Tronconi, MC	1
Chang, SH; Chen, YJ; Hsu, CS; Huang, SW; Kao, JK; Li, ZY; Lin, PY; Liu, KT; Shieh, JJ; Wong, TW; Wu, CY; Wu, TK	1
Bisbee, E; Missall, TA; Raman, J; Saikaly, SK	1
Chen, YC; Liu, WT; Lo, TK; Wong, TW	1
Algarin, YA; Jambusaria-Pahlajani, A; Patel, VA; Ruiz, E	1
Hassan, S; Patel, V; Safadi, MG; Viglione, M; Zahner, SL	1
Chang, CH; Wang, WE	1
Alam, M; Anvery, N; Christensen, RE; Dirr, MA; Harikumar, V; Poon, E; Reynolds, K; Worley, B; Yi, MD	1
Deng, L; Dickson, MA; Gu, L; Kurtansky, N; Lezcano, C; Lin, E; Liu, S; Markova, A; Neumann, NM; Noor, S; Pulitzer, M; Rossi, A; Stoll, J; Yang, N	1
Aguila, KP; Anupol, EBJ; Balete, SL; Barcelona, MV; Castro, VCS; Espinoza-Thaebtharm, A; Fineza-Dela Cruz, AMB; Gulmatico-Flores, Z; Lansangan, PP; Ligeralde-Bascones, KI; Lim-Bueser, HG; Manrique, AMB; Olitoquit, KD; Ortiz, ACG; Palisoc, ED; Rescober-Valencia, MC; Santos, DGV; See, MRV; Sy, AJF; Sy, GC; Tana, MG; Tayag, JJS; Teo, HMT	1
DeSimone, JA; DiLorenzo, A; Lindberg, MR	1
Avancini, J; Castro, LP; de Oliveira, ZNP; Ferreira, P; Festa Neto, C; Gianotti, MA; Menck, CFM; Pereira, NV; Rivitti, MC; Rocha, LKFL; Samorano, LP	1
Chung, PH; D'mello, D; Jones, EK; Leong, JY; Shumaker, A	1
Bedane, C; Bens, G; Beylot-Barry, M; Bossard, C; Daude, M; Debarbieux, S; Denis, MG; Dinulescu, M; Dréno, B; Khammari, A; Le Duff, F; Leccia, MT; Legoupil, D; Machet, L; Maillard, H; Meyer, N; Monestier, S; Nguyen, JM; Vergier, B; Wierzbicka-Hainaut, E	1
Carr, M; Correa, L; Culbreth, A; Cunningham, K; DePalo, DK; Harkins, A; Longbottom, B; Patel, N; Puleo, C; Reed, R; Seminario-Vidal, L; Ward, C; Zager, JS	1
Colombo, J; De Giorgi, V; Silvestri, F; Trane, L; Venturi, F; Zuccaro, B	1
Alonso-Martinez de Salinas, L; Azcarraga-Llobet, C; Bea-Ardebol, S; Berna-Rico, E; de Nicolas-Ruanes, B; Garcia-Mouronte, E	1
Javed, MU; Kaur, A; Murison, M; Venables, B; Yarrow, J	1
Krieter, M; Schultz, E	1
Aranda Lopez, P; Bialojan, A; Denny, M; Hartmann, AK; Langguth, P; Probst, HC; Radsak, MP; Rausch, J; Schild, H; Sohl, J; Yagita, H	1
Axon, E; Grindlay, DJ	1
Bowen, GM; Sampson, BP	1
Collins, A; Doerfler, L; Savas, J	1
Lam, M; Olabi, B; Patel, A; Smith, H; Varma, S; Veitch, D	1
Braun, TL; Dao, H; Patel, V; Rosen, T	1
Aw Yeang, HX; Behren, A; Caramia, F; Cebon, J; Halse, H; Haskett, M; Keam, SP; Ly, L; Mar, VJ; McArthur, GA; McLean, CA; Neeson, PJ; Wang, M	1
Arimura, A; Kanekura, T; Kirishima, M; Tanimoto, A	1
Marchetti, MA; Marghoob, AA; Navarrete-Dechent, C	1
Cao, XC; Duan, XB; Li, MY; Zhang, XP; Zhao, HJ	1
Bellmann, L; Brinckerhoff, CE; Cappellano, G; Mullins, DW; Ortner, D; Prokopi, A; Schachtl-Riess, JF; Seretis, A; Stoitzner, P; Tripp, CH	1
Boyle, GM; Cullen, JK; Parsons, PG; Simmons, JL	1
Egawa, G; Egawa, K; Egawa, N; Honda, Y; Ihn, H; Kawano, Y; Noguchi, H	1
Barton, VR; Cheng, MY; Kao, J; Kirane, AR; Kiuru, M; Ma, C; Maverakis, E; Petukhova, TA; Wang, EA	1
Elizalde-Amatria, AG; Elizalde-Benito, AG; Elizalde-Benito, FX; Quintana-Martínez, I; Urra-Palos, M	1
Aróstegui Aguilar, J; Azcona Rodríguez, M; Hervella Garcés, M; Martínez de Espronceda Ezquerro, I; Sarriugarte Aldecoa-Otalora, J; Yanguas Bayona, JI	1
Olabi, B; Tasker, F; Williams, HC	1
Kulakov, EL; Logan, IT; Perrett, CM	1
Conforti, C; Corneli, P; di Meo, N; Dianzani, C; Farinazzo, E; Giuffrida, R; Magaton Rizzi, G; Moret, A; Zalaudek, I	1
Binic, I; Cantisani, C; Cantoresi, F; Golubovic, M; Marino, R; Mercuri, SR; Paolino, G	1
Chang, SH; Chen, YJ; Chuang, KC; Huang, SW; Kao, JK; Kao, SH; Liang, SM; Shieh, JJ; Wang, HY; Wang, ST; Wu, CY	1
Corbeddu, M; Ferreli, C; Fumo, G; Robustelli Test, E; Rongioletti, F	1
Bartenstein, DW; Fisher, J; Hawryluk, EB; Kroshinsky, D; Lilly, E; Moustafa, D; Su, KA	1
Chung, C; Fabbro, S; Hastings, J; Haverkos, B; Hwang, S; Johnson, A; Porcu, P; William, B	1
Fayne, R; Nanda, S; Nichols, A; Shen, J	1
Mahatma, G; Sweeney, AR; Yen, MT	1
Cantisani, C; Cantoresi, F; Mercuri, SR; Paolino, G	1
Arits, AHMM; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Sinx, KAE; Winnepenninckx, VJL	1
Asinari, J; Feliciani, C; Goldust, M; Lotti, T; Pedrazzi, G; Satolli, F; Zucchi, A	1
Dika, E; Lambertini, M; Melotti, B; Patrizi, A; Ravaioli, GM; Scarfì, F; Veronesi, G	1
Chang, CR; Chang, SH; Chen, YJ; Chuang, KC; Chuang, SM; Huang, SW; Kao, JK; Li, ZY; Shieh, JJ; Wang, ST	1
Kopera, D	1
Griffiths, CC; Roman, EM; Wang, TS	1
Cheng, ST; Ke, CK; Su, YC; Sun, Y	1
Abeni, D; Fania, L; Mazzanti, C; Panebianco, A; Pilla, MA; Provini, A; Ricci, F; Ruggeri, S	1
Bartenjev, I; Bartenjev, MS; Isaković-Vidović, S	1
Abadir, W; Alavi, N; Look Hong, NJ; Nadler, A; Wright, FC	1
Dika, E; Lambertini, M; Melotti, B; Mussi, M; Patrizi, A; Scarfì, F; Tartari, F; Veronesi, G	1
Baker, C; MacMahon, B; Sinclair, R; Spelman, L; Supranowicz, M	1
Fujiwara, M; Fujiwara, S; Miura, H; Takada, M	1
Muir, J; Pitney, T	1
Mosterd, K; Sinx, K	1
Cater, Z; Gurnani, P; Marlow, M; Ogilvie, J; Sabri, AH; Scurr, DJ; Segal, J	1
Lobo, Y; Templeman, R	1
Bassukas, ID; Gaitanis, G; Ganiatsa, A; Karamoutsios, A; Pappas, P; Vartholomatos, G	1
Gantenbein, L; Hammerl, V; Mueller, SM; Navarini, A; Parlar, B; Väth, H	1
Bergvall, KE; Broström, H; Humblot, P; Pettersson, CM	1
Apalla, Z; Gkentsidi, T; Ioannidis, D; Kyrmanidou, E; Lallas, A; Lallas, K; Manoli, SM; Moutsoudis, A; Papadimitriou, I; Papageorgiou, C; Paschou, E; Rigas, HM; Sotiriou, E; Spyridis, I; Vakirlis, E	1
Bath-Hextall, FJ; Hogan, S; Leonardi-Bee, J; Thomson, J; Williams, HC	2
Chambers, M; Chapman, MS; O'Hern, K; Ryan, C	1
Barbarot, S; Fraitag, S; Legroux, J; Mesnard, C; Petrot, D; Thomas, C	1
Feldman, SR; Heron, CE	1
Blake, T; Lobo, Y; Wheller, L	1
Kim, JK; Thompson, HM	1
Badiavas, EV; Gonzalez, AM; Kirsner, RS; Moore, K; Nagrani, N; Nahm, WJ; Nichols, AJ; Shen, J; Zito, PM	1
Baker, C; Chambers, M; Chapman, MS; Saunders, E; Swetter, SM	1
Bossard, C; Denis Musquer, M; Dréno, B; Khammari, A; Nguyen, JM; Soenen, A; Vergier, B; Vourc'h, M	1
Fontenete, S; Haedersdal, M; Lerche, CM; Olesen, UH; Paasch, U; Perez-Moreno, M	1
Gesing, M; Hlebowicz, M; Iżycka-Świeszewska, E; Nowicki, RJ; Sikorska, M; Smiatacz, T; Sobjanek, M; Sokołowska-Wojdyło, M; Sławińska, M	1
Bates, SE; Dana, AN; Del Guzzo, CA; Geskin, LJ; Kojadinovic, A; Langhoff, E; Newman, JC; Park, YA; Vinnakota, RR	1
Apalla, Z; Argenziano, G; di Meo, N; Kittler, H; Kyrgidis, A; Lallas, A; Longo, C; Manoli, SM; Moscarella, E; Papageorgiou, C; Thomas, L; Zalaudek, I	1
Piqué-Duran, E	1
Kerner, JD; Kerner, JV; Ondo, AL; Ondo, IP; Shanler, SD; Trainor, P	1
Basehore, BM; Globerson, JA; Nessel, T; Saleeby, ER	1
Catorze, G; Labareda, J; Miroux Catarino, A; Queirós, C; Silva, L; Viana, I	1
Chianese-Bullock, KA; Deacon, D; Grosh, WW; Lynch, KT; Meneveau, MO; Olson, WC; Patterson, JW; Petroni, GR; Salerno, EP; Slingluff, CL; Smolkin, M; Woodson, E	1
Giacomantonio, CA; Helyer, LK; Pasternak, S; Peltekian, K; Simms, GA; Stein, J; Vidovic, D; Walsh, M	1
Bennardo, F; Bennardo, L; Dastoli, S; Giudice, A; Morrone, P; Nisticò, SP; Passante, M; Patruno, C; Provenzano, E	1
Joyce, C; Kwak, R; Lin, JY; Tsibris, HC; Werchniak, AE	1
Gupta, P; Kaur, M; Mehta Grewal, A; Sharma, M; Singh, H; Singh, M; Zadeng, Z	1
Ahmed, E; El-Khalawany, M; Mosbeh, A; Rageh, MA; Sameh, A; Saudi, WM	1
Brewer, JD; Lang, ME; Stewart, JR	1
de Coster, D; Essers, BA; Mosterd, K; Sinx, KAE	1
Gupta, S; Gupta, V; Pangti, R	1
Chapman, MS; Park, AJ; Paul, J; Samie, FH	1
Guitera, P; Maher, NG	1
Lv, R; Sun, Q	1
Ariza, S; Espinosa, S; Naranjo, M	1
Byekova, YA; Duvic, M; Emge, DA; Lewis, DJ	1
Alflen, A; Denny, M; Hartmann, AK; Langguth, P; Lopez, PA; Probst, HC; Radsak, MP; Schild, H; Stassen, M; Tenzer, S; von Stebut, E	1
Bialojan, A; Denny, M; Langguth, P; Lopez, PA; Probst, HC; Radsak, MP; Rausch, J; Schild, H	1
Arits, AH; Essers, BAB; Hendriks, MR; Kelleners-Smeets, NW; Mosterd, K	1
De Felici, MB; Feliciani, C; Pagliarello, C; Rovesti, M; Satolli, F; Zucchi, A	1
Aranda Lopez, P; Freichel, M; Hartmann, AK; Radsak, MP; Schild, H; Stassen, M; Zajac, M	1
Chiricozzi, A; Costanza, G; Di Cesare, A; Di Stefani, A; Fargnoli, MC; Ferlosio, A; Orlandi, A; Pellegrini, C; Peris, K; Piccioni, A	1
Schwarz, T; Wehkamp, U	1
Can Kuru, B; Cinel, L; Ergun, T; Salman, A; Sarac, G; Yucelten, AD	1
Read, T; Schaider, H; Smithers, BM; Soyer, HP; Thomas, J; Wagels, M; Webber, S	1
Bostanci, S; Botsali, A; Heper, AO; Kocyigit, P; Vural, S	1
Arits, AHMM; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF; Roozeboom, MH; Sommer, A; Steijlen, PM; van Pelt, HPA	1
Hida, T; Horimoto, K; Kato, J; Sato, S; Sawada, M; Uhara, H; Yamashita, T; Yoneta, A	1
Hoekzema, R; Kirtschig, G; Tio, D; van Montfrans, C	1
Shi, L; Wang, P; Wang, X; Zhang, G; Zhang, H; Zhang, L; Zhao, Z; Zhou, Z	1
Cheng, MY; Kirane, A; Kulkarni, R; Luxardi, G; Ma, C; Maverakis, E; Monjazeb, AM; Ogawa, H	1
Kim, JYS; Kozlow, JH; Mittal, B; Moyer, J; Olencki, T; Rodgers, P	1
Ged, C; Hernández-Martín, A; Knöpfel, N; Latour, I; Taïeb, A; Torrelo, A	1
Shaw, FM; Weinstock, MA	1
Jansen, MHE; Kelleners-Smeets, NWJ; Mosterd, K; Sinx, KAE	1
Alegre, N; Gazzaniga, S; Pozner, R; Rocco, R; Wainstok, R	1
Augustin, M; Dréno, B; Hoekzema, R; Prinsen, CAC; Tio, D; van Montfrans, C	1
Casanova, JM; García-de-la-Fuente, MR; Gatius, S; Huerva, V; Martí, RM; Matas-Nadal, C; Ortega, E; Sòria, X; Vilardell, F	1
Bowen, GM; Flores, S; Luby, NJ	1
Chen, WR; Luo, M; Shi, L; Wang, B; Wang, P; Wang, X; Yang, D; Zhang, F; Zhang, G; Zhang, H; Zhang, L; Zhang, Y; Zhou, F	1
Apalla, Z; Ioannides, D; Lallas, A; Nikolaidou, C; Sotiriou, E; Tsorova, A; Vakirlis, E	1
Que, SKT; Schmults, CD; Zwald, FO	1
Dias, MF; Fialho, SL; Figueiredo, BCP; Guerra, MCA; Silva Cunha, A; Teixeira-Neto, J	1
Arits, AHMM; Jansen, MHE; Kelleners-Smeets, NWJ; Koekelkoren, FHJ; Mosterd, K; Nelemans, PJ; Roozeboom, MH	1
Bowen, GM; Bowling, M; Donigan, JM; Goldgar, DE; Hadley, ML; Hyde, MA	1
Fosko, SW; Navarrete-Dechent, CP; Nehal, KS	1
Collier, NJ; Exton, LS; Green, AC; Haylett, AK; Ibbotson, SH; Mallipeddi, R; McKenna, KE; Mohd Mustapa, MF; Morton, CA; Moseley, H; Rhodes, LE; Seukeran, D; Ward, KA; Wong, TH	1
Baraldi, C; Dika, E; Fanti, PA; Guglielmo, A; Lambertini, M; Patrizi, A; Ravaioli, GM; Scarfì, F; Veronesi, G	1
Aberbigbe, O; Etzkorn, JR; Neal, DE; Smith, RJ	1
Arai, T; Kanda, Y; Kanzaki, A; Kariya, T; Kato, Y; Shirai, K; Tsuboi, R	1
Bhatta, AK; Ji, J; Keyal, U; Wang, P; Wang, X; Zhang, G; Zhao, Z; Zhu, L	1
Arora, H; Darwin, E; Kamath, P; Nouri, K	1
Balasis, S; Georgiou, S; Koumoundourou, D; Mallioris, AF; Plachouri, KM	1
Delman, KA; Farley, CR; Lopez-Aguiar, AG; Lowe, MC; Oh, G; Russell, MC	1
Miura, T; Yamamoto, T	1
Bassukas, ID; Gaitanis, G	4
Guevara-Gutiérrez, E; Hernández-Torres, M; Ledesma, GS; Ruiz-González, JF; Tlacuilo-Parra, A	1
Alfano, R; Argenziano, G; Corneli, P; DI Brizzi, EV; Donadio, C; Moscarella, E; Zalaudek, I	1
Astorino, S; Astorre, P; Di Nunno, D; Paolino, G; Pasquini, P; Pellegrini, F	1
Asgari, MM; Chren, MM; Friedman, GD; Neugebauer, R; Sokil, M; Su, KA; Zhu, Z	1
Bottoni, U; Calvieri, S; Cantisani, C; Cantoresi, F; Didona, D; Kyriakou, A; Mercuri, SR; Paolino, G; Piccolo, D; Scarnò, M; Tallarico, M	1
Brand, FL; Hunger, RE; Seyed Jafari, SM	1
Arits, AHMM; Hamid, MA; Jansen, MHE; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Roozeboom, MH; van Delft, LCJ	1
Brown, TS; Jung, JY; Wetzel, M	1
Lawrence, CM; Papanikolaou, M	1
Cataisson, C; Day, CP; Flowers, B; Fraser, E; Li, L; Sanchez, V; Yuspa, SH	1
Deinlein, T; El-Shabrawi-Caelen, L; Gschwandtner, M; Hofmann-Wellenhof, R; Kupsa, R; Woltsche, N; Zalaudek, I	1
Caruntu, C; Constantin, MM; Draghici, CC; Lisievici, CV; Lupu, M; Popa, AV; Sebe, TI; Solomon, I; Vajaitu, C; Voiculescu, VM	1
Al-Mayahy, MH; Holmes, A; Marlow, M; McKenna, J; Rutland, CS; Sabri, AH; Scurr, DJ	1
Chen, L; Cornelius, LA; Demehri, S; Faulkner-Jones, BE; Khalifian, S; Molina, GE; Mull, JL; Ngo, KH; Rosman, IS; Wu, PA	1
Hsu, CK; Lee, CN; Lee, JY	1
Hsia, HC; Kim, S; Narayan, D; Norwich-Cavanaugh, A; Tsay, C	1
DeWane, ME; Grant-Kels, JM; Kelsey, A; Oliviero, M; Rabinovitz, H	1
Colato, C; Giannetti, L; Girolomoni, G; Maurelli, M	1
Council, ML; Nemer, KM	1
Aung, PP; Duvic, M; Kubicki, SL; Park, KE	1
Adams, S; Bedognetti, D; Chiriboga, L; Darvishian, F; Demaria, S; Egeblad, M; Heguy, A; Hendrickx, W; Loomis, C; Marincola, FM; Ray, K; Rozenblit, M	1
Bekkenk, MW; Hoekzema, R; Ruijter, CGH; Tio, DCKS; van Montfrans, C	1
Conforti, C; Di Meo, N; Giuffrida, R; Hamilko de Barros, M; Seabra Resende, FS; Zalaudek, I	1
Bassukas, IM; Gaitanis, G	1
Antaya, RJ; Craiglow, BG	1
Beer, HD; Belloni, B; Bloch, W; Cecconi, V; Dummer, R; Knuth, A; Matter, C; Schäfer, M; Schönewolf, N; Urosevic-Maiwald, M; van den Broek, M; Walter, A; Werner, S	1
Halpern, AC; Quigley, EA	1
Chen, H; Hu, X; Jin, Y; Lin, X; Ma, G; Qiu, Y; Yang, J	1
Bassett, RL; Chon, S; Fox, PS; McKay, KM; Prieto, VG; Sambrano, BL	1
Dummer, R	1
Arits, AH; De Rooij, MJ; Essers, BA; Kelleners-Smeets, NW; Krekels, GA; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJ; Rijzewijk, JJ; Sommer, A; Spoorenberg, E; Steijlen, PM; van Geest, AJ; van Neer, PA; van Pelt, HP	1
Brett, AS; Ridley, EP; Voss, T	1
Bath-Hextall, FJ; Leonardi-Bee, J; Matin, RN; Wilkinson, D	1
Bassukas, ID; Nakuçi, M	1
Chitwood, K; Cohen, G; Etzkorn, J	1
Calzavara Pinton, P; Catricalà, C; Neri, L; Pellacani, G; Peris, K; Peserico, A; Pimpinelli, N	2
Bajek, A; Czajkowski, R; Drewa, T; Schwartz, RA; Uzarska, M; Zegarska, B	1
Banzhaf, CA; Jemec, GB; Mogensen, M; Ring, HC; Themstrup, L	1
Fujioka, A; Nakajima, H; Okino, T; Sano, S; Shuin, T; Tarutani, M	1
Apalla, Z; Argenziano, G; Evangelou, G; Ioannides, D; Kyrgidis, A; Lallas, A; Lazaridou, E; Lefaki, I; Patsatsi, A; Sidiropoulos, T; Sotiriou, E; Stratigos, A; Trakatelli, M; Tzellos, T; Zalaudek, I	1
Birnie, AJ; Eedy, DJ; Morton, CA	1
Dhote, V; Gupta, V; Paul, BN; Trivedi, P	1
Lear, JT	1
Armstrong, SJ; Bath-Hextall, F; Colver, GB; Miller, PS; Ozolins, M; Perkins, W; Williams, HC	1
Bahoric, B; Basik, M; Batist, G; Guay, MP; Henriques, L; Kavan, P; Palumbo, M	1
Huen, AO; Rook, AH	1
Cohen, DN; Johnson, DB; Joseph, RW; Kelley, MC; Likhari, SS; Powers, JG; Shinn, L; Sosman, JA; Wallender, EK; Zwerner, JP	1
Bourgault-Villada, I; Clerici, T; Elfatoiki, FZ; Longvert, C; Roudier-Pujol, C; Saiag, P; Vasseur, E	1
Schmutz, JL; Trechot, P	1
Argenziano, G; Drummond, A; Lallas, A; Longo, C; Moscarella, E; Piana, S; Pichler, J; Zalaudek, I	1
Crandall, ML; Gibbs, NF; Rivard, SSC	1
Jiayuan, C; Jing, W; Juan, X; Li, X; Qin, H; Qing, L; Shengmei, X	1
Kirtschig, G; van Doorn, R; van Meurs, T	3
Alarcon, I; Alos, L; Carrera, C; Malvehy, J; Palou, J; Puig, S	1
Erkan, F; Kaçar, SD; Karaca, Ş; Özuğuz, P	1
Fields, J; Fields, K; Jewell, T; Milikowski, C	1
Arits, AH; Essers, BA; Kelleners-Smeets, NW; Mosterd, K; Nelemans, P; Spoorenberg, E	1
Aspord, C; Charles, J; Leccia, MT; Leloup, C; Molens, JP; Plumas, J; Tramcourt, L	1
Apalla, Z; Chovarda, E; Ioannides, D; Lallas, A; Sotiriou, E; Vrani, F	1
Bassukas, ID; Gaitanis, G; Kempf, W; Markatseli, TE; Voulgari, PV	1
Kerl, H; Kopera, D	1
Martín-Gorgojo, A; Pastushenko, I	1
Arits, AH; Kelleners-Smeets, NW; Mosterd, K; Nelemans, PJ; Roozeboom, MH; Steijlen, PM	1
Evangelia Iavazzo, P; Gkegkes, ID; Iavazzo, C; Karachalios, C; Ntziora, F	1
Brian Jiang, SI; Hamman, MS	1
Chong, WS; Lim, JH; Lim, KS	1
Hanlon, A; Lazova, R; Narayan, D; Sue, GR	1
Costa, C; Mascolo, M; Palmisano, F; Russo, D; Scalvenzi, M	1
D'Errico, A; De Giorgi, V; Gori, A; Grazzini, M; Massi, D; Papi, F; Savarese, I; Vannucchi, M	1
Bonilla, R; Jones, CA; Khandwala, MA; Solebo, AL	1
Bahali, AG; Biyik Ozkaya, D; Demirkesen, C; Dizman, D; Onsun, N; Su, O; Tosuner, Z	1
Amano, H; Ishikawa, O; Kato, M; Kishi, C; Shimizu, A	1
Sligh, JE	1
Gao, X; Geng, L; Shi, J; Wang, H; Xu, Y	1
Cegielska, A; Fiedor, P; Imko-Walczuk, B; Kaszewski, S; Placek, W	1
Bontumasi, NM; Hurst, EA; Sheinbein, D	1
Khaiboullina, SF; Lombardi, VC; Rizvanov, AA	1
Apalla, Z; Chan, AW; Kyrgidis, A; Mocellin, S; Pilati, P; Tzellos, T	1
Macknet, C; Macknet, KD; Nino, T; Panther, D	1
González-González, JG; González-Saldivar, G; Rodarte-Shade, M; Rodríguez-Gutiérrez, R	1
Philipp-Dormston, WG	1
Ariyan, S; Choi, JN; Geiger, EJ; Narayan, D; Pandit, AS	1
Hu, L; Huang, HZ; Li, W; Li, X; Lin, XX	1
Knackstedt, TJ; Quitadamo, M	1
Oranges, CM; Sisti, A; Sisti, G	1
Chen, YJ; Chen, YY; Huang, SW; Kao, JK; Liang, SM; Shieh, JJ; Wang, ST; Wu, CY	1
Chen, FW; Egbert, BM; Kim, DD; Swetter, SM	1
Gaastra, MT; Hollestein, LM; Holterhues, C; Kuijpers, DI; Nijsten, TE; Schuttelaar, ML; van Hattem, S; Waalboer-Spuij, R	1
Arits, AH; Kelleners-Smeets, NW; Mosterd, K; Nelemans, PJ; Roozeboom, MH; van Kleef, L; van Marion, AM; Winnepenninckx, VJ	1
Cohen, JL; Friedman, A; Ruiz, ES	1
Karia, PS; Mora, AN; Nguyen, BM	1
Galan, A; Higgins, HW; Lee, KC; Leffell, DJ	1
Burrall, BA; Christensen, SD; Fitzmaurice, SD; Fung, MA; Garcia, MS; Joo, J; King, B; Konia, T; Leventhal, J; Martinez, S; Maverakis, E; Monjazeb, AM; Patel, F; Shi, VY; Tran, K; Wilken, R	1
Ishiuji, Y; Nakagawa, H; Nobeyama, Y	1
Egekvist, H; Erlendsson, AM; Haedersdal, M; Lorentzen, HF; Philipsen, PA; Stausbøl-Grøn, B; Stender, IM	1
Baraldi, C; Dika, E; Fanti, PA; Patrizi, A; Venturi, M	1
Bruinsmann, FA; Buffon, A; Contri, RV; D'Amore, CM; Fonseca, FN; Frank, LA; Guterres, SS; Pohlmann, AR; Raffin, RP; Venturini, CG	1
Papakostas, D; Stockfleth, E	1
Ahmad, K; Alani, A; Ramsay, B	1
Alaibac, M; Frigo, AC; Michelotto, A; Piaserico, S	1
Bassukas, ID; Gaitanis, G; Kalogeropoulos, CD	1
Barlow, R; Coleman, A; Craythorne, EE; Kai, AC; Mallipeddi, R; Richards, T	1
Baumgartner, M; Gadaldi, K; Gautschi, M; Hunger, RE; Oberholzer, PA; Yawalkar, N	1
de Vries, K; Greveling, K; Prens, EP; van Doorn, MB	1
Baradad, M; Martí, R; Nagore, E; Ortiz-Brugués, A; Requena, C; Rivas-Tolosa, N; Sanmartín, V; Soriano, V; Toledo-Pastrana, T; Traves, V	1
Bay, C; Haedersdal, M; Lerche, CM; Togsverd-Bo, K	1
Chang, SH; Chen, YJ; Huang, JL; Huang, SW; Jiang, HY; Kao, JK; Mu, SW; Shieh, JJ; Wang, ST; Wu, CY	1
Mohd Amin, MC; Rehman, K; Yuen, NP; Zulfakar, MH	1
Caglia, M; Hashemi, P; Kim, C; Shulman, K	1
Das, G; Nicholls, K; Tan, B	1
Federman, DG; Wiznia, LE	1
Aukrust, P; Kolberg, ES; Nordal, K; Norum, HM; Solhaug, V	1
Chang, SE; Lee, MW; Lee, YJ; Rhee, do Y; Won, CH; Won, KH	1
Bartha, Á; Dirschka, T; Schmitz, L	1
Arits, AHMM; de Rooij, MJM; Essers, BAB; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF; Roozeboom, MH; Sommer, A; Steijlen, PM	1
Bagaria, S; Cappel, M; Gilstrap, C; Jambusaria-Pahlajani, A; Joseph, RW; Swaika, A; Tzou, K	1
Araki, Y; Arima, M; Iwata, Y; Kobayashi, T; Matsunaga, K; Numata, S; Okamura, K; Sugiura, K; Suzuki, T; Yagami, A	1
Alfano, R; Argenziano, G; Kyrgidis, A; Lallas, A; Longo, C; Moscarella, E; Reggiani, C; Urech, M; Zalaudek, I	1
Arnold, P; Gogoll, K; Langguth, P; Lee, KD; Peters, T; Radsak, M; Schild, H; Stein, P	1
Martínez-Leborans, L; Ortiz-Salvador, JM; Pérez-Ferriols, A; Victoria-Martínez, AM	1
Abadi, R; Abbas, O; Hanna, E	1
Gilaberte, Y; González, S; Gracia-Cazaña, T	1
Fujita, M; Mitsuishi, T; Nishimura, M	1
Chianese-Bullock, KA; Clark, RA; Deacon, DH; Galeassi, N; Marincola, FM; Mauldin, IS; Mullins, DW; Olson, WC; Petroni, GR; Slingluff, CL; Smith, KT; Smolkin, ME; Stowman, AM; Teague, JE; Wages, NA; Wang, E	1
Fukuda, T; Okazaki, A; Shiohara, T; Yamazaki, Y	1
Rehman, K; Zulfakar, MH	1
Billingham, LJ; Boota, NM; Cook, M; Fox, R; Marsden, JR; Steven, NM; Wheatley, K	1
Al Saïf, F; Carmi, E; Dillies, AS; Fraitag-Spinner, S; Gras-Champel, V	1
Cousins, VC; Gamboni, SE; Nixon, RL; Rodrigues, M	1
Armstrong, SJ; Bath-Hextall, F; Colver, GB; Miller, PSJ; Ozolins, M; Perkins, W; Williams, HC	1
Darby, JM; Lyons, AB; Patchett, AL; Tovar, C; Woods, GM	1
Hoekzema, R; Jansma, EP; Prinsen, CAC; Tio, D; van der Woude, J; van Montfrans, C	1
Grady, BE; Spencer, JM	1
Allison, KH; Childs, JS; Coveler, AL; Dang, Y; Disis, ML; Higgins, DM; Lu, H; Reichow, JL; Salazar, LG; Waisman, J	1
Affleck, A; Hawkey, S	1
Gioia Di Chiacchio, N; Haneke, E; le Voci, F; Ocampo-Garza, J; Paschoal, FM	1
Brodland, DG; Murphy, ME; Zitelli, JA	1
Allam, JP; Bieber, T; Novak, N; Yu, CF	1
Affleck, AG; Evans, A; Ezughah, FI; Fleming, CJ; Ibbotson, SH	1
Lear, JT; Madan, V; Murphy, JV; West, CA	1
Belonwu, N; Bodman-Smith, MD; Dalgleish, AG; Fischer, MD; Green, DS	1
Campione, E; Chimenti, S; Diluvio, L; Orlandi, A; Paternò, EJ	1
Jacobs, AA; Markus, J; Rosen, T; Snavely, N	1
Braathen, LR; Buettiker, UV; Hunger, RE; Yawalkar, NY	1
Chimenti, S; Saraceno, R; Teoli, M	1
Calvieri, S; Curzio, M; Devirgiliis, V; Gobbi, S; Panasiti, V; Roberti, V; Rossi, M	1
Aguilar Bernier, M; Blázquez Sánchez, N; de Troya-Martín, M; Fernández-Canedo, NI; Frieyro-Elicegui, M; Fúnez Liébana, R	1
Joseph, MG; Mahoney, MH; Temple, C	1
Campione, E; Chimenti, S; Diluvio, L; Orlandi, A; Paternò, EJ; Terrinoni, A	1
Carroll, S; Czarnecki, C; Czarnecki, D	1
Balkrishnan, R; Feldman, SR; Karve, SJ; Pearce, DJ; Yentzer, BA	1
Lacarrubba, F; Micali, G; Nardone, B; Nasca, MR	1
French, LE; Hofbauer, GF; Koch, S; Läuchli, S; Pini, AM; Schärer, L	1
Cintra, ML; de Souza, EM; Metze, K; Rybka, MO	1
Arechavala, RS; García-Río, I; González, LC; González-Pérez, R; Michelena, IA; Murua, AA; Santarén, BC; Urra, IT	1
Baer, KE; Bergman, PJ; Craft, D; Gill, VL; Leung, C	1
Baskan, EB; Saricaoglu, H; Toker, SC; Tunali, S; Turan, A	1
Krekels, GA; Ostertag, JU; van der Geer, S	1
Krajka, K; Matuszewski, M; Michajłowski, I; Michajłowski, J; Sokołowska-Wojdyło, M; Włodarczyk, A	1
Ramsdell, AM; Zeitouni, N	1
Barlow, RJ; Powell, AM; Robson, AM; Russell-Jones, R	1
Harth, W; Heber, G; Helbig, D; Pönitzsch, I; Simon, JC; Wetzig, T	1
Carli, P; Chiarugi, A; De Giorgi, V; Maio, V; Massi, D; Nicoletti, P; Paglierani, M; Salvini, C; Santucci, M	1
Eickenscheidt, L; Kowalzick, L	1
Walling, HW	1
Fosko, SW; Missall, TA	1
Bolat, FA; Caliskan, K; Colakoglu, T; Ezer, A; Moray, G; Parlakgumus, A; Yildirim, S	1
Uhara, H	1
Stockfleth, E	1
Ulrich, C	1
Bauza, A; Del Pozo, LJ; Martin, A; Saus, C	1
McCall, MW; Woodmansee, CS	1
Schlosser, KA	1
Daudén Tello, E; Goiriz Valdés, R; Santiago Sánchez-Mateos, D	1
Hussain, W; Judge, MR	1
Calarese, AW; Clark, RA; Hijnen, D; Huang, SJ; Kupper, TS; Miller, DM; Mollet, IG; Murphy, GF; Schanbacher, CF; Schmults, CD	1
A Gaspari, A; Rosen, T; Tyring, SK	1
Coldiron, BM; Rogers, HW	1
Alexopoulos, EC; Bassukas, ID; Gaitanis, G; Nomikos, K; Vava, E	1
Fitzpatrick, JE; Gaspari, AA; Goldenberg, G; Gowda, S; Tillman, DK	1
Dengel, LT; Grosh, WW; Harris, RC; Patterson, JW; Slingluff, CL; Turza, K; White, K	1
Burkhardt-Pérez, P; Ruiz-Villaverde, R; Sánchez-Cano, D	1
Godbolt, A; Sriprakash, K	1
Rosen, T	2
Jacobs, AA; McClung, A; Modi, G; Orengo, IF; Rosen, T	1
Benito, DM; Casado, M; Feito, M; Feltes, R; Floristán, U; Herranz, P; Ramírez, P; Sendagorta, E	1
Alessi, SS; Festa Neto, C; Messina, MC; Oliveira, WR; Pimentel, ER; Sanches, JA	1
Bonnet, PA; Bressolle, FM; Cooper, JF; Deleuze-Masquéfa, C; Gattacceca, F; Khier, S; Margout, D; Moarbess, G; Pinguet, F; Solassol, I	1
Bernhard, JD; Bordeaux, JS; Love, WE	1
Busam, K; Marghoob, AA; Nadiminti, H; Nehal, KS; Scope, A	1
Bartoli, L; Brunetti, L; Cecchi, R; Pavesi, M; Rapicano, V	1
Cheikhrouhou, H; Claeys, A; Pouaha, J; Truchetet, F	1
Echeverría-García, B; Guillén, C; Sanmartín, O	1
Bessinger, G; Cable, B; Dann, M; Senchak, AJ	1
Baek, GH; Cho, JH; Chung, MS; Gong, HS; Roh, YH	1
Firoz, BF; Goldberg, LH	1
Collins, C; Harrad, RA; Kennedy, CT; Ross, AH	1
Breuninger, H; Häfner, HM; Moehrle, M; Schippert, W	1
Dinotta, F; Lacarrubba, F; Massimino, D; Micali, G; Nasca, MR	1
Armstrong, SJ; Bath-Hextall, FJ; Ozolins, M; Williams, HC	1
Chang, CC; Chen, YJ; Huang, SW; Liu, CM; Liu, KT; Lu, WC; Shieh, JJ; Tsai, JJ; Wang, YT; Wu, CY	1
Kemény, L; Nagy, N	1
Aguilar, M; Benítez, N; de Troya, M; González, M; Martin, L	1
Cordoro, KM; Greer, KE; Lonergan, CL; McNamara, EK	1
Bos, JD; Filippov, DV; Konijnenberg, D; Luiten, RM; Meeuwenoord, NJ; Melief, CJ; Picavet, DI; Tjin, EP; van den Boorn, JG; van der Veen, JP	1
Muhn, C; Rosen, N; Shoimer, I	1
Adam, F; Fenske, NA; Spencer, J	1
Erickson, C; Miller, SJ	1
Taeron, C	1
Alaibac, M; Bernardini, B; Calabró, L; Faggion, D; Oro, E	1
Bianciotto, CG; Demirci, H; Shields, CL; Shields, JA	1
De'Ambrosis, B; Gebauer, K; Meng, TC; Quirk, C; Slade, HB	1
Ayers, D; Kenealy, J; O'Neill, J	1
Bilaç, C; Bilaç, DB; Ermertcan, AT; Kocabaş, E; Temiz, P	1
Alfaro, J; Fernandez, J; Garcia-Martin, E; Gil, LM; Idoipe, M; Pablo, LE; Pueyo, V; Zubiri, ML	1
Braga, JC; Busam, K; Dusza, SW; Gill, M; Halpern, AC; Marghoob, AA; Scope, A; Terushkin, V	1
Cannon, PS; Huilgol, SC; O'Donnell, B; Selva, D	1
Bopp, T; Fuhr, T; Langguth, P; Probst, HC; Prüfer, S; Radsak, MP; Rechtsteiner, G; Schild, H; Stassen, M; Stein, P; Warger, T	1
Alexis, I; Bassukas, ID; Gaitanis, G; Mitsou, G; Tsiouri, G	1
Edmonds, J; Marr, PJ; Martin, LK; Murrell, DF; Pas, HH; Rubin, AI; Sebaratnam, DF; Tran, K	1
Bordeaux, JS; Capaldi, L; Maloney, ME; Martires, KJ; Pattee, SF	1
Prokosch, V; Spaniol, K; Stupp, T; Thanos, S	1
Bruckner-Tuderman, L; Burger, B; Has, C; Itin, P; Kohlhase, J; Volz, A	1
Bassukas, ID; Gaitanis, G; Nomikos, K; Vlachos, C	1
Doherty, SD; Rosen, T; Shah, AY	1
Aguayo-Leiva, IR; Jaén-Olasolo, P; Ríos-Buceta, L	1
Becker, M; Fasel, JH; Kaya, G; Kostaki, M; Pham, XC; Piguet, V; Salomon, D; Stimec, BV; Toutous-Trellu, L	1
Fosko, SW; Hurley, MY; Missall, TA	1
LeLeux, TM; Orengo, I; Rosen, T; Venkatarajan, S; Yang, D	1
Jia, J; Zhao, YF	1
Parlette, EC; Toren, KL	1
Bonnekoh, B; Fehsecke, D; Franke, I; Froster, UG; Gollnick, HP; Helmdach, M; Kraus, C; Quist, SR; Reis, A	1
Griffin, TD; Jan, MM; Laskas, JW	1
Gaspari, AA; Grossberg, AL	1
Delaney, T; Foxton, G	1
Daudén, E	1
Aires, D; Dusing, R; Meggison, A; Miller, AK	1
Kouba, DJ; LoPiccolo, MC; Sage, RJ	1
Frankel, A; Goldenberg, G	1
Akarsu, S; Aktan, S; Atahan, A; Koç, P; Özkan, S	1
Chen, SL; Fung, MA; Garcia, MS; Goodarzi, H; Martinez, SR; Maverakis, E; Miyamura, Y; Ono, Y; Phan, T; Wehrli, LN	1
Chan, MP; Zimarowski, MJ	1
Apalla, Z; Ioannides, D; Lallas, A; Sotiriou, E	1
Botella-Estrada, R; Nagore, E	1
Anolik, R; Brightman, L; Geronemus, R; Warycha, M	1
Barysch, MJ; Dummer, R; Kamarashev, J; Lockwood, LL	1
Akkilic-Materna, M; Komericki, P; Massone, C	1
Borden, E; Triozzi, PL; Tuthill, RJ	1
Aguayo, R; Baradad, M; Casanova, JM; Sanmartín, V	1
Choudhary, S; Giannakakis, G; McLeod, M; Nouri, K	1
Caminal, JM; Fabra, A; Ferreres, JR; Marcoval, J; Penín, RM; Piulats, JM	1
Burkemper, NM; Fosko, SW; Green, JS	1
Alaibac, M; Salmaso, R; Tonin, E; Zattra, E	1
Desmedt, E; Florin, V; Mortier, L; Vercambre-Darras, S	1
Echeverria, B; Guillen, C; Llombart, B; Messeguer, F; Nagore, E; Requena, C; Sanmartin, O; Serra-Guillen, C	1
Fishelevich, R; Gaspari, AA; Lee, J; Liu, H; Meng, TC; Nakazono, A; Tammaro, A; Tuchinda, P; Zhao, Y	1
Coyner, K; Loeffler, D	1
Gurgone, S; Lacarrubba, F; Micali, G; Potenza, MC	1
Izumi, AK; Jim On, SC	1
Bentow, JJ; Bruhn, KW; Chang, PL; Comin-Anduix, B; Craft, N; Dauphine, C; Economou, JS; Greger, S; Haskell, J; Konishi, T; Lee, DK; Moy, L; Narayan, R; Nguyen, H; Ribas, A; Tsui, S; Vanchinathan, V; Vargas, HI	1
Barbosa, VH; Beutner, KR; Bhushan, R; Bichakjian, CK; Chuang, TY; Duvic, M; Foote Hood, A; Grichnik, JM; Halpern, AC; Ho, VC; Johnson, TM; Smith Begolka, W; Sober, AJ; Swetter, SM; Tsao, H	1
Cerio, R; Gibbon, K; Harwood, CA; Matin, RN; Rizvi, H	1
Badiglian-Filho, L; Baiocchi, G; Begnami, MD; Costa, FD; Faloppa, CC; Fukazawa, EM; Kumagai, LY; Oliveira, RA; Soares, FA; Surima, WS	1
Agro, J; Guiote, V; Henrique, M; Mascarenhas, R	1
García-Almagro, D; Lapresta, A; Sejas, AG	1
Byrne, M; Chamberlain, A; Curr, N; Dowling, JP; Haskett, M; Kelly, JW; Ly, L; O'Keefe, R; Sutton, T; Swain, S; Wolfe, R	1
Chu, J; Hartman, R; Meehan, S; Patel, R; Stein, JA	1
Chen, CL; Desai, A; Desai, T; Kirby, W	1
Arits, AH; Kelleners-Smeets, NW; Mosterd, K; Nelemans, PJ	1
El Tal, AK; MacFarlane, DF	1
Humphreys, TR; Rubenzik, MK; Schwartz, LR	1
Marghoob, AA; Tang, JY	1
Fotiadou, C; Giannopoulou, C; Ioannides, D; Lazaridou, E	1
Jadotte, YT; Schwartz, RA	1
Kaushal, S; Kopparthy, P; Merideth, M; Pulanic, TK; Stratton, P	1
Chen, D; Chen, H; Chen, XD; Hu, XJ; Jiang, CH; Jin, YB; Li, W; Lin, XX; Ma, G; Ye, XX	1
Dummer, R; French, LE; Hofbauer, GF; Kempf, W; Prinz Vavricka, BM	1
Chang, CC; Chen, YJ; Huang, SW; Lin, CC; Liu, KT; Shieh, JJ; Tsai, JJ; Wu, CY	1
Cohen, JL; Ellis, LZ; High, W; Stewart, L	1
Brand, E; Krekels, GA; Martens, J; Neumann, HA; Ostertag, JU; van der Geer, S; van Roij, J; Verhaegh, ME	1
Attili, SK; Fleming, C; Ibbotson, SH	1
Digiovanni, J; Kamijima, R; Nakajima, K; Sano, S; Takaishi, M; Yokogawa, M	1
Bowen, GM; Goldgar, D; Hadley, ML; Hyde, MA; Tristani-Firouzi, P	1
Guillén, C; Llombart, B; Messeguer, F; Requena, C; Serra-Guillén, C	1
Cooper, A; Hong, E	1
Guillén, C; Hilari, H; Llombart, B; Llorca, D; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillén, C; Traves, V; Villanueva, A	1
He, Q; Introcaso, CE; Kovarik, CL; Rady, PL; Tyring, SK	1
Arits, AH; Kelleners-Smeets, NW; Nelemans, PJ; Roozeboom, MH	1
Ghafouri-Fard, S	1
Jwa, SW; Kim, BS; Kim, HS; Kim, MB; Ko, HC; Mun, JH; Park, JM; Song, M	1
Adams, S; Axelrod, D; Bhardwaj, N; Chiriboga, L; Demaria, S; Formenti, SC; Goldberg, JD; Hochman, T; Kozhaya, L; Liebes, L; Martiniuk, F; Meng, TC; Novik, Y; Shuman, N; Speyer, J; Tiersten, A; Unutmaz, D	1
Arbiser, JL; Bips, M; Bonner, MY; Kovach, C; Seidler, A	1
Burnett, CT; Kouba, DJ	1
Liu, LF; Mao, XH; Wang, JY	1
Bachmann, MF; Baumgaertner, P; Dummer, R; Geldhof, C; Goldinger, SM; Hammann-Haenni, A; Kündig, TM; Michielin, O; Mihic-Probst, D; Prior, JO; Schwarz, K; Speiser, DE; Willers, J	1
Sullivan, TJ	1
Mao, XH; Wang, JY; Yan, JL	1
Firnhaber, JM	1
Boccaletti, V; Casanova, D; Di Nuzzo, S; Martignoni, G	1
Brodell, RT; Tandon, Y	1
Bath-Hextall, F; Ozolins, M; Tinelli, M; Williams, HC	1
Benmously-Mlika, R; Debbiche, A; Hammami-Ghorbel, H; Koubaa, W; Mokhtar, I	1
Adams, S; Babb, JS; Demaria, S; Dewan, MZ; DiNapoli, S; Formenti, SC; Kawashima, N; Vanpouille-Box, C	1
Mengjun, B; Tasleem, MM; Zheng-Qiang, W	1
Kohrt, H	1
de Vries, K; Habets, JM; Prens, EP; Rellum, R	1
Maatouk, I; Moutran, R; Stephan, F; Tomb, R	1
Apalla, Z; Karteridou, A; Lallas, A; Lefaki, I; Sotiriou, E; Tzellos, T; Varytimiadis, D	1
Urbina, F	1
Cleaver, L; Knabel, P	1
Moon, SD; Spencer, JM	1
Andres, K; Geisse, JK; Ginkel, A; Gross, K; Owens, M; Pandya, A; Rich, P	1
Pföhler, C; Reinhold, U; Tilgen, W; Ugurel, S; Wagner, A	1
Bong, AB; Bonnekoh, B; Franke, I; Gollnick, H; Schön, M; Ulrich, J	1
Junkins-Hopkins, JM; Rook, AH; Suchin, KR	1
Amies, M; Andres, K; Golitz, L; Greenway, H; Kossard, S; Owens, M; Robinson, J; Schroeter, A; Shumack, S	1
Caltabiano, R; De Pasquale, R; Impallomeni, R; Lacarrubba, F; Micali, G	1
Rudy, SJ	1
Flowers, FP; Hassenein, AM; Roth, WI; Zampogna, JC	1
Cowen, E; Gaspari, AA; Mercurio, MG	1
Lloret, P; Redondo, P	1
Andres, K; Bichel, J; Ding, L; Herrera, E; Ruzicka, T; Sterry, W; Takwale, A; Thissen, MR	1
Conant, M; Marini, M; Tyring, S; Van Der Meijden, W; Washenik, K	1
Stanley, MA	1
Hruza, G	1
Altmeyer, P; Oster-Schmidt, C; Stücker, M	1
Fox, CA; Goldgeier, M; Gonzalez, S; Harris, D; Zavislan, JM	1
Koenig, C; Walker, JK	1
Binder, B; Cerroni, L; Kerl, H; Richtig, E; Smolle, J; Wolf, IH	1
Laffitte, E; Saurat, JH	1
Awada, A; Heenen, M; Laporte, M; Mathieu, A; Petein, M; Velu, T; Vereecken, P	1
Holt, PJ; Loo, WJ	1
Garland, SM	1
Siller, G; Whitehead, K; Wu, JK	1
Caglar, S; Crespo, J; Saini, R; Tutrone, WD; Weinberg, JM	1
Piérard, GE; Piérard-Franchimont, C; Quatresooz, P; Uhoda, I	1
Hermanns-Lê, T; Nikkels, AF; Paquet, P; Piérard, GE; Piérard-Franchimont, C	1
Hamza, S; Skelton, H; Smith, KJ	2
Burg, G; Dummer, R; Kazakov, D; Kempf, W; Urosevic, M	1
Hafner, J; Heinzerling, LM; Kamarashev, J; Kempf, W; Nestle, FO	1
Godfrey, JC; Vaughan, MC; Williams, JV	1
Eklind, J; Hengge, UR; Lidbrink, P; Maschke, J; Tartler, U	1
Brennick, JB; Chapman, MS; Spencer, SK	1
Epstein, E	1
Fisher, GH; Lang, PG	1
Goldberg, LH; Peterson, SR	1
Hengge, UR; Meykadeh, N	1
Gaspari, AA; Sauder, DN	1
Schmook, T; Stockfleth, E	1
Beyeler, M; Burg, G; Dummer, R; Morcinek, J	1
Benninghoff, B; Burg, G; Dummer, R; Maier, T; Slade, H; Urosevic, M	1
Hurwitz, DJ; Kupper, TS; Pincus, L	1
Borucki, U; Metze, D	1
Del Rosso, JQ	2
Chosidow, O; Dummer, R	1
Rigel, D; Shumack, S	1
Meyer, T; Nindl, I; Schmook, T; Sterry, W; Stockfleth, E; Ulrich, C	1
Arlette, JP	1
Garcia-Bartels, C; Schmook, T; Sterry, W; Stockfleth, E; Trefzer, U; Wegner, T	1
Burg, G; Dummer, R; Hafner, J; Hoek, K; Kempf, W; Urosevic, M	1
Berman, B; De Araujo, T; Nadji, M; Sullivan, T	1
Botella-Estrada, R; Guillen, C; Nagore, E; Requena, C; Sanchez-Pedreño, P; Sanmartin, O; Serra-Guillen, C; Sevila, A	1
Chen, K; Shumack, S	1
De Pasquale, R; Lacarrubba, F; Micali, G; Nasca, MR	1
Bianchi, L; Campione, E; Chimenti, S; Costanzo, A; Nisticò, S	1
Piérard, GE; Quatresooz, P	1
Roseeuw, D	1
Berman, B; Elgart, G; Poochareon, V; Spencer, J; Villa, A	1
Reifenberger, J; Schön, MP	1
Beyeler, M; Dummer, R	1
Alam, M; Goldberg, LH; Silapunt, S	1
Anderson, ER; Hernandez, C; Nickoloff, B; Robinson, JK	1
Ingves, C; Jemec, GB	1
Oster-Schmidt, C	2
Nouri, K; O'Connell, C; Rivas, MP	1
Barlow, RJ; Powell, AM; Russell-Jones, R	1
Berman, B; Dearaujo, T; Sullivan, TP; Vincek, V	1
Kerl, H; Kopera, D; Richtig, E; Wolf, IH	1
Arlette, JP; Trotter, MJ	1
Siller, G; Strutton, G; Wu, JK	1
Beiteke, U; Grabbe, S; Loquai, C; Luger, TA; Metze, D; Nashan, D; Rüping, KW	1
Amonette, RA; Haque, R; Huber, A; Huber, JD; Kuwahara, RT; Skinner, RB	1
Hengge, UR; Schaller, J	2
Caro, I; Geisse, J; Golitz, L; Lindholm, J; Owens, M; Stampone, P	1
Powell, AM; Russell-Jones, R	1
Bignon, YJ; Chèvenet, C; Corbin-Duval, A; D'Incan, M; Déchelotte, P; Franck, F; Hesling, C; Madelmont, JC; Mansard, S; Souteyrand, P; Veyre, A	1
Alomar, A; Vidal, D	1
Bong, AB; Drewniok, C; Eberle, J; Geilen, CC; Gollnick, H; Schön, M; Schön, MP; Wienrich, BG	1
Leverkus, M	1
Cruces, M; de la Torre, C; Feal, C; Flórez, A	1
Banney, L; Chong, A; Grant, JW; Loo, WJ; Norris, PG	1
Heenen, M; Monsieur, E; Petein, M; Vereecken, P	1
Ciambellotti, A; Muzio, G; Rebora, A	1
Amerio, P; Benucci, R; Canzona, F; Cavalieri, R; Didona, B; Rienzo, O	1
Schön, M; Schön, MP	2
Ladd, DJ; Lin, R; Powell, DJ; Way, BV	1
Bryden, AM; Dawe, RS; Evans, A; Fleming, CJ; Ibbotson, SH	1
Barton, JC	1
Alomar, A; Matías-Guiu, X; Vidal, D	3
Huntley, A; Navi, D	1
Astner, S; Curiel-Lewandrowski, C; Frankenthaler, RA; González, S; Swindells, KJ; Tahan, SR; Williams, CM	1
Carre, JL; Guillet, G; Kupfer-Bessaguet, I; Leroy, JP; Misery, L; Sassolas, B	1
Berman, B; Gómez, M; Olazarán, Z; Salas, J; Welsh, O	1
Braathen, LR; Brönnimann, M; Kappeler, A; Michalopoulos, P; Yawalkar, N	1
Marks, R; Owens, M; Walters, SA	1
Gebauer, K; Macdonald, K; Owens, M; Quirk, C; Shumack, S; Walters, SA	1
Barnetson, RS; Halliday, GM; Satchell, A; Slade, HB; Zhuang, L	1
Fein, H; McGillis, ST	1
Cavalcanti, SM; Nunes, Mde G; Oliveira, Ldo H; Ramos-e-Silva, M; Trope, BM	1
Arenberger, P; Benninghoff, B; Hengge, UR; Lysa, B; Ruzicka, T; Tartler, U; Walz, M; Wolf, R	1
Berkes, B; González, S; Marra, D; Morgan, B; Niemeyer, A; Owens, M; Schanbacher, C; Torres, A	1
Martín-García, RF; Muñoz, CM; Sánchez, JL	1
Brown, MD; Burns, CA	1
Lambert, J; Lapière, K; Nijsten, T	1
Zitelli, JA	1
Skinner, R	1
Dummer, R; Urosevic, M	1
Benninghoff, B; Jablonska, S; Majewski, S; Marczak, M; Mlynarczyk, B	1
Aeling, JL; Chapman, JT; Deeths, MJ; Dellavalle, RP; Zeng, C	1
Bauer, J; Eigentler, TK; Garbe, C; Kamin, A; Radny, P; Weide, B	1
Cheney, RT; Dawson, K; Zeitouni, NC	1
Bieber, T; Haller, O; Tueting, T; Uerlich, M; Wenzel, J	1
Armario-Hita, J; Fernández-Vozmediano, J	1
Korting, H; Prinz, J; Weisenseel, P	1
Korman, N; Lee, JH; Ling, M; Matheson, R; McKane, S; Moy, R; Smith, S	1
Cerroni, L; Kerl, H; Kodama, K; Wolf, IH	2
Campione, E; Chimenti, S; Fargnoli, MC; Marulli, GC; Micantonio, T; Peris, K	1
Martín-García, RF	1
Delli, F; Dionyssopoulos, A; Koussidou-Eremondi, T; Mandekou-Lefaki, I; Mourellou-Tsatsou, O	1
Morton, CA	1
Grant-Kels, JM; Grin, CM; Kluk, M; Ray, CM	1
Cribier, B; Ferrándiz, C; Garcia Diez, A; McRae, S; Reifenberger, J; Requena, L; Schulze, HJ; Tebbs, V	1
Nikkels, AF; Paquet, P; Piérard, GE; Piérard-Franchimont, C; Quatresooz, P	1
Keating, GM; Oldfield, V; Perry, CM	1
Grossman, L; Mena, J; Miller, RL; Shi, Y; Sorrenti, V; Spaner, DE	1
Marty, CL; Randle, HW; Walsh, JS	1
Keller, CD	1
Jang, HS; Jo, JH; Kim, MB; Ko, HC; Kwon, KS; Oh, CK	1
Anderson, HK; Brannan, PA; Kersten, RC; Kulwin, DR	1
Beyeler, M; Burg, G; Conrad, C; Dummer, R; Gilliet, M; Laine, E; Urosevic, M	1
Atkins, CL; Brown, VL; Cerio, R; Ghali, L; Harwood, CA; Proby, CM	1
Hengge, UR; Roth, S; Tannapfel, A	1
Higgins, SP; Poluri, RM	1
Dirschka, T; Oster-Schmidt, C	1
Hauschild, A	1
Germolic, D; Hamann, MS; Kotwall, C; McCutcheon, B; Rebolloso, Y; Stiles, A; White, K	1
Lorentzen, HF; Weismann, K	1
Bourguignon, R; Paquet, P; Piérard, GE; Quatresooz, P	1
Bohmeyer, J; Gellrich, S; Kremer, A; Luger, T; Muche, M; Nashan, D; Stadler, R; Sterry, W	1
Altmeyer, P; Markus, S; Oster-Schmidt, C	1
Kunzle, N; Noel, B	1
de Diego Rodríguez, E; Gómez Ortega, JM; Hernández Castrillo, A; Villanueva Peña, A	1
Langtry, JA; Rajan, N	1
Haustein, UF; Paasch, U	1
Micali, M; Musumeci, ML; Nasca, MR	1
Khachemoune, A	1
Spencer, JM	1
Egberts, F; Hauschild, A; Jensen, JM; Proksch, E	1
Oh, C; Siller, G; Strutton, G; Wu, JK	1
Berman, B; Frankel, S; Nouri, K; Poochareon, V; Ramirez, CC; Villa, AM	1
Markus, J; Orengo, I; Pielop, JA; Rivera, A	1
Kim, JW; Kim, YJ; Koh, BK	1
Ogawa, H; Palungwachira, P	1
Alfaro-Rubio, A; Botella, R; Guillén, C; Hueso, L; Llombart, B; Nagore, E; Requena, C; Sanmartín, O; Serra, C	1
Botella-Estrada, R; Guillén, C; Nagore, E; Sanmartín, O	1
Martín, T; Martínez, S; Ojeda, A; Vera, A	1
Casado, M; González-Beato, M; Mayor, M; Miralles, L; Pizarro, A; Sigüenza, M; Vidaurrázaga, C	1
Dissemond, J; Grabbe, S	2
Wilson, LD	1
Derry, S; Hadley, G; Moore, RA	1
Scott, DR	1
Fargnoli, MC; Micantonio, T; Peris, K	1
Boonchai, W	1
Hollenbach, E; Huynh, NT; Tsang, HH	1
Baughman, RD; Chapman, MS; Kornik, RI; Schalock, PC	1
Cohen, PR; Hetherington, GW; Nelson, BR; Schulze, KE; Tschen, JA	1
Badgwell, C; Rosen, T	1
Konstantopoulou, M; Lord, MG; Macfarlane, AW	1
Berman, B; Bienstock, L; Kuritzky, L; Mayeaux, EJ; Tyring, SK	1
Coscojuela-Santaliestra, C; Gilaberte-Calzada, Y; Martínez-Morales, J; Osán-Tello, M; Soler-Machín, J; Vera-Alvarez, J	1
Ceilley, RI; Del Rosso, JQ	1
Krekels, GA; Kuijpers, DI; Thissen, MR	1
Chawla, M; Finlay, AY; Goodwin, R; Laidler, P; Motley, RJ; Patel, GK; Price, PE	1
Cartwright, N; Coyle, A; Fitzgerald, KA; Mitchell, JA; Silverman, N	1
Bogeschdorfer, F; Gronau, S; Riechelmann, H	1
Crespo, V; del Boz, J; Martínez, S; Sanz, A; Vera, A	1
Berman, B; Perez, OA; Zell, D	1
Hackethal, M; Stockfleth, E; Ulrich, C	1
Diaz, SF; Gilbert, S; Jessen, C; Malone, ED; Nogueira, SA; Torres, SM	1
Dirschka, T; Krahl, D; Oster-Schmidt, C	1
Chimenti, S; Fargnoli, MC; Lozzi, GP; Micantonio, T; Peris, K	1
Ammoury, A; Bazex, J; El Sayed, F; Lamant, L; Messer, L; Mirer, E	1
Adim, SB; Baskan, EB; Toker, S; Tunali, S; Turan, A	1
Siller, G; Vun, Y	1
Goh, MS	1
Carrington, PR; D'Addario, S	1
Busch, JO; Meyer, T; Nindl, I; Schmook, T; Sterry, W; Stockfleth, E; Ulrich, C	1
Figl, R; Goerdt, S; Hildenbrand, R; Kettelhack, C; Schadendorf, D; Thoelke, A; Ugurel, S; Utikal, J; Zimpfer, A	1
Ferreres, JR; Jucglà, A; Macaya, A; Muniesa, C; Peyrí, J; Prats, C	1
Liu, YH; Xu, KJ	1
Stashower, ME	1
Marsden, JR; Rajpar, SF	1
Pillow, J; Skinner, RB; Woodmansee, C	1
Takenouchi, T	1
Gebauer, K; Owens, M; Quirk, C; Stampone, P	1
Ariffin, N; Khorshid, M	1
Diwan, AH; Hearne, R; Polk, A; Prieto, VG; Treviño, J	1
Mings, SM; Ondo, AL; Pestak, RM; Shanler, SD	1
Chen, WR; Naylor, MF; Nordquist, RE; Perry, LA; Teague, TK	1
Bug, R; Gille, J; Kaufmann, R; Kovács, A; Spieth, K; Wolter, M	1
Cornelison, R; Crowson, AN; Haque, R; Metcalf, S; Naylor, M	1
Ho, NT; Lansang, P; Pope, E	1
Cox, NH; Eedy, DJ; Morton, CA	1
Li, LJ; Wagamon, K	1
Chia, AL; Lim, A; Moreno, G; Shumack, S	1
Bodman-Smith, MD; Dalgleish, AG; Fischer, MD; Green, DS	1
Badía, X; Conejo-Mir, JS; Daudén, E; Guillén, C; Hamel, L; Llorens, MA; Sainz de Los Terreros, M; Vanaclocha, F	1
Khachemoune, A; Prager, R	1
Chan, YC; Chiam, LY	1
Hoedemaker, C; Sinclair, R; van Egmond, S	1
Jang, BS; Jang, HS; Kim, MB; Kwon, KS; Oh, CK; Park, HJ	1
Berthelot, C; Dickerson, MC; He, Q; Niroomand, F; Pandya, AG; Rady, P; Tyring, SK	1
Bendandi, M; del Olmo, J; Inoges, S; López-Diaz de Cerio, A; Marquina, M; Melero, I; Redondo, P	1
Beltrani, V; Brennick, JB; Chapman, MS; Perry, AE; Spenny, ML; Storm, CA; Walford, J; Werchniak, AE	1
Goldberg, RA; Huilgol, SC; Lee, S; Leibovitch, I; Selva, D	1
Gibson, M; Harting, M; Rosen, T	1
Blasco Melguizo, J; Bukhardt Pérez, MP; Naranjo Díaz, MJ; Naranjo Sintes, R; Ruiz-Villaverde, R	1
Dixon, A	1
Alomar, A; Bichel, J; McRae, S	1
Awada, A; Ghanem, G; Hendlisz, A; Larsimont, D; Marques da Costa, C; Mendes da Costa, P; Simoens, C; Vereecken, P	1
Brown, VL; Coutts, I; Stavrakoglou, A	1
Choi, GS; Lee, JR; Park, JH; Shin, JH; Song, SU	1
Breuninger, H; Caroli, UM; Eigentler, TK; Garbe, C; Kamin, A; Möhrle, M; Radny, P; Weide, BM	1
Hu, SL; Yeh, MH	1
du Plessis, PJ	1
Carroll, MT; Tillman, DK	2
Offner, F; Schiessl, C; Strohal, R; Tauber, M; Wolber, C	1
Ben M'barek, L; Euvrard, S; Frances, C; Lebbe, C; Legendre, C; Mebazaa, A; Menasché, S; Morel, P; Thervet, E	1
Falagas, ME; Papadavid, E; Stratigos, AJ	1
Bunker, CB; Singh, S	1
Bernardino, CR; Murchison, AP; Soloman, AR; Washington, CV	1
Fenske, NA; Glass, LF; Prakash, AV; Shistik, G	1
Bedwell, SA; Downs, MR; McIntyre, WJ	1
Dawe, RS; Ezughah, FI; Fleming, CJ; Ibbotson, SH	1
Dummer, R; Urosevic, M; Wuest, M	1
Perry, CM; Wagstaff, AJ	1
Jorizzo, JL; Neville, JA; Williford, PM	1
Fargnoli, MC; Micantonio, T; Peris, K; Piccolo, D	1
Hopson, B; Richey, D; Sajben, FP	1
Finato, N; Forcione, M; Frattasio, A; Patrone, P; Quinkenstein, E; Stinco, G	1
Nafz, J; Nindl, I; Ohnesorge, M; Rösl, F; Stockfleth, E	1
Ferrándiz, C	1
Amerio, P; Bichel, J; Euvrard, S; Guidi, B; Proby, CM; Rønnevig, J; Slade, HB; Stockfleth, E; Ulrich, C; van de Kerkhof, PC	1
Krawtchenko, N; Mann, I; Roewert-Huber, J; Sterry, W; Stockfleth, E; Ulrich, M	1
Bichel, J; Carey-Yard, M; Sterry, W; Stockfleth, E	1
Célestin Schartz, NE; Chevret, S; Kerob, D; Lebbé, C; Morel, P; Paz, C; Verola, O	1
Goldberg, LH; Harting, M; Vujevich, J	1
Bowen, GM; Cotter, MA; McKenna, JK	1
Brownell, I	1
Bazarbachi, A; Bonnet, PA; Deleuze-Masquéfa, C; El-Hajj, H; El-Sabban, ME; Hermine, O; Kfoury, Y; Lepelletier, Y; Moarbess, G	1
Berman, B	1
Li, VW; Li, WW	1
Ely, H; Rigel, DS; Torres, AM	1
Mitropoulos, P; Norman, R	1
Blyumin, M; Jacob, SE	1
Weinberg, JM	1
Bassukas, ID; Fotika, C; Gamvroulia, C; Nomikos, K; Zioga, A	1
Miller, WH; Peters-Kennedy, J; Scott, DW	1
Barry, RB; Cook, LJ; Hughes, BR	1
Warshauer, BL; Warshauer, E	1
Cohen, GF; Taliaferro, SJ	1
Beutner, KR; Fox, TL; Geisse, JK; Ginkel, A; Helman, D; Owens, ML	1
Kashani-Sabet, M	1
Amonette, R; Kagy, MK	1
Funk, JO; Schuler, G; Steinmann, A; von den Driesch, P	1
Ahmed, I; Berth-Jones, J	1
Arrese, J; Claessens, N; Paquet, P; Piérard, G; Piérard-Franchimont, C	1
Germain, M; Skelton, H; Smith, KJ	2
Luger, T; Metze, D; Wigbels, B	1
Amies, M; Bryden, J; Fox, TL; Gebauer, K; Marks, R; Owens, ML; Shumack, S	1
Benninghoff, B; Christophers, E; Meyer, T; Stockfleth, E	1
Hengge, UR; Stark, R	1
Hengge, U	1
Cook-Bolden, F; Weinberg, JM	1
Sinclair, RD; Thai, KE	1
Schroeder, TL; Sengelmann, RD	1
Chen, TM; Orengo, I; Rosen, T	1
Cook-Bolden, F; Drehs, MM; Tanzi, EL; Weinberg, JM	1
Kerr, C	1
Martinez, MI; Mihm, MC; North, PE; Sanchez-Carpintero, I	1
Varghese, M; Weisberg, NK	1
Flowers, F	1
Salasche, S	1
Eedy, DJ	1
Brodersen, JP; Gutzmer, R; Kapp, A; Kaspari, M; Kiehl, P; Vogelbruch, M; Werfel, T	1

Reviews

154 review(s) available for imiquimod and Skin Neoplasms

Article	Year
A practical guide on the use of imiquimod cream to treat lentigo maligna. The Australasian journal of dermatology, 2021, Volume: 62, Issue:4 Topics: Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin Neoplasms	2021
Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease. JAMA oncology, 2022, 04-01, Volume: 8, Issue:4 Topics: Aged; Humans; Imiquimod; Paget Disease, Extramammary; Prospective Studies; Sentinel Lymph Node Biopsy; Skin Neoplasms	2022
Imiquimod-side effects in the treatment of periocular skin cancers: A review of the literature. Dermatologic therapy, 2022, Volume: 35, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Skin Neoplasms	2022
A systematic review of observational management of cutaneous basal cell carcinoma. Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2022, Volume: 75, Issue:7 Topics: Carcinoma, Basal Cell; Humans; Imiquimod; Skin Neoplasms; United Kingdom	2022
Treatment of periocular lentigo maligna with topical 5% Imiquimod: a review. Eye (London, England), 2023, Volume: 37, Issue:3 Topics: Aminoquinolines; Eyelids; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Melanoma; Skin Neoplasms	2023
Advances in Topical Treatments of Cutaneous Malignancies. American journal of clinical dermatology, 2023, Volume: 24, Issue:1 Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Photosensitizing Agents; Quality of Life; Skin Neoplasms	2023
Treatment of actinic keratosis: a systematic review. Archives of dermatological research, 2023, Volume: 315, Issue:5 Topics: Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Skin Neoplasms; Treatment Outcome	2023
Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer. International journal of molecular sciences, 2023, Jun-29, Volume: 24, Issue:13 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Immunotherapy; Precancerous Conditions; Skin; Skin Neoplasms	2023
Nonsurgical Treatments for Nonmelanoma Skin Cancer. Dermatologic clinics, 2019, Volume: 37, Issue:4 Topics: Administration, Cutaneous; Anilides; Antineoplastic Agents; Antineoplastic Agents, Immunological; Biphenyl Compounds; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Programmed Cell Death 1 Receptor; Pyridines; Radiotherapy; Skin Neoplasms; Watchful Waiting	2019
A meta-analysis of treatment effects of imiquimod for basal cell carcinoma. Journal of cosmetic dermatology, 2020, Volume: 19, Issue:1 Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Disease-Free Survival; Drug Administration Schedule; Humans; Imiquimod; Neoplasm Grading; Skin Cream; Skin Neoplasms	2020
Topical treatments for skin cancer. Advanced drug delivery reviews, 2020, 01-01, Volume: 153 Topics: Administration, Cutaneous; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; Diterpenes; Drug Delivery Systems; Fluorouracil; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis, Actinic; Melanoma; Neoplasms, Squamous Cell; Photochemotherapy; Retinoids; Skin; Skin Neoplasms; Ultraviolet Rays	2020
'Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trial': a critical appraisal. The British journal of dermatology, 2020, Volume: 183, Issue:4 Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Male; Photochemotherapy; Skin Neoplasms	2020
Current therapies for actinic keratosis. International journal of dermatology, 2020, Volume: 59, Issue:6 Topics: Aftercare; Carcinoma, Squamous Cell; Chemexfoliation; Cryotherapy; Curettage; Dermoscopy; Diclofenac; Disease Progression; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy; Photochemotherapy; Practice Guidelines as Topic; Protective Clothing; Skin; Skin Neoplasms; Sunlight; Sunscreening Agents	2020
The role of topical imiquimod in melanoma cutaneous metastases: A critical review of the literature. Dermatologic therapy, 2020, Volume: 33, Issue:6 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Melanoma; Retrospective Studies; Skin Neoplasms	2020
A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies. The Australasian journal of dermatology, 2021, Volume: 62, Issue:2 Topics: Antineoplastic Agents; Diclofenac; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Recurrence; Skin Neoplasms	2021
Mucosal side effects in patients treated with topical imiquimod-A scoping review of the literature. Dermatologic therapy, 2021, Volume: 34, Issue:1 Topics: Adjuvants, Immunologic; Administration, Topical; Aged, 80 and over; Aminoquinolines; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Skin Neoplasms	2021
Interventions for basal cell carcinoma of the skin. The Cochrane database of systematic reviews, 2020, 11-17, Volume: 11 Topics: Adult; Aminolevulinic Acid; Antineoplastic Agents; Carcinoma, Basal Cell; Cryotherapy; Female; Humans; Imiquimod; Immunocompetence; Laser Therapy; Male; Mohs Surgery; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Radiotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome	2020
Management of multiple trichoepithelioma: A review of pharmacological therapies. The Australasian journal of dermatology, 2021, Volume: 62, Issue:2 Topics: Adalimumab; Administration, Topical; Anilides; Antineoplastic Agents; Aspirin; Humans; Imiquimod; Lasers, Gas; Neoplasms, Adnexal and Skin Appendage; Pyridines; Sirolimus; Skin Neoplasms; Tretinoin	2021
Interventions for basal cell carcinoma: abridged Cochrane systematic review and GRADE assessments. The British journal of dermatology, 2021, Volume: 185, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Humans; Imiquimod; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Skin Neoplasms; Young Adult	2021
Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient. Frontiers in immunology, 2021, Volume: 12 Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Graft Rejection; Humans; Imiquimod; Immunocompromised Host; Immunosuppression Therapy; Infusions, Intralesional; Interleukin-2; Kidney Transplantation; Liver Transplantation; Male; Neoplasm Recurrence, Local; Skin Neoplasms; Transplant Recipients; Treatment Outcome	2021
Local Chemotherapy as an Adjuvant Treatment in Unresectable Squamous Cell Carcinoma: What Do We Know So Far? Current oncology (Toronto, Ont.), 2021, 06-23, Volume: 28, Issue:4 Topics: Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms	2021
Efficacy of nonexcisional treatment modalities for superficially invasive and in situ squamous cell carcinoma: A systematic review and meta-analysis. Journal of the American Academy of Dermatology, 2022, Volume: 87, Issue:1 Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Skin Neoplasms	2022
A Network Meta-Analysis of Non-Melanoma Skin Cancer (NMSC) Treatments: Efficacy and Safety Assessment. Journal of cellular biochemistry, 2017, Volume: 118, Issue:11 Topics: Aminoquinolines; Cryotherapy; Fluorouracil; Humans; Imiquimod; Melanoma; Photochemotherapy; PubMed; Skin Neoplasms	2017
Nonsurgical Therapies for Basal Cell Carcinoma: A Review. Actas dermo-sifiliograficas, 2017, Volume: 108, Issue:9 Topics: Administration, Cutaneous; Aminoquinolines; Anilides; Antineoplastic Agents; Biphenyl Compounds; Carcinoma, Basal Cell; Clinical Trials as Topic; Fluorouracil; Humans; Imiquimod; Interferons; Meta-Analysis as Topic; Molecular Targeted Therapy; Neoplasm Invasiveness; Photochemotherapy; Pyridines; Randomized Controlled Trials as Topic; Risk Assessment; Skin Neoplasms	2017
Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis. The British journal of dermatology, 2018, Volume: 179, Issue:6 Topics: Administration, Topical; Antineoplastic Agents; Carcinoma, Basal Cell; Cryosurgery; Dose Fractionation, Radiation; Esthetics; Humans; Imiquimod; Neoplasm Recurrence, Local; Pain; Pain Measurement; Patient Safety; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome	2018
A Review on Imiquimod Therapy and Discussion on Optimal Management of Basal Cell Carcinomas. Clinical drug investigation, 2018, Volume: 38, Issue:10 Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; Disease Management; Humans; Imiquimod; Mohs Surgery; Skin Neoplasms; Treatment Outcome	2018
Mediators of Inflammation in Topical Therapy of Skin Cancers. Mediators of inflammation, 2019, Volume: 2019 Topics: Administration, Topical; Aminoquinolines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cytokines; Diterpenes; Fluorouracil; Humans; Imiquimod; Inflammation; Melanoma; Neoplasm Metastasis; Skin; Skin Neoplasms; Toll-Like Receptor 7	2019
Melanoma on chronically sun-damaged skin: Lentigo maligna and desmoplastic melanoma. Journal of the American Academy of Dermatology, 2019, Volume: 81, Issue:3 Topics: B7-H1 Antigen; Biopsy; Dermatologic Surgical Procedures; Dermoscopy; Diagnosis, Differential; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunotherapy; Margins of Excision; Microscopy, Confocal; Mutation Rate; Neoplasm Invasiveness; Neurofibromin 1; Proto-Oncogene Proteins c-kit; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Skin; Skin Aging; Skin Neoplasms; Sunlight; Treatment Outcome	2019
Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer. Dermatologic clinics, 2019, Volume: 37, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemoprevention; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Niacinamide; Photochemotherapy; Retinoids; Skin Neoplasms	2019
Clinical usefulness of dermoscopy in the management of lentigo maligna melanoma treated with topical imiquimod: A case report. Dermatologic therapy, 2019, Volume: 32, Issue:5 Topics: Adjuvants, Immunologic; Administration, Topical; Aged, 80 and over; Combined Modality Therapy; Dermatologic Surgical Procedures; Dermoscopy; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Preoperative Care; Prognosis; Risk Assessment; Skin Neoplasms; Treatment Outcome	2019
Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches. Paediatric drugs, 2013, Volume: 15, Issue:2 Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Aminoquinolines; Hemangioma; Humans; Imiquimod; Infant; Off-Label Use; Propranolol; Skin Neoplasms; Timolol	2013
Microinvasive melanoma: cutaneous pharmacotherapeutic approaches. American journal of clinical dermatology, 2013, Volume: 14, Issue:2 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Dicarboxylic Acids; Female; Fluorouracil; Geriatric Assessment; Humans; Imiquimod; Immunohistochemistry; Interferon-alpha; Male; Melanoma; Neoplasm Invasiveness; Pharmaceutical Preparations; Prognosis; Risk Assessment; Skin Neoplasms; Survival Analysis; Treatment Outcome	2013
Interventions for cutaneous Bowen's disease. The Cochrane database of systematic reviews, 2013, Jun-24, Issue:6 Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Cryotherapy; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2013
Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:9 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Bleomycin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Interferon alpha-2; Interferon-alpha; Keratoacanthoma; Methotrexate; Recombinant Proteins; Skin Neoplasms	2013
Chemoprevention of skin melanoma: facts and myths. Melanoma research, 2013, Volume: 23, Issue:6 Topics: Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Cell Line, Tumor; Cell Transformation, Neoplastic; Chemoprevention; Curcumin; Flavonoids; Humans; Imiquimod; Melanoma; Melanoma, Cutaneous Malignant; Pigmentation; Randomized Controlled Trials as Topic; Resveratrol; Retinoids; Risk; Skin; Skin Neoplasms; Stilbenes; Tea; Treatment Outcome; Vitamin D	2013
Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma. Current opinion in oncology, 2014, Volume: 26, Issue:2 Topics: Aminoquinolines; Humans; Imiquimod; Lymphoma, T-Cell, Cutaneous; Oligodeoxyribonucleotides; Quinolinium Compounds; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptor 9; Toll-Like Receptors	2014
Localized diffuse melanosis associated with melanoma successfully treated with imiquimod cream 5%: a case report and review of the literature. Cutis, 2014, Volume: 93, Issue:3 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Melanoma; Melanosis; Skin Neoplasms	2014
New perspectives in the management of basal cell carcinoma. Actas dermo-sifiliograficas, 2014, Volume: 105, Issue:9 Topics: Aminoquinolines; Anilides; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Disease Management; Humans; Imiquimod; Immunotherapy; Molecular Targeted Therapy; Neoplasm Proteins; Pyridines; Receptors, G-Protein-Coupled; Skin Neoplasms; Smoothened Receptor	2014
The clinical evidence and the role of imiquimod in the extramammary Paget disease. Acta dermatovenerologica Croatica : ADC, 2014, Volume: 22, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Paget Disease, Extramammary; Skin Neoplasms	2014
Management of trichilemmal carcinoma: an update and comprehensive review of the literature. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2014, Volume: 40, Issue:7 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma; Hair Follicle; Humans; Imiquimod; Male; Mohs Surgery; Skin Neoplasms	2014
Melanoma of the glans penis successfully treated with topical imiquimod: dermoscopy usefulness in clinical monitoring and review of the literature. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2017, Volume: 152, Issue:6 Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Dermoscopy; Humans; Imiquimod; Male; Melanoma; Penile Neoplasms; Skin Neoplasms; Treatment Outcome	2017
Treatment of localized pagetoid reticulosis with imiquimod: a case report and literature review. Journal of the European Academy of Dermatology and Venereology : JEADV, 2016, Volume: 30, Issue:2 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Biopsy; Female; Follow-Up Studies; Humans; Imiquimod; Middle Aged; Pagetoid Reticulosis; Skin; Skin Neoplasms	2016
New therapeutic options for actinic keratosis and basal cell carcinoma. Seminars in cutaneous medicine and surgery, 2014, Volume: 33, Issue:4 Suppl Topics: Aminoquinolines; Anilides; Antineoplastic Agents; Carcinoma, Basal Cell; Cryosurgery; Diterpenes; Humans; Imiquimod; Keratosis, Actinic; Mutation; Patched Receptors; Pyridines; Receptors, Cell Surface; Skin Neoplasms; Treatment Outcome	2014
Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis. Photodermatology, photoimmunology & photomedicine, 2015, Volume: 31, Issue:1 Topics: Administration, Topical; Aminoquinolines; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Incidence; Neoplasm Recurrence, Local; Photochemotherapy; Skin Neoplasms; Time Factors	2015
Plasmacytoid dendritic cells, a role in neoplastic prevention and progression. European journal of clinical investigation, 2015, Volume: 45 Suppl 1 Topics: Adjuvants, Immunologic; Aminoquinolines; Cancer Vaccines; Dendritic Cells; Disease Progression; Humans; Imiquimod; Immunotherapy; Melanoma; Neoplasms; Skin Neoplasms; T-Lymphocytes; Toll-Like Receptor 7; Toll-Like Receptors; Tumor Escape; Tumor Microenvironment	2015
Interventions for melanoma in situ, including lentigo maligna. The Cochrane database of systematic reviews, 2014, Dec-19, Issue:12 Topics: Aminoquinolines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Melanoma; Melanoma, Cutaneous Malignant; Nicotinic Acids; Randomized Controlled Trials as Topic; Skin Neoplasms	2014
Topical treatment of melanoma skin metastases with imiquimod: a review. Dermatology online journal, 2015, 02-15, Volume: 21, Issue:2 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Humans; Imiquimod; Melanoma; Skin Cream; Skin Neoplasms; Treatment Outcome	2015
Before or after: is there a connection between the use of adjunctive nonmelanoma skin cancer treatments and subsequent invasive tumors? Journal of drugs in dermatology : JDD, 2015, Volume: 14, Issue:5 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Skin Neoplasms	2015
A quantitative systematic review of the efficacy of imiquimod monotherapy for lentigo maligna and an analysis of factors that affect tumor clearance. Journal of the American Academy of Dermatology, 2015, Volume: 73, Issue:2 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Risk Assessment; Skin Neoplasms; Survival Rate; Treatment Outcome	2015
Melanoma in situ: Part II. Histopathology, treatment, and clinical management. Journal of the American Academy of Dermatology, 2015, Volume: 73, Issue:2 Topics: Administration, Topical; Aminoquinolines; Biopsy, Needle; Carcinoma in Situ; Female; Humans; Imiquimod; Immunohistochemistry; Immunotherapy; Injections, Intralesional; Interferon-alpha; Laser Therapy; Male; Melanoma; Melanoma, Cutaneous Malignant; Mohs Surgery; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome	2015
Retiform hemangioendothelioma treated with conservative therapy: report of a case and review of the literature. International journal of dermatology, 2016, Volume: 55, Issue:2 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Glucocorticoids; Hemangioendothelioma; Humans; Imiquimod; Injections, Intralesional; Lasers, Dye; Male; Nose Neoplasms; Skin Neoplasms; Triamcinolone Acetonide	2016
Topical treatment of basal cell carcinoma with the immune response modifier imiquimod. Future oncology (London, England), 2015, Volume: 11, Issue:22 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; Humans; Imiquimod; Immunologic Factors; Neoplasm Staging; Product Surveillance, Postmarketing; Skin Neoplasms; Treatment Outcome	2015
Treatment of Basal Cell Carcinoma in the Elderly: What Nondermatologists Need to Know. The American journal of medicine, 2016, Volume: 129, Issue:7 Topics: Aminoquinolines; Anilides; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Dermatologic Surgical Procedures; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Pyridines; Radiotherapy; Skin Neoplasms	2016
Imiquimod in dermatology: an overview. International journal of dermatology, 2016, Volume: 55, Issue:8 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Condylomata Acuminata; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Prognosis; Skin Diseases; Skin Neoplasms; Treatment Outcome	2016
Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments. Actas dermo-sifiliograficas, 2016, Volume: 107, Issue:9 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antigen-Presenting Cells; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Clinical Trials as Topic; Dermatologic Agents; Diclofenac; Diterpenes; Drug Resistance, Neoplasm; Fluorouracil; Humans; Imiquimod; Meta-Analysis as Topic; Neoplasm Proteins; Neoplastic Stem Cells; Skin Neoplasms	2016
A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures. Journal of the European Academy of Dermatology and Venereology : JEADV, 2017, Volume: 31, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Disease Progression; Drug Administration Schedule; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Skin Neoplasms	2017
Toll-like receptor 7 agonists and skin. Drug news & perspectives, 2008, Volume: 21, Issue:3 Topics: Aminoquinolines; Animals; Antineoplastic Agents; Humans; Imiquimod; Ligands; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Toll-Like Receptor 7	2008
Imiquimod: a review of basal cell carcinoma treatments. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:11 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Mohs Surgery; Neoplasm Recurrence, Local; Neoplasms, Basal Cell; Quality of Life; Skin Neoplasms	2008
Treatment of basal cell carcinomas in patients with nevoid basal cell carcinoma syndrome. Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:3 Topics: Aminoquinolines; Basal Cell Nevus Syndrome; Humans; Imiquimod; Laser Therapy; Photochemotherapy; Skin Neoplasms	2009
Lentigo maligna: current concepts in diagnosis and management. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2009, Volume: 144, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Cryotherapy; Curettage; Early Diagnosis; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Mohs Surgery; Skin Neoplasms; Treatment Outcome	2009
Actinic keratoses. Cancer treatment and research, 2009, Volume: 146 Topics: Aged; Aminoquinolines; Carcinoma, Squamous Cell; Cryotherapy; Dermatology; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Lasers; Medical Oncology; Models, Biological; Organ Transplantation; Photochemotherapy; Retinoids; Skin Neoplasms	2009
Topical treatment of field cancerization. Cancer treatment and research, 2009, Volume: 146 Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Immunosuppression Therapy; Immunosuppressive Agents; Keratosis, Actinic; Organ Transplantation; Photochemotherapy; Recurrence; Skin Neoplasms; Tissue Distribution	2009
Infantile hemangioma: how to treat this benign neoplasm of childhood. JAAPA : official journal of the American Academy of Physician Assistants, 2009, Volume: 22, Issue:5 Topics: Adrenal Cortex Hormones; Aminoquinolines; Antineoplastic Agents; Child, Preschool; Female; Hemangioma; Humans; Imiquimod; Infant; Infant, Newborn; Interferon-alpha; Laser Therapy; Male; Skin Neoplasms	2009
Beyond a decade of 5% imiquimod topical therapy. Journal of drugs in dermatology : JDD, 2009, Volume: 8, Issue:5 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Condylomata Acuminata; Humans; Imiquimod; Keratosis, Actinic; Papillomavirus Infections; Skin Diseases; Skin Neoplasms; Toll-Like Receptor 7	2009
Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma. The Australasian journal of dermatology, 2009, Volume: 50, Issue:3 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Biopsy, Needle; Carcinoma, Basal Cell; Follow-Up Studies; Humans; Hypopigmentation; Imiquimod; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Risk Assessment; Skin Neoplasms; Vitiligo	2009
Imiquimod for superficial and in situ skin malignancy. Drug and therapeutics bulletin, 2009, Volume: 47, Issue:10 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Skin Neoplasms	2009
Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. Archives of dermatology, 2009, Volume: 145, Issue:12 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Metabolic Clearance Rate; Skin Neoplasms	2009
Treating skin cancer with topical cream. Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:9 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Retinoids; Skin Neoplasms	2010
[New perspective in immunotherapy: local imiquimod treatment]. Orvosi hetilap, 2010, May-09, Volume: 151, Issue:19 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antiviral Agents; Carcinoma, Basal Cell; Condylomata Acuminata; Dendritic Cells; Humans; Imiquimod; Immunity, Innate; Keratosis, Actinic; Langerhans Cells; Off-Label Use; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptors	2010
Actinic keratoses: past, present and future. Journal of drugs in dermatology : JDD, 2010, Volume: 9, Issue:5 Suppl OD Topics: Adjuvants, Immunologic; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Cryosurgery; Diclofenac; Fluorouracil; Humans; Imiquimod; Immunosuppressive Agents; Keratosis, Actinic; Photochemotherapy; Precancerous Conditions; Skin Neoplasms	2010
Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery. International journal of dermatology, 2010, Volume: 49, Issue:5 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Melanoma; Mohs Surgery; Skin Neoplasms; Treatment Outcome	2010
Actinic cheilitis: a treatment review. International journal of dermatology, 2010, Volume: 49, Issue:11 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Caustics; Cheilitis; Cryosurgery; Electrocoagulation; Fluorouracil; Humans; Imiquimod; Laser Therapy; Lip; Photochemotherapy; Precancerous Conditions; Risk Factors; Skin Neoplasms; Trichloroacetic Acid	2010
Biomarkers: important clues to the pathogenesis of infantile haemangioma and their clinical significance. The Chinese journal of dental research, 2010, Volume: 13, Issue:2 Topics: AC133 Antigen; Adjuvants, Immunologic; Aminoquinolines; Antigens, CD; Biomarkers; Calcium-Binding Proteins; DNA-Binding Proteins; Female; Glucose Transporter Type 1; Glycoproteins; Hemangioma, Capillary; Humans; Imiquimod; Infant; Microfilament Proteins; Neoplastic Syndromes, Hereditary; Neovascularization, Pathologic; Peptides; Placenta; Pregnancy; Receptors, Androgen; Skin Neoplasms	2010
Managing melanoma in situ. Seminars in cutaneous medicine and surgery, 2010, Volume: 29, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Laser Therapy; Melanoma; Mohs Surgery; Skin Neoplasms	2010
Topical antineoplastic agents in the treatment of mucocutaneous diseases. Current problems in dermatology, 2011, Volume: 40 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Mucositis; Mucous Membrane; Skin Diseases; Skin Neoplasms	2011
[Imiquimod in the treatment of lentigo maligna]. Actas dermo-sifiliograficas, 2011, Volume: 102, Issue:8 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Contraindications; Cryotherapy; Disease Progression; Drug Approval; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Melanoma; Microscopy, Confocal; Mohs Surgery; Neoplasm Invasiveness; Skin Neoplasms; Treatment Outcome	2011
Do lasers or topicals really work for nonmelanoma skin cancers? Seminars in cutaneous medicine and surgery, 2011, Volume: 30, Issue:1 Topics: Administration, Cutaneous; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemexfoliation; Dermatologic Agents; Fluorouracil; Humans; Imiquimod; Laser Therapy; Nicotinic Acids; Paget Disease, Extramammary; Photochemotherapy; Skin Neoplasms	2011
Surgical treatments for lentigo maligna: a review. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2011, Volume: 37, Issue:9 Topics: Aminoquinolines; Antineoplastic Agents; Cryosurgery; Curettage; Electrosurgery; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunohistochemistry; Laser Therapy; Mohs Surgery; Skin Neoplasms	2011
Successful treatment and management of large superficial basal cell carcinomas with topical imiquimod 5% cream: a case series and review. The Journal of dermatological treatment, 2011, Volume: 22, Issue:6 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy, Needle; Carcinoma, Basal Cell; Emollients; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Sampling Studies; Skin Neoplasms; Time Factors; Treatment Outcome	2011
Extramammary Paget disease. Dermatology online journal, 2011, Oct-15, Volume: 17, Issue:10 Topics: Aminoquinolines; Antineoplastic Agents; Asian People; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therapy; Diagnostic Errors; Eczema; Humans; Imiquimod; Male; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Penile Neoplasms; Scrotum; Skin Neoplasms	2011
Basic pharmacology of topical imiquimod, 5-fluorouracil, and diclofenac for the dermatologic surgeon. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2012, Volume: 38, Issue:1 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Diclofenac; Fluorouracil; Humans; Imiquimod; Skin Neoplasms	2012
Emerging treatments and signaling pathway inhibitors. Seminars in cutaneous medicine and surgery, 2011, Volume: 30, Issue:4 Suppl Topics: Aminoquinolines; Anilides; Antineoplastic Agents; Basal Cell Nevus Syndrome; Benzamides; Carcinoma, Basal Cell; Deoxyribonuclease (Pyrimidine Dimer); Fluorouracil; Hedgehog Proteins; Humans; Imiquimod; Photochemotherapy; Pyridines; Quinazolines; Retinoids; Secondary Prevention; Signal Transduction; Skin Neoplasms; Viral Proteins	2011
Role of non-surgical therapies in the management of periocular basal cell carcinoma and squamous intra-epidermal carcinoma: a case series and review of the literature. Photodermatology, photoimmunology & photomedicine, 2012, Volume: 28, Issue:2 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Eye; Female; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Skin Neoplasms	2012
Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials. The British journal of dermatology, 2012, Volume: 167, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Disease-Free Survival; Humans; Imiquimod; Photochemotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome	2012
Immunotherapy in nonmelanoma skin cancer. Immunotherapy, 2012, Volume: 4, Issue:5 Topics: Aminoquinolines; Animals; Antibodies, Monoclonal; Cancer Vaccines; Carcinoma; Cytokines; Humans; Imiquimod; Immunologic Factors; Immunotherapy; Skin Neoplasms; T-Lymphocytes	2012
Imiquimod-induced depigmentation: report of two cases and review of the literature. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2012, Volume: 38, Issue:11 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Hypopigmentation; Imiquimod; Male; Middle Aged; Skin Neoplasms; Vitiligo	2012
Topical therapies for periorbital cutaneous malignancies: indications and treatment regimens. Current opinion in ophthalmology, 2012, Volume: 23, Issue:5 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Fluorouracil; Humans; Imiquimod; Mitomycin; Orbital Neoplasms; Skin Neoplasms	2012
Diagnosis and treatment of Basal cell and squamous cell carcinoma. American family physician, 2012, Jul-15, Volume: 86, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryotherapy; Curettage; Dermatologic Surgical Procedures; Desiccation; Fluorouracil; Humans; Imiquimod; Mohs Surgery; Risk Factors; Skin; Skin Neoplasms	2012
Local reactions to imiquimod in the treatment of basal cell carcinoma. Dermatology online journal, 2012, Sep-15, Volume: 18, Issue:9 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Keratosis, Actinic; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome	2012
Extramammary Paget's disease of the perianal region: a review of the literature emphasizing management. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:1 Pt 1 Topics: Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Humans; Imiquimod; Paget Disease, Extramammary; Photochemotherapy; Skin Neoplasms	2013
Imiquimod (Aldara): modifying the immune response. Dermatology nursing, 2002, Volume: 14, Issue:4 Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Herpes Simplex; Humans; Imiquimod; Molluscum Contagiosum; Skin Neoplasms; Warts	2002
Treatment of primary limited cutaneous extramammary Paget's disease with topical imiquimod monotherapy: two case reports. Journal of the American Academy of Dermatology, 2002, Volume: 47, Issue:4 Suppl Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Diagnosis, Differential; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Paget Disease, Extramammary; Perineum; Scrotum; Skin Neoplasms	2002
Imiquimod; an international update on therapeutic uses in dermatology. International journal of dermatology, 2002, Volume: 41, Issue:11 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma; Condylomata Acuminata; Dermatologic Agents; DNA Virus Infections; Humans; Imiquimod; Immunocompromised Host; Papillomaviridae; Papillomavirus Infections; Skin Neoplasms	2002
Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clinical and experimental dermatology, 2002, Volume: 27, Issue:7 Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Disease Models, Animal; Humans; Imiquimod; Skin Diseases; Skin Neoplasms; Virus Diseases	2002
Imiquimod. Current opinion in infectious diseases, 2003, Volume: 16, Issue:2 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Condylomata Acuminata; Humans; Imiquimod; Interferon Inducers; Molluscum Contagiosum; Skin Neoplasms	2003
Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod. Cutis, 2003, Volume: 71, Issue:5 Topics: Administration, Cutaneous; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Fluorouracil; Humans; Imiquimod; Keratosis; Precancerous Conditions; Randomized Controlled Trials as Topic; Skin Neoplasms	2003
The imidazoquinolines and their place in the therapy of cutaneous disease. Expert opinion on pharmacotherapy, 2003, Volume: 4, Issue:7 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Condylomata Acuminata; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Skin Neoplasms	2003
Successful treatment of bowenoid papulosis in a 9-year-old girl with vertically acquired human immunodeficiency virus. Pediatrics, 2003, Volume: 112, Issue:1 Pt 1 Topics: Acquired Immunodeficiency Syndrome; Adult; Aminoquinolines; Antineoplastic Agents, Phytogenic; Bowen's Disease; Child; Female; Humans; Imiquimod; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Papillomaviridae; Papillomavirus Infections; Perineum; Podophyllin; Pregnancy; Pregnancy Complications, Infectious; Remission Induction; Skin Neoplasms; Tumor Virus Infections; Vulvar Neoplasms	2003
Immunotherapy of basal cell carcinoma: evolving approaches. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2003, Volume: 29, Issue:10 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Immunity; Immunotherapy; Skin Neoplasms; Sunlight; Ultraviolet Rays	2003
Current treatment patterns in non-melanoma skin cancer across Europe. The Journal of dermatological treatment, 2003, Volume: 14 Suppl 3 Topics: Administration, Cutaneous; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryotherapy; Dermatology; Europe; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Skin Neoplasms	2003
[Cutaneous neoplasms]. Praxis, 2003, Sep-03, Volume: 92, Issue:36 Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Hemangiosarcoma; HIV Infections; Humans; Imiquimod; Immunotherapy; Keratosis; Lymph Node Excision; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Neoplasm Recurrence, Local; Photochemotherapy; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Skin; Skin Neoplasms; Time Factors	2003
New and emerging topical approaches for actinic keratoses. Cutis, 2003, Volume: 72, Issue:4 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Diclofenac; Humans; Imiquimod; Keratosis; Skin Neoplasms; Treatment Outcome; United States	2003
Imiquimod: mode of action and therapeutic potential. Acta dermato-venereologica. Supplementum, 2003, Issue:214 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Imiquimod; Immune System; Papillomaviridae; Papillomavirus Infections; Skin Diseases; Skin Neoplasms	2003
Treatment of non-melanoma skin cancer: immunotherapy as a viable option. Acta dermato-venereologica. Supplementum, 2003, Issue:214 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Clinical Trials as Topic; Humans; Imiquimod; Keratosis; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays	2003
Viral warts in organ transplant recipients: new aspects in therapy. The British journal of dermatology, 2003, Volume: 149 Suppl 66 Topics: Adjuvants, Immunologic; Aminoquinolines; Humans; Imiquimod; Organ Transplantation; Papillomaviridae; Skin Neoplasms; Transplantation Immunology; Warts	2003
The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview. The British journal of dermatology, 2003, Volume: 149 Suppl 66 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Clinical Trials, Phase II as Topic; Cytokines; Humans; Imiquimod; Membrane Glycoproteins; Receptors, Cell Surface; Skin Neoplasms; Th1 Cells; Toll-Like Receptor 7; Toll-Like Receptors; Treatment Outcome	2003
[Standard and experimental therapy of cutaneous T-cell lymphoma]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:12 Topics: Adrenal Cortex Hormones; Aminoquinolines; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Imiquimod; Interferon alpha-2; Interferon-alpha; Lymphoma, T-Cell; Methotrexate; Photopheresis; Prednisone; PUVA Therapy; Radioisotope Teletherapy; Radiotherapy Dosage; Radiotherapy, High-Energy; Recombinant Proteins; Retinoids; Skin Neoplasms; Tetrahydronaphthalenes; Vincristine	2003
Topical and light-based treatments for actinic keratoses. Seminars in cutaneous medicine and surgery, 2003, Volume: 22, Issue:3 Topics: Adjuvants, Immunologic; Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclooxygenase Inhibitors; Diclofenac; Fluorouracil; Humans; Hyaluronic Acid; Imiquimod; Keratosis; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Precancerous Conditions; Retinoids; Skin Neoplasms; Vitamin A	2003
Topical and light-based treatments for basal cell carcinoma. Seminars in cutaneous medicine and surgery, 2003, Volume: 22, Issue:3 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Immunotherapy; Interferons; Laser Therapy; Photochemotherapy; Skin Neoplasms	2003
Combined imiquimod and acitretin for non-surgical treatment of basal cell carcinoma. Scandinavian journal of plastic and reconstructive surgery and hand surgery, 2003, Volume: 37, Issue:5 Topics: Acitretin; Algorithms; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Drug Synergism; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms; Treatment Outcome	2003
Squamous cell carcinoma in situ of the skin: history, presentation, biology and treatment. The Australasian journal of dermatology, 2004, Volume: 45, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Female; Humans; Imiquimod; Male; Papillomavirus Infections; Skin; Skin Neoplasms; Ultraviolet Rays	2004
Imiquimod: unexpected killer. The Journal of investigative dermatology, 2004, Volume: 122, Issue:5 Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Humans; Imiquimod; Melanoma; Skin Neoplasms	2004
Immune modulation and apoptosis induction: two sides of the antitumoral activity of imiquimod. Apoptosis : an international journal on programmed cell death, 2004, Volume: 9, Issue:3 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Basal Cell; Caspases; Cytochrome c Group; Enzyme Activation; Humans; Imiquimod; Melanoma; Mitochondria; Models, Biological; Neoplasms; Ointments; Proto-Oncogene Proteins c-bcl-2; Skin Neoplasms; Vascular Neoplasms	2004
Imiquimod 5 percent cream and the treatment of cutaneous malignancy. Dermatology online journal, 2004, Jul-15, Volume: 10, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Clinical Trials as Topic; Condylomata Acuminata; Drug Screening Assays, Antitumor; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunity, Cellular; Immunologic Factors; Keratoacanthoma; Keratosis; Male; Melanoma; Multicenter Studies as Topic; Mycosis Fungoides; Ointments; Paget Disease, Extramammary; Precancerous Conditions; Randomized Controlled Trials as Topic; Skin Neoplasms	2004
Topical treatment strategies for non-melanoma skin cancer and precursor lesions. Seminars in cutaneous medicine and surgery, 2004, Volume: 23, Issue:3 Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Basal Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photochemotherapy; Precancerous Conditions; Skin Neoplasms; Sunlight	2004
Imiquimod for the treatment of skin cancer. Dermatologic clinics, 2005, Volume: 23, Issue:1 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Clinical Trials as Topic; Humans; Imiquimod; Skin Neoplasms	2005
Role of topical therapies in the management of cutaneous disease. Journal of cutaneous medicine and surgery, 2004, Volume: 8 Suppl 3 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Dermatitis, Atopic; Dermatitis, Seborrheic; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis; Melanoma; Membrane Glycoproteins; Receptors, Cell Surface; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Toll-Like Receptors	2004
Role of imiquimod in skin cancer treatment. American journal of clinical dermatology, 2004, Volume: 5, Issue:6 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Imiquimod; Immunologic Factors; Melanoma; Skin Neoplasms	2004
Non-surgical treatment of skin cancer. The Australasian journal of dermatology, 2005, Volume: 46 Suppl 3 Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Agents; Cyclooxygenase Inhibitors; Deoxyribonuclease (Pyrimidine Dimer); Diclofenac; Humans; Imiquimod; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2005
[How I treat ... basal cell carcinoma by imiquimod]. Revue medicale de Liege, 2005, Volume: 60, Issue:4 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Humans; Imiquimod; Skin Neoplasms	2005
Imiquimod: in superficial basal cell carcinoma. American journal of clinical dermatology, 2005, Volume: 6, Issue:3 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Multicenter Studies as Topic; Ointments; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome	2005
Infiltrative trichilemmal carcinoma treated with 5% imiquimod cream. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2005, Volume: 31, Issue:8 Pt 1 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Diagnosis, Differential; Face; Female; Hair Follicle; Humans; Imiquimod; Skin Neoplasms	2005
[Solar keratosis: from precancerous lesion to pre-invasive squamous cell carcinoma--therapeutic approach with a bioinductive method]. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2003, Volume: 1, Issue:10 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Middle Aged; Ointments; Precancerous Conditions; Prospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome; Ultraviolet Rays	2003
The small-molecule immune response modifier imiquimod--its mode of action and clinical use in the treatment of skin cancer. Expert opinion on therapeutic targets, 2006, Volume: 10, Issue:1 Topics: Aminoquinolines; Animals; Humans; Imiquimod; Immunologic Factors; Skin Neoplasms	2006
[Topical treatment of melanoma skin metastases with imiquimod]. Actas dermo-sifiliograficas, 2005, Volume: 96, Issue:2 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Head and Neck Neoplasms; Humans; Imiquimod; Male; Melanoma; Scalp; Skin Neoplasms	2005
[Non-surgical therapy of basal cell carcinoma of the head-neck region]. Laryngo- rhino- otologie, 2006, Volume: 85, Issue:2 Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Basal Cell; Diclofenac; Female; Humans; Imiquimod; Immunotherapy; Interferon Inducers; Interferons; Laser Therapy; Male; Ointments; Photochemotherapy; Prognosis; Radiotherapy Dosage; Skin Neoplasms; Time Factors; Urea	2006
Imiquimod for actinic keratosis: systematic review and meta-analysis. The Journal of investigative dermatology, 2006, Volume: 126, Issue:6 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Keratosis; Ointments; Randomized Controlled Trials as Topic; Skin Neoplasms	2006
Treatment of extramammary Paget disease with topical imiquimod cream: case report and literature review. Southern medical journal, 2006, Volume: 99, Issue:4 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Groin; Humans; Imiquimod; Male; Paget Disease, Extramammary; Skin Neoplasms	2006
Actinic keratoses: sequelae and treatments. Recommendations from a consensus panel. The Journal of family practice, 2006, Volume: 55, Issue:5 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Consensus Development Conferences as Topic; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photosensitivity Disorders; Practice Guidelines as Topic; Risk Factors; Skin Neoplasms; Ultraviolet Rays	2006
Current modalities and new advances in the treatment of basal cell carcinoma. International journal of dermatology, 2006, Volume: 45, Issue:5 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cryosurgery; Curettage; Electrosurgery; Humans; Imiquimod; Mohs Surgery; Neoplasm Recurrence, Local; Photochemotherapy; Skin Neoplasms	2006
[New substances in the therapy of head and neck cancer]. Laryngo- rhino- otologie, 2006, Volume: 85, Issue:7 Topics: Administration, Oral; Aminoquinolines; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Basal Cell; Carcinoma, Non-Small-Cell Lung; Cetuximab; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Controlled Clinical Trials as Topic; Double-Blind Method; Erlotinib Hydrochloride; Fibroblast Growth Factor 7; Gefitinib; Head and Neck Neoplasms; Humans; Imiquimod; Infusions, Intravenous; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Ointments; Protein Kinase Inhibitors; Quinazolines; Radioimmunotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms; Time Factors; United States; United States Food and Drug Administration	2006
[Spindle-cell carcinoma in situ treated with 5% imiquimod]. Actas dermo-sifiliograficas, 2006, Volume: 97, Issue:4 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Female; Humans; Imiquimod; Ointments; Remission Induction; Skin Neoplasms	2006
Immunological strategies to fight skin cancer. Skin therapy letter, 2006, Volume: 11, Issue:5 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Immunologic Factors; Interferons; Skin Neoplasms	2006
[Skin cancer after organ transplantation]. Deutsche medizinische Wochenschrift (1946), 2006, Jul-14, Volume: 131, Issue:28-29 Topics: Adjuvants, Immunologic; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Diclofenac; Gels; Humans; Hyaluronic Acid; Imiquimod; Immunosuppression Therapy; Immunosuppressive Agents; Organ Transplantation; Photochemotherapy; Risk Factors; Skin Neoplasms	2006
[Actinic keratosis]. MMW Fortschritte der Medizin, 2006, Jun-15, Volume: 148, Issue:24 Topics: Adjuvants, Immunologic; Age Factors; Aged; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Humans; Imiquimod; Interferon Inducers; Keratosis; Laser Therapy; Male; Ointments; Photochemotherapy; Precancerous Conditions; Risk Factors; Skin Neoplasms; Time Factors; Ultraviolet Rays	2006
Imiquimod in the treatment of lentigo maligna. The British journal of dermatology, 2006, Volume: 155, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Interferon Inducers; Skin Neoplasms	2006
The role of topical immune response modifiers in skin cancer. Drugs, 2006, Volume: 66, Issue:13 Topics: Adjuvants, Immunologic; Aminoquinolines; Antineoplastic Agents; Cytokines; Humans; Imidazoles; Imiquimod; Models, Biological; Skin Neoplasms; Toll-Like Receptors	2006
[Basal cell carcinoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:10 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Humans; Imiquimod; Mohs Surgery; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2006
Guidelines for management of Bowen's disease: 2006 update. The British journal of dermatology, 2007, Volume: 156, Issue:1 Topics: Adjuvants, Immunologic; Aminoquinolines; Bowen's Disease; Cautery; Cryotherapy; Curettage; Disease Progression; Evidence-Based Medicine; Fluorouracil; Humans; Imiquimod; Immunosuppression Therapy; Laser Therapy; Photochemotherapy; Risk Factors; Skin Neoplasms	2007
Therapeutic options for Bowen's disease. The Australasian journal of dermatology, 2007, Volume: 48, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Cautery; Cryotherapy; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2007
Successful treatment of perianal Bowen's disease with imiquimod. International journal of dermatology, 2007, Volume: 46, Issue:3 Topics: Aminoquinolines; Anal Canal; Antineoplastic Agents; Bowen's Disease; Humans; Imiquimod; Male; Middle Aged; Remission Induction; Skin Neoplasms	2007
Pharmacological treatments for basal cell carcinoma. Drugs, 2007, Volume: 67, Issue:6 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Injections, Intralesional; Photochemotherapy; Skin Neoplasms	2007
The treatment of viral infections and nonmelanoma skin cancers. Cutis, 2007, Volume: 79, Issue:4 Suppl Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Antiviral Agents; Humans; Imiquimod; Interferons; Skin Diseases, Viral; Skin Neoplasms	2007
Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer. Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:11 Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Carcinoma, Basal Cell; Humans; Imiquimod; Photosensitivity Disorders; Precancerous Conditions; Skin Diseases; Skin Neoplasms	2007
Treatment options for actinic keratoses. American family physician, 2007, Sep-01, Volume: 76, Issue:5 Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Chemexfoliation; Cryosurgery; Curettage; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photochemotherapy; Prevalence; Skin Neoplasms	2007
Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions. Drugs, 2007, Volume: 67, Issue:15 Topics: Aminoquinolines; Animals; Antineoplastic Agents; Carcinoma, Basal Cell; Condylomata Acuminata; Humans; Imiquimod; Photosensitivity Disorders; Skin Diseases; Skin Neoplasms	2007
Update on actinic keratosis in clinical trial experience with imiquimod. The British journal of dermatology, 2007, Volume: 157 Suppl 2 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Imiquimod; Keratosis; Neoplasms, Radiation-Induced; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays	2007
Scientific rationale: combining imiquimod and surgical treatments for basal cell carcinomas. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:1 Suppl 1 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cicatrix; Combined Modality Therapy; Humans; Imiquimod; Skin Neoplasms	2008
Antiangiogenesis in the treatment of skin cancer. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:1 Suppl 1 Topics: Adjuvants, Immunologic; Aminoquinolines; Angiogenesis Inhibitors; Antineoplastic Agents; Drug Delivery Systems; Humans; Imiquimod; Neovascularization, Pathologic; Signal Transduction; Skin Neoplasms	2008
Nevoid basal cell carcinoma syndrome (Gorlin syndrome): updated review of minimally invasive treatments. Cutis, 2008, Volume: 81, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Cryosurgery; Electrochemotherapy; Fluorouracil; Humans; Imiquimod; Immunologic Factors; Interferons; Photochemotherapy; Randomized Controlled Trials as Topic; Retinoids; Skin Neoplasms	2008
Topical therapy for actinic keratoses: current and evolving therapies. Reviews on recent clinical trials, 2006, Volume: 1, Issue:1 Topics: Administration, Cutaneous; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Colchicine; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Neoplasms, Squamous Cell; Retinoids; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays	2006
Treatment of a large superficial basal cell carcinoma with 5% imiquimod: a case report and review of the literature. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2002, Volume: 28, Issue:4 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Arm; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms	2002
Successful treatment of multiple superficial basal cell carcinomas with topical imiquimod: case report and review of the literature. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2002, Volume: 28, Issue:5 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms	2002
Imiquimod: a potential role in dermatology? The British journal of dermatology, 2002, Volume: 147, Issue:1 Topics: Aminoquinolines; Condylomata Acuminata; Dermatologic Agents; Humans; Imiquimod; Interferon Inducers; Keratosis; Skin Diseases; Skin Neoplasms	2002

Trials

91 trial(s) available for imiquimod and Skin Neoplasms

Article	Year
Randomized trial of topical ascorbic acid in DMSO versus imiquimod for the treatment of basal cell carcinoma. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 148 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Ascorbic Acid; Carcinoma, Basal Cell; Dimethyl Sulfoxide; Humans; Imiquimod; Skin Neoplasms; Treatment Outcome	2022
Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis: A Secondary Analysis of a Randomized Clinical Trial. JAMA dermatology, 2022, 06-01, Volume: 158, Issue:6 Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Skin Neoplasms; Treatment Outcome	2022
Efficacy of imiquimod in the management of lentigo maligna. Journal of the European Academy of Dermatology and Venereology : JEADV, 2023, Volume: 37, Issue:9 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms	2023
Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial. Journal of the American Academy of Dermatology, 2020, Volume: 83, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Combined Modality Therapy; Curettage; Dermatologic Surgical Procedures; Disease-Free Survival; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Skin; Skin Cream; Skin Neoplasms	2020
Change in lentigo maligna score assessed by in vivo reflectance confocal microscopy after 1 month of imiquimod treatment for lentigo maligna management. Journal of the American Academy of Dermatology, 2022, Volume: 86, Issue:5 Topics: Dermoscopy; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Microscopy, Confocal; Skin Neoplasms	2022
Antibiotics and Imiquimod for Cutaneous T-Cell Lymphoma in Veterans: A Patient Population with Agent Orange Exposure. The oncologist, 2021, Volume: 26, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Agent Orange; Anti-Bacterial Agents; Humans; Imiquimod; Lymphoma, T-Cell, Cutaneous; Middle Aged; Skin Neoplasms; Veterans	2021
Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist. Journal for immunotherapy of cancer, 2021, Volume: 9, Issue:5 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adolescent; Adult; Aged; Cancer Vaccines; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Freund's Adjuvant; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Imiquimod; Immunogenicity, Vaccine; Injections, Intradermal; Injections, Subcutaneous; Lipids; Male; Melanoma; Melanoma-Specific Antigens; Middle Aged; Skin Neoplasms; Time Factors; Toll-Like Receptor 7; Treatment Outcome; Vaccination; Vaccines, Subunit; Young Adult	2021
Patient preferences for the attributes of a noninvasive treatment for superficial basal cell carcinoma: a discrete choice experiment. The British journal of dermatology, 2018, Volume: 178, Issue:1 Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Choice Behavior; Dermatologic Agents; Drug Therapy, Combination; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Patient Preference; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2018
Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases-a phase II, single centre, randomised, pilot study. BMJ open, 2017, Oct-06, Volume: 7, Issue:10 Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Clinical Protocols; Cyclopropanes; Female; Humans; Imiquimod; Immunotherapy; Male; Melanoma; Middle Aged; Pilot Projects; Remission Induction; Research Design; Skin Neoplasms; Treatment Outcome; Young Adult	2017
Imiquimod 5% cream as a therapeutic option for extramammary Paget's disease. The Journal of dermatology, 2018, Volume: 45, Issue:2 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Paget Disease, Extramammary; Prospective Studies; Remission Induction; Skin; Skin Cream; Skin Neoplasms; Treatment Outcome	2018
Comparison of long-term cosmetic outcomes for different treatments of superficial basal cell carcinoma. Journal of the American Academy of Dermatology, 2018, Volume: 79, Issue:5 Topics: Adult; Aged; Carcinoma, Basal Cell; Dermatologic Surgical Procedures; Esthetics; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Netherlands; Photochemotherapy; Risk Assessment; Skin Neoplasms; Time Factors; Treatment Outcome	2018
Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod. Scientific reports, 2019, 06-12, Volume: 9, Issue:1 Topics: Adult; Aged; Breast Neoplasms; CD8-Positive T-Lymphocytes; Female; Gene Expression Profiling; Humans; Imiquimod; Immunity, Cellular; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Th1 Cells	2019
Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. The Lancet. Oncology, 2013, Volume: 14, Issue:7 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents; Prognosis; Single-Blind Method; Skin Neoplasms	2013
Immunocryosurgery for non-superficial basal cell carcinoma: a pro-spective, open-label phase III study for tumours ≤ 2 cm in diameter. Acta dermato-venereologica, 2014, Volume: 94, Issue:1 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Facial Neoplasms; Feasibility Studies; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms; Treatment Failure; Tumor Burden	2014
Optical coherence tomography imaging of non-melanoma skin cancer undergoing imiquimod therapy. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2014, Volume: 20, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Melanoma; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, Optical Coherence; Treatment Outcome	2014
Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. The Lancet. Oncology, 2014, Volume: 15, Issue:1 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Ointments; Skin Neoplasms	2014
Twelve-week treatment of lentigo maligna with imiquimod results in a high and sustained clearance rate. Acta dermato-venereologica, 2015, Volume: 95, Issue:1 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Drug Administration Schedule; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Prospective Studies; Remission Induction; Skin Neoplasms; Time Factors; Treatment Outcome	2015
Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma. The British journal of dermatology, 2014, Volume: 171, Issue:6 Topics: Administration, Cutaneous; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Cost Savings; Cost-Benefit Analysis; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2014
Photodynamic therapy vs. imiquimod 5% cream as skin cancer preventive strategies in patients with field changes: a randomized intraindividual comparison study. Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:2 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Female; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Skin Neoplasms	2015
Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial. The British journal of dermatology, 2015, Volume: 172, Issue:3 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Ointments; Photochemotherapy; Photosensitizing Agents; Single-Blind Method; Skin Neoplasms; Treatment Outcome	2015
Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma. Dermatology (Basel, Switzerland), 2015, Volume: 230, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Extremities; Facial Neoplasms; Female; Hemangioma, Capillary; Humans; Imiquimod; Infant; Male; Neoplastic Syndromes, Hereditary; Non-Randomized Controlled Trials as Topic; Ointments; Ophthalmic Solutions; Skin Neoplasms; Timolol; Torso	2015
Patient Perception of Imiquimod Treatment for Actinic Keratosis and Superficial Basal Cell Carcinoma in 202 Patients. Dermatology (Basel, Switzerland), 2015, Volume: 231, Issue:1 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Patient Satisfaction; Quality of Life; Skin Cream; Skin Neoplasms; Surveys and Questionnaires	2015
Prognostic markers in lentigo maligna patients treated with imiquimod cream: A long-term follow-up study. Journal of the American Academy of Dermatology, 2016, Volume: 74, Issue:1 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biomarkers, Tumor; Biopsy, Needle; Disease-Free Survival; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunohistochemistry; Male; Melanocytes; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Risk Assessment; Skin Cream; Skin Neoplasms; Switzerland; Time Factors; Treatment Outcome	2016
Three-Year Follow-Up Results of Photodynamic Therapy vs. Imiquimod vs. Fluorouracil for Treatment of Superficial Basal Cell Carcinoma: A Single-Blind, Noninferiority, Randomized Controlled Trial. The Journal of investigative dermatology, 2016, Volume: 136, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Proportional Hazards Models; Single-Blind Method; Skin Neoplasms; Treatment Outcome	2016
Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT-1 study. The British journal of dermatology, 2017, Volume: 176, Issue:5 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Skin Neoplasms; Treatment Outcome	2017
Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial. The Journal of investigative dermatology, 2017, Volume: 137, Issue:3 Topics: Administration, Topical; Adolescent; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Child; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Young Adult	2017
Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical Trial. JAMA oncology, 2017, Jul-01, Volume: 3, Issue:7 Topics: Administration, Cutaneous; Administration, Intravenous; Aged; Aged, 80 and over; Albumins; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Flow Cytometry; Humans; Imiquimod; Lymphocytes, Tumor-Infiltrating; Middle Aged; Monocytes; Paclitaxel; Programmed Cell Death 1 Receptor; Salvage Therapy; Skin Neoplasms; Treatment Outcome	2017
Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% cream. The Journal of dermatological treatment, 2008, Volume: 19, Issue:3 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Follow-Up Studies; Histocytological Preparation Techniques; Humans; Imiquimod; Male; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Skin; Skin Neoplasms; Treatment Outcome	2008
Topical imiquimod and intralesional interleukin-2 increase activated lymphocytes and restore the Th1/Th2 balance in patients with metastatic melanoma. The British journal of dermatology, 2008, Volume: 159, Issue:3 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Biomarkers; Female; Flow Cytometry; Humans; Imiquimod; Immunotherapy, Active; Injections, Intralesional; Interferon Inducers; Interferon-gamma; Interleukin-2; Interleukin-4; Interleukin-5; Longitudinal Studies; Lymphocyte Activation; Male; Melanoma; Middle Aged; Skin Neoplasms; Statistics, Nonparametric; Th1 Cells; Th2 Cells	2008
Imiquimod treatment of lentigo maligna: an open-label study of 34 primary lesions in 32 patients. Archives of dermatology, 2008, Volume: 144, Issue:7 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Face; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Skin Neoplasms; Treatment Outcome	2008
In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma. International journal of dermatology, 2009, Volume: 48, Issue:3 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Apoptosis; Carcinoma, Basal Cell; CD3 Complex; CD4 Antigens; Female; Humans; Imiquimod; Inflammation; Male; Middle Aged; Ointments; Skin Neoplasms; T-Lymphocyte Subsets	2009
The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma. Trials, 2010, Apr-21, Volume: 11 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cost-Benefit Analysis; Drug Costs; Female; Genotype; Health Care Costs; Humans; Imiquimod; Male; Ointments; Patient Satisfaction; Phenotype; Polymorphism, Genetic; Prospective Studies; Recurrence; Research Design; Skin Neoplasms; Time Factors; Treatment Outcome	2010
Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study. Cutis, 2010, Volume: 85, Issue:6 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Follow-Up Studies; Humans; Imiquimod; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms; Treatment Outcome	2010
Comparison of topical 3% diclofenac sodium gel and 5% imiquimod cream for the treatment of actinic keratoses. Clinical and experimental dermatology, 2011, Volume: 36, Issue:5 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Diclofenac; Female; Gels; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Ointments; Single-Blind Method; Skin Neoplasms; Treatment Outcome	2011
Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil. Investigational new drugs, 2012, Volume: 30, Issue:4 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Imiquimod; Melanoma; Neoplasm Metastasis; Skin Neoplasms; Skin Ulcer; Treatment Outcome	2012
Immunomodulation by imiquimod in patients with high-risk primary melanoma. The Journal of investigative dermatology, 2012, Volume: 132, Issue:1 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Female; Humans; Imiquimod; Immunologic Factors; Male; Melanoma; Pilot Projects; Preoperative Care; Prospective Studies; Risk Factors; Skin; Skin Neoplasms; T-Lymphocytes; Toll-Like Receptor 7; Treatment Outcome	2012
Efficacy of imiquimod cream, 5%, for lentigo maligna after complete excision: a study of 43 patients. Archives of dermatology, 2011, Volume: 147, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Emollients; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Skin Neoplasms; Treatment Outcome; Young Adult	2011
Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study. The British journal of dermatology, 2012, Volume: 167, Issue:1 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aminoquinolines; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Male; Middle Aged; Mohs Surgery; Ointments; Preoperative Care; Prospective Studies; Skin Neoplasms; Treatment Outcome; Tumor Burden	2012
A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions. Archives of dermatology, 2012, Volume: 148, Issue:5 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Cheek; Dermatologic Agents; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Gels; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Mohs Surgery; Nicotinic Acids; Off-Label Use; Ointments; Postoperative Care; Prospective Studies; Skin Neoplasms; Treatment Outcome	2012
Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Dec-15, Volume: 18, Issue:24 Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Cytokines; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms; T-Lymphocytes; Toll-Like Receptor 7; Treatment Outcome; Tumor Microenvironment	2012
Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patients. European journal of immunology, 2012, Volume: 42, Issue:11 Topics: Adjuvants, Immunologic; Aminoquinolines; Cancer Vaccines; CD8-Positive T-Lymphocytes; Flow Cytometry; Freund's Adjuvant; Humans; Imiquimod; Immunologic Memory; Ligands; Lipids; MART-1 Antigen; Melanoma; Nanoparticles; Oligodeoxyribonucleotides; Skin Neoplasms; Statistics, Nonparametric; Toll-Like Receptor 7; Toll-Like Receptor 9	2012
What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial. BMC dermatology, 2012, Oct-04, Volume: 12 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Choice Behavior; Female; Humans; Imiquimod; Male; Middle Aged; Patient Preference; Risk Factors; Skin Cream; Skin Neoplasms; Surgical Procedures, Operative; Surveys and Questionnaires	2012
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. Journal of the American Academy of Dermatology, 2002, Volume: 47, Issue:3 Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Double-Blind Method; Female; Humans; Imiquimod; Male; Middle Aged; Ointments; Skin Neoplasms	2002
Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Archives of dermatology, 2002, Volume: 138, Issue:9 Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Australia; Biopsy, Needle; Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; New Zealand; Probability; Prospective Studies; Reference Values; Skin Neoplasms; Treatment Outcome	2002
Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. The British journal of dermatology, 2002, Volume: 147, Issue:6 Topics: Administration, Cutaneous; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Administration Schedule; Drug Eruptions; Female; Humans; Imiquimod; Male; Middle Aged; Occlusive Dressings; Skin Neoplasms; Treatment Outcome	2002
Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Archives of dermatology, 2003, Volume: 139, Issue:10 Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 2; ATP-Binding Cassette Transporters; Carcinoma, Basal Cell; Fas Ligand Protein; fas Receptor; Genes, bcl-2; Humans; Imiquimod; Intercellular Adhesion Molecule-1; Interleukin-10; Membrane Glycoproteins; Pilot Projects; Remission Induction; Skin Neoplasms	2003
Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle. The British journal of dermatology, 2003, Volume: 149 Suppl 66 Topics: Adjuvants, Immunologic; Aminoquinolines; Apoptosis; Carcinoma, Basal Cell; Case-Control Studies; fas Receptor; Humans; Imiquimod; Immunohistochemistry; Lymphocyte Activation; Single-Blind Method; Skin Neoplasms	2003
Evaluation of superficial basal cell carcinomas after treatment with imiquimod 5% cream or vehicle for apoptosis and lymphocyte phenotyping. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2003, Volume: 29, Issue:12 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Apoptosis; Carcinoma, Basal Cell; Dosage Forms; Female; Humans; Imiquimod; Lymphocytes; Male; Middle Aged; Phenotype; Skin Neoplasms	2003
Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2004, Volume: 30, Issue:3 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Follow-Up Studies; Humans; Imiquimod; Prospective Studies; Skin Neoplasms	2004
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. Journal of the American Academy of Dermatology, 2004, Volume: 50, Issue:5 Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Aminoquinolines; Carcinoma, Basal Cell; Double-Blind Method; Female; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Ointments; Pharmaceutical Vehicles; Skin Neoplasms	2004
Efficacy of imiquimod 5% cream for basal cell carcinoma in transplant patients. Clinical and experimental dermatology, 2004, Volume: 29, Issue:3 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Heart Transplantation; Humans; Imiquimod; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Skin Neoplasms; Treatment Outcome	2004
Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod. The Journal of investigative dermatology, 2004, Volume: 122, Issue:5 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Biopsy; Cell Line, Tumor; fas Receptor; Humans; Imidazoles; Imiquimod; Melanocytes; Melanoma; Membrane Glycoproteins; Proto-Oncogene Proteins c-bcl-2; Receptors, Tumor Necrosis Factor; Skin Neoplasms; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha	2004
Imiquimod 5% cream in the treatment of mycosis fungoides--a pilot study. The Journal of dermatological treatment, 2004, Volume: 15, Issue:2 Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Double-Blind Method; Female; Humans; Imiquimod; Male; Middle Aged; Mycosis Fungoides; Pilot Projects; Skin Neoplasms; Treatment Outcome	2004
Occlusive medication with imiquimod in Bowen's disease. Acta dermato-venereologica, 2004, Volume: 84, Issue:2 Topics: Administration, Topical; Aged; Aminoquinolines; Biopsy, Needle; Bowen's Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Imiquimod; Immunohistochemistry; Male; Prognosis; Prospective Studies; Risk Assessment; Skin Neoplasms; Treatment Outcome	2004
Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma. Clinical and experimental dermatology, 2004, Volume: 29, Issue:5 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antigens, CD; Antineoplastic Agents; Apoptosis; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Ki-67 Antigen; Male; Middle Aged; Multivariate Analysis; Neoplasm Proteins; Prospective Studies; Proto-Oncogene Proteins c-bcl-2; Skin Neoplasms; Treatment Outcome; Tumor Suppressor Protein p53	2004
Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis. The British journal of dermatology, 2004, Volume: 151, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Apoptosis; Carcinoma, Basal Cell; Cell Division; Double-Blind Method; Down-Regulation; Female; Humans; Imiquimod; Immunoenzyme Techniques; Ki-67 Antigen; Male; Middle Aged; Neoplasm Proteins; Prospective Studies; Proto-Oncogene Proteins c-bcl-2; Skin Neoplasms; Tumor Suppressor Protein p53	2004
Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream. Journal of the American Academy of Dermatology, 2004, Volume: 51, Issue:4 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Female; Follow-Up Studies; Hemangioma; Humans; Imiquimod; Infant; Male; Skin Neoplasms; Treatment Outcome	2004
Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas. Archives of dermatology, 2004, Volume: 140, Issue:10 Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Extremities; Female; Humans; Imiquimod; Male; Neck; Skin Neoplasms; Thorax; Treatment Outcome	2004
5% imiquimod cream for the treatment of large superficial basal cell carcinoma. Archives of dermatology, 2004, Volume: 140, Issue:10 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Australia; Carcinoma, Basal Cell; Humans; Imiquimod; New Zealand; Skin Neoplasms; Treatment Outcome	2004
Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells. Clinical and experimental dermatology, 2004, Volume: 29, Issue:6 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; CD4-Positive T-Lymphocytes; Dendritic Cells; Humans; Imiquimod; Lymphocytes, Tumor-Infiltrating; Skin Neoplasms; Treatment Outcome	2004
5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2004, Volume: 30, Issue:12 Pt 1 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Boston; California; Carcinoma, Basal Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Double-Blind Method; Female; Hospitals, University; Humans; Imiquimod; Male; Microscopy, Confocal; Middle Aged; Mohs Surgery; Predictive Value of Tests; Skin Neoplasms; Treatment Outcome	2004
Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream. Journal of the American Academy of Dermatology, 2005, Volume: 52, Issue:2 Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Eruptions; Female; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Mycosis Fungoides; Ointments; Pilot Projects; PUVA Therapy; Skin Neoplasms	2005
Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials. Archives of dermatology, 2005, Volume: 141, Issue:4 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Keratosis; Male; Middle Aged; Ointments; Precancerous Conditions; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Skin Neoplasms; Statistics, Nonparametric; Treatment Outcome	2005
Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod. Archives of dermatology, 2005, Volume: 141, Issue:4 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunohistochemistry; Male; Pilot Projects; Risk Assessment; Single-Blind Method; Skin Neoplasms; Treatment Outcome	2005
Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2005, Volume: 31, Issue:3 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms; Treatment Outcome	2005
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. The British journal of dermatology, 2005, Volume: 152, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms; Treatment Outcome	2005
Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial. Archives of dermatology, 2005, Volume: 141, Issue:8 Topics: Acitretin; Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Double-Blind Method; Female; Humans; Imiquimod; Immunosuppression Therapy; Keratolytic Agents; Kidney Transplantation; Male; Middle Aged; Ointments; Precancerous Conditions; Risk Factors; Skin; Skin Neoplasms	2005
Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2006, Volume: 32, Issue:1 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Chemotherapy, Adjuvant; Desiccation; Double-Blind Method; Electrosurgery; Female; Humans; Imiquimod; Male; Neoplasm, Residual; Pilot Projects; Skin Neoplasms; Treatment Outcome	2006
An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma. The Australasian journal of dermatology, 2006, Volume: 47, Issue:1 Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy, Needle; Carcinoma, Basal Cell; Combined Modality Therapy; Curettage; Emollients; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Risk Assessment; Single-Blind Method; Skin Neoplasms; Treatment Outcome	2006
Double-blind, randomized, placebo-controlled, prospective study evaluating the tolerability and effectiveness of imiquimod applied to postsurgical excisions on scar cosmesis. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2005, Volume: 31, Issue:11 Pt 1 Topics: Adolescent; Adult; Aminoquinolines; Child; Cicatrix; Double-Blind Method; Esthetics; Female; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Nevus, Pigmented; Ointments; Prospective Studies; Skin Neoplasms; Treatment Outcome	2005
Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): a randomized, double-blind, placebo-controlled trial. Journal of the American Academy of Dermatology, 2006, Volume: 54, Issue:6 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Dosage Forms; Double-Blind Method; Female; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms	2006
Efficacy of imiquimod 5% cream in the treatment of equine sarcoids: a pilot study. Veterinary dermatology, 2006, Volume: 17, Issue:4 Topics: Administration, Cutaneous; Aminoquinolines; Animals; Antineoplastic Agents; Female; Horse Diseases; Horses; Imiquimod; Male; Neoplasm Recurrence, Local; Pilot Projects; Skin Neoplasms; Treatment Outcome	2006
Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:2 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Bowen's Disease; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Male; Neoplasm Invasiveness; Skin Neoplasms; Treatment Outcome	2006
Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases. The British journal of dermatology, 2006, Volume: 155, Issue:2 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Drug Administration Schedule; Humans; Imiquimod; Immunocompromised Host; Immunologic Factors; Keratosis; Male; Middle Aged; Photosensitivity Disorders; Pilot Projects; Precancerous Conditions; Skin Neoplasms; Transplants; Treatment Outcome	2006
Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks. The Australasian journal of dermatology, 2006, Volume: 47, Issue:4 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Australia; Carcinoma, Basal Cell; Drug Administration Schedule; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; New Zealand; Severity of Illness Index; Skin Neoplasms; Treatment Outcome	2006
Imiquimod as an antiaging agent. Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:3 Topics: Aminoquinolines; Antineoplastic Agents; Cell Count; Collagen; Dermis; Drug Administration Schedule; Epidermis; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Melanins; Melanocytes; Ointments; Skin Aging; Skin Neoplasms	2007
Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma. The British journal of dermatology, 2007, Volume: 156, Issue:2 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Female; Humans; Imiquimod; Injections, Intralesional; Interleukin-2; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Ointments; Skin Neoplasms; Treatment Outcome	2007
Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up. Archives of dermatology, 2007, Volume: 143, Issue:2 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Prospective Studies; Skin Neoplasms; Treatment Outcome	2007
Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head. The British journal of dermatology, 2007, Volume: 157, Issue:1 Topics: Aged; Aged, 80 and over; Aminoquinolines; Double-Blind Method; Female; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Middle Aged; Ointments; Photosensitivity Disorders; Scalp Dermatoses; Skin Neoplasms; Sunlight; Treatment Outcome	2007
A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma. Journal of the American Academy of Dermatology, 2007, Volume: 57, Issue:4 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Administration Schedule; Emollients; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm, Residual; Skin Neoplasms; Treatment Outcome	2007
Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up. Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:5 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome	2007
A randomized parallel study to assess the safety and efficacy of two different dosing regimens of 5% imiquimod in the treatment of superficial basal cell carcinoma. The Journal of dermatological treatment, 2008, Volume: 19, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Administration Schedule; Female; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms; Treatment Outcome	2008
Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage. Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:9 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Curettage; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatigue; Female; Headache; Humans; Imiquimod; Male; Middle Aged; Ointments; Pilot Projects; Skin Neoplasms; Treatment Outcome	2007
Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients. The British journal of dermatology, 2007, Volume: 157 Suppl 2 Topics: Administration, Cutaneous; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imiquimod; Immunocompromised Host; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Organ Transplantation; Skin Neoplasms; Treatment Outcome	2007
A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. The British journal of dermatology, 2007, Volume: 157 Suppl 2 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryosurgery; Esthetics; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Immunocompetence; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays	2007
Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head. The British journal of dermatology, 2007, Volume: 157 Suppl 2 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Facial Neoplasms; Female; Humans; Imiquimod; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Patient Compliance; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays	2007
Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients. Journal of the American Academy of Dermatology, 2008, Volume: 58, Issue:4 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Drug-Related Side Effects and Adverse Reactions; Female; HIV Seronegativity; Humans; Imiquimod; Male; Middle Aged; Patient Compliance; Prospective Studies; Sarcoma, Kaposi; Skin Neoplasms	2008
Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:1 Suppl 1 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Curettage; Desiccation; Follow-Up Studies; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome	2008
A 36-month clinical experience of the effectiveness of curettage and imiquimod 5% cream in the treatment of basal cell carcinoma. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:1 Suppl 1 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Combined Modality Therapy; Curettage; Electrosurgery; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms	2008
Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. Journal of the American Academy of Dermatology, 1999, Volume: 41, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Carcinoma, Basal Cell; Double-Blind Method; Humans; Imiquimod; Interferon Inducers; Middle Aged; Skin Neoplasms; Treatment Outcome	1999
Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. Journal of the American Academy of Dermatology, 2001, Volume: 44, Issue:5 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Australia; Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Imiquimod; Male; Middle Aged; New Zealand; Skin Neoplasms; Treatment Outcome	2001

Other Studies

534 other study(ies) available for imiquimod and Skin Neoplasms

Article	Year
Immunotherapy for the treatment of penile intraepithelial neoplasia associated with human papilloma virus type 16 using topical imiquimod and human papilloma virus vaccination. The Australasian journal of dermatology, 2021, Volume: 62, Issue:4 Topics: Aged; Human papillomavirus 16; Humans; Imiquimod; Male; Middle Aged; Papillomavirus Infections; Papillomavirus Vaccines; Penile Neoplasms; Skin Neoplasms	2021
Therapeutic efficacy of topical imiquimod cream on keratoacanthoma: A retrospective single-center study. Journal of the American Academy of Dermatology, 2022, Volume: 87, Issue:3 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Keratoacanthoma; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2022
Prognostic factors for treatment failure of imiquimod treatment in basal cell carcinoma - an observational study. Journal of the European Academy of Dermatology and Venereology : JEADV, 2022, Volume: 36, Issue:6 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Prognosis; Skin Neoplasms; Treatment Failure; Treatment Outcome	2022
Re: Reply to letter to the editor re: 'practical guide on the use of imiquimod cream to treat lentigo maligna'. The Australasian journal of dermatology, 2022, Volume: 63, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin Neoplasms	2022
Immunocryosurgery is a safe and feasible treatment for basal cell carcinoma and Bowen disease in renal transplant recipients. Dermatologic therapy, 2022, Volume: 35, Issue:5 Topics: Aged; Anus Neoplasms; Bowen's Disease; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Kidney Transplantation; Male; Middle Aged; Skin Neoplasms	2022
Reply to: A practical guide on the use of imiquimod cream to treat lentigo maligna. The Australasian journal of dermatology, 2022, Volume: 63, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin Neoplasms	2022
Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences. Actas dermo-sifiliograficas, 2022, Volume: 113, Issue:4 Topics: Aminoquinolines; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms	2022
Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences. Actas dermo-sifiliograficas, 2022, Volume: 113, Issue:4 Topics: Aminoquinolines; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms	2022
A comparison of invasive squamous cell carcinoma greater than 1 year after treatment with 5-fluorouracil, imiquimod, or photodynamic therapy with aminolevulinic acid. Journal of the American Academy of Dermatology, 2022, Volume: 87, Issue:3 Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2022
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statem International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2022, 07-04, Volume: 32, Issue:7 Topics: Carcinoma in Situ; Cidofovir; Colposcopy; Female; Genital Neoplasms, Female; Humans; Imiquimod; Melanoma; Melanoma, Cutaneous Malignant; Paget Disease, Extramammary; Pregnancy; Skin Neoplasms; Vulvar Neoplasms	2022
Treatment of solar lentigo with imiquimod 3.75% cream: A dermoscopic study. Journal of cosmetic dermatology, 2022, Volume: 21, Issue:11 Topics: Dermoscopy; Humans; Imiquimod; Lentigo; Skin Neoplasms	2022
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statem Journal of lower genital tract disease, 2022, Jul-01, Volume: 26, Issue:3 Topics: Carcinoma in Situ; Colposcopy; Female; Humans; Imiquimod; Melanoma; Melanoma, Cutaneous Malignant; Paget Disease, Extramammary; Pregnancy; Skin Neoplasms; Squamous Intraepithelial Lesions; Vulvar Neoplasms	2022
Complete response of locally advanced cutaneous squamous cell carcinoma of the eyelid to topical imiquimod 3.75. Dermatologic therapy, 2022, Volume: 35, Issue:11 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Eyelids; Humans; Imiquimod; Skin Neoplasms; Treatment Outcome	2022
Imiquimod-induced ROS production causes lysosomal membrane permeabilization and activates caspase-8-mediated apoptosis in skin cancer cells. Journal of dermatological science, 2022, Volume: 107, Issue:3 Topics: Animals; Antiviral Agents; Apoptosis; Caspase 8; Cathepsins; DNA; Humans; Imiquimod; Ligands; Lysosomes; Mice; Reactive Oxygen Species; Signal Transduction; Skin Neoplasms; Toll-Like Receptor 7	2022
A case of topical imiquimod induced fatigue. The Journal of dermatological treatment, 2022, Volume: 33, Issue:8 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Skin Neoplasms	2022
Successful treatment of giant Bowen's disease with photodynamic therapy and subsequent imiquimod in a case with chronic arsenic exposure. Photodiagnosis and photodynamic therapy, 2022, Volume: 40 Topics: Aminolevulinic Acid; Bowen's Disease; Humans; Imiquimod; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2022
Imiquimod-induced hypertrophic lupus erythematosus-like reaction. Dermatology online journal, 2022, Aug-15, Volume: 28, Issue:4 Topics: Aged, 80 and over; Aminoquinolines; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Immunologic Factors; Interferons; Lupus Erythematosus, Discoid; Skin Neoplasms; Toll-Like Receptor 7	2022
Successful treatment of extremely large Bowen's disease lesion by topical photodynamic therapy and imiquimod: Using optical coherence tomography to detect early recurrence loci and validate the cure. Photodiagnosis and photodynamic therapy, 2023, Volume: 41 Topics: Aminoquinolines; Bowen's Disease; Humans; Imiquimod; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Tomography, Optical Coherence	2023
Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcoma. Journal of medical virology, 2023, Volume: 95, Issue:1 Topics: Cryotherapy; Female; HIV Infections; Homosexuality, Male; Humans; Imiquimod; Immunotherapy; Male; Middle Aged; Sarcoma, Kaposi; Sexual and Gender Minorities; Skin Neoplasms	2023
Diagnosis and management of basal cell carcinoma: interdisciplinary consensus statements of Jose R. Reyes Memorial Medical Center, a Department of Health Tertiary Hospital in Manila, Philippines. International journal of dermatology, 2023, Volume: 62, Issue:6 Topics: Carcinoma, Basal Cell; Humans; Imiquimod; Mohs Surgery; Philippines; Skin Neoplasms; Tertiary Care Centers	2023
Cutaneous T-Cell Lymphoma Treatment: Case Series of Combination Therapy With Intralesional Injections of 5-Fluorouracil and Topical Imiquimod. Cutis, 2023, Volume: 111, Issue:1 Topics: Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Lymphoma, T-Cell, Cutaneous; Skin Neoplasms	2023
Imiquimod chemoprophylaxis for field cancerization in xeroderma pigmentosum patients-A prospective study. The Australasian journal of dermatology, 2023, Volume: 64, Issue:3 Topics: Chemoprevention; Humans; Imiquimod; Prospective Studies; Skin Neoplasms; Xeroderma Pigmentosum	2023
Patient's Experience With Imiquimod for Extramammary Paget Disease. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2023, 07-01, Volume: 49, Issue:7 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Paget Disease, Extramammary; Skin Neoplasms	2023
Assessing the Efficacy of Imiquimod Use in Patients With Persistent Locally Advanced Melanoma In Situ Journal of drugs in dermatology : JDD, 2023, 05-01, Volume: 22, Issue:5 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Melanoma; Melanoma, Cutaneous Malignant; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2023
RECURRENT LENTIGO MALIGNA: CONSERVATIVE CONTINUOUS TREATMENT WITH IMIQUIMOD OR REPEATED SURGERY? A LONG-TERM FOLLOW-UP DERMOSCOPIC CASE STUDY. Experimental oncology, 2023, 06-26, Volume: 45, Issue:1 Topics: Aminoquinolines; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Skin Neoplasms	2023
Rate of recurrence following treatment of lentigo maligna with carbon dioxide laser alone or in combination with imiquimod: Results of a long-term study. Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2023, Volume: 85 Topics: Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Lasers, Gas; Longitudinal Studies; Neoplasm Recurrence, Local; Skin Neoplasms	2023
[Current Management of Basal Cell Carcinoma]. Deutsche medizinische Wochenschrift (1946), 2023, Volume: 148, Issue:17 Topics: Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Cryotherapy; Fluorouracil; Humans; Imiquimod; Phototherapy; Radiotherapy; Skin Neoplasms	2023
Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice. European journal of immunology, 2019, Volume: 49, Issue:11 Topics: Administration, Cutaneous; Allografts; Animals; CD27 Ligand; CD40 Ligand; Cytotoxicity, Immunologic; Gene Expression; Graft Rejection; Imiquimod; Immunization; Immunologic Memory; Immunotherapy; Melanoma, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Ovalbumin; Skin; Skin Neoplasms; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Helper-Inducer; Toll-Like Receptor 7	2019
Letter to the editor submitted in response to "efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a Meta-analysis of randomised controlled trial". The Journal of dermatological treatment, 2021, Volume: 32, Issue:4 Topics: Aminoquinolines; Carcinoma, Basal Cell; Humans; Imiquimod; Skin Neoplasms	2021
Strategies for Reducing Final Surgical Defect Sizes in the Treatment of Lentigo Maligna. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2020, Volume: 46, Issue:4 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Biopsy; Chemotherapy, Adjuvant; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Margins of Excision; Middle Aged; Neoplasm Staging; Retrospective Studies; Skin Neoplasms; Surgical Wound; Suture Techniques; Treatment Outcome	2020
Response to 'Long-term outcomes of imiquimod-treated lentigo maligna'. Clinical and experimental dermatology, 2020, Volume: 45, Issue:2 Topics: Aminoquinolines; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin Neoplasms	2020
What are the ethical and legal considerations when your patient refuses the standard of care? Dermatology online journal, 2019, Aug-15, Volume: 25, Issue:8 Topics: Aged; Antineoplastic Agents; Carcinoma, Basal Cell; Dermatologists; Female; Humans; Imiquimod; Informed Consent; Mohs Surgery; Off-Label Use; Patient Transfer; Referral and Consultation; Refusal to Treat; Skin Neoplasms; Standard of Care; Treatment Refusal	2019
A Distinct Pretreatment Immune Gene Signature in Lentigo Maligna Is Associated with Imiquimod Response. The Journal of investigative dermatology, 2020, Volume: 140, Issue:4 Topics: Adjuvants, Immunologic; Administration, Topical; B7-H1 Antigen; Biopsy; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunity, Cellular; Skin Neoplasms	2020
Eruptive squamous cell carcinoma in a patient treated with concomitant pembrolizumab and imiquimod. The Journal of dermatology, 2019, Volume: 46, Issue:12 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Lung Neoplasms; Neoplasms, Second Primary; Skin Neoplasms; Urinary Bladder Neoplasms	2019
Contemporary management of actinic keratosis. The Journal of dermatological treatment, 2021, Volume: 32, Issue:5 Topics: Carcinoma, Squamous Cell; Cryotherapy; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms	2021
A TLR7 agonist strengthens T and NK cell function during BRAF-targeted therapy in a preclinical melanoma model. International journal of cancer, 2020, 03-01, Volume: 146, Issue:5 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Imiquimod; Indoles; Killer Cells, Natural; Lymphocytes, Tumor-Infiltrating; Male; Melanoma, Experimental; Membrane Glycoproteins; Mice; Mutation; Natural Killer T-Cells; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; T-Lymphocytes; Toll-Like Receptor 7	2020
Spontaneous regression of genital warts at untreated sites following electrocoagulation treatment for lesions at the other sites. The Journal of dermatology, 2020, Volume: 47, Issue:2 Topics: Adult; Antineoplastic Agents; Combined Modality Therapy; Condylomata Acuminata; Cryotherapy; Electrocoagulation; Human papillomavirus 6; Humans; Imiquimod; Male; Perineum; Remission, Spontaneous; Skin; Skin Cream; Skin Neoplasms; Treatment Outcome	2020
Non-surgical management of primary invasive melanoma. The Journal of dermatological treatment, 2021, Volume: 32, Issue:6 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Melanoma; Skin Neoplasms; Treatment Outcome; Tretinoin	2021
Severe balanoposthitis secondary to treatment with topical imiquimod. Archivos espanoles de urologia, 2019, Volume: 72, Issue:10 Topics: Administration, Topical; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Skin Neoplasms	2019
[Dermoscopic signs as predictors of non-response to imiquimod treatment in superficial basal cell carcinoma]. Anales del sistema sanitario de Navarra, 2019, Dec-05, Volume: 42, Issue:3 Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Carcinoma, Basal Cell; Dermoscopy; Female; Humans; Imiquimod; Male; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2019
Sequential Treatment of Superficial Basal Cell Carcinomas With Topical Methyl Aminolevulinate Photodynamic Therapy and Imiquimod 5% Cream: A Retrospective Study of Clinical and Cosmetic Outcomes. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2020, Volume: 46, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Combined Modality Therapy; Esthetics; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Skin Cream; Skin Neoplasms; Treatment Outcome	2020
Efficacy of imiquimod 3.75% cream for the treatment of solar lentigo. Dermatologic therapy, 2020, Volume: 33, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Lentigo; Skin Neoplasms; Treatment Outcome	2020
Imiquimod Exerts Antitumor Effects by Inducing Immunogenic Cell Death and Is Enhanced by the Glycolytic Inhibitor 2-Deoxyglucose. The Journal of investigative dermatology, 2020, Volume: 140, Issue:9 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Deoxyglucose; Drug Synergism; Glycolysis; Humans; Imiquimod; Immunogenic Cell Death; Male; Melanoma, Experimental; Mice; Skin Neoplasms	2020
Efficacy of Imiquimod 3.75% for the treatment of extensive Bowen's disease of the face in an elderly patient. Dermatologic therapy, 2020, Volume: 33, Issue:2 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Squamous Cell; Humans; Imiquimod; Skin Neoplasms; Treatment Outcome	2020
A pediatric approach to management of skin growths in basal cell nevus syndrome. Pediatric dermatology, 2020, Volume: 37, Issue:3 Topics: Aminoquinolines; Basal Cell Nevus Syndrome; Child; Child, Preschool; Fluorouracil; Humans; Imiquimod; Skin Neoplasms	2020
Topical imiquimod monotherapy for indolent primary cutaneous B-cell lymphomas: a single-institution experience. The British journal of dermatology, 2020, Volume: 183, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Lymphoma, B-Cell; Skin Neoplasms	2020
Combination Topical Chemotherapy for the Treatment of an Invasive Cutaneous Squamous Cell Carcinoma Journal of drugs in dermatology : JDD, 2020, Feb-01, Volume: 19, Issue:2 Topics: Administration, Cutaneous; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Diagnosis, Differential; Ear, External; Fluorouracil; Humans; Imiquimod; Male; Mohs Surgery; Skin Neoplasms	2020
Imiquimod for Superficial Basal Cell Carcinomas. International ophthalmology clinics, 2020,Spring, Volume: 60, Issue:2 Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Skin Neoplasms	2020
Clinical evaluation and efficacy of Imiquimod 3.75% cream for the treatment of actinic keratosis, pigmented basal cell carcinomas, and actinic cheilitis. Dermatologic therapy, 2020, Volume: 33, Issue:3 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Cheilitis; Humans; Imiquimod; Keratosis, Actinic; Skin Neoplasms	2020
Actinic keratosis: Treatment with imiquimod 3.75%-A comparative study between patients with previous in situ melanoma, patients with invasive melanoma and patients with negative history of melanoma. Dermatologic therapy, 2020, Volume: 33, Issue:4 Topics: Aminoquinolines; Humans; Imiquimod; Keratosis, Actinic; Melanoma; Skin Neoplasms	2020
In transit melanoma and imiquimod: A case of disease progression. Dermatologic therapy, 2020, Volume: 33, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Disease Progression; Humans; Imiquimod; Melanoma; Skin Neoplasms	2020
Imiquimod-induced ROS production disrupts the balance of mitochondrial dynamics and increases mitophagy in skin cancer cells. Journal of dermatological science, 2020, Volume: 98, Issue:3 Topics: Animals; Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Cell Survival; Free Radical Scavengers; Humans; Imiquimod; Keratinocytes; Mice; Mitochondria; Mitochondrial Dynamics; Mitophagy; Primary Cell Culture; Reactive Oxygen Species; Signal Transduction; Skin Neoplasms	2020
Earliest stage treatment of actinic keratosis with imiquimod 3.75% cream: Two case reports-Perspective for non melanoma skin cancer prevention. Dermatologic therapy, 2020, Volume: 33, Issue:4 Topics: Aged, 80 and over; Aminoquinolines; Child, Preschool; Female; Humans; Imiquimod; Infant; Keratosis, Actinic; Middle Aged; Skin Neoplasms; Treatment Outcome	2020
Should topical imiquimod be used for positive margins in lentigo maligna? Journal of the American Academy of Dermatology, 2021, Volume: 85, Issue:2 Topics: Administration, Topical; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Margins of Excision; Skin Neoplasms	2021
Successful treatment of topical imiquimod-resistant basal cell carcinoma by electronic X-ray brachytherapy. Dermatologic therapy, 2020, Volume: 33, Issue:4 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Brachytherapy; Carcinoma, Basal Cell; Electronics; Humans; Imiquimod; Skin Neoplasms; X-Rays	2020
Successful treatment of two cases of perianal Bowen disease with photodynamic therapy followed by imiquimod cream. Dermatologic therapy, 2020, Volume: 33, Issue:4 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Humans; Imiquimod; Photochemotherapy; Skin Neoplasms	2020
Topical Imiquimod for Management of Recurrent Lentigo Maligna Melanoma in Situ. Acta dermatovenerologica Croatica : ADC, 2020, Volume: 28, Issue:1 Topics: Administration, Topical; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms	2020
Lesional therapies for in-transit melanoma. Journal of surgical oncology, 2020, Volume: 122, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclopropanes; Female; Follow-Up Studies; Humans; Imiquimod; Injections, Intralesional; Interleukin-2; Male; Melanoma; Middle Aged; Prognosis; Retrospective Studies; Skin Neoplasms; Survival Rate	2020
Topical imiquimod monotherapy for a recurrent lesion of Merkel cell carcinoma. The British journal of dermatology, 2021, Volume: 184, Issue:2 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Humans; Imiquimod; Skin Neoplasms	2021
Comment on "Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial". Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:1 Topics: Carcinoma, Basal Cell; Curettage; Humans; Imiquimod; Skin Neoplasms	2021
Reply to: Comment on "Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial". Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:1 Topics: Carcinoma, Basal Cell; Curettage; Humans; Imiquimod; Skin Neoplasms	2021
Intradermal delivery of imiquimod using polymeric microneedles for basal cell carcinoma. International journal of pharmaceutics, 2020, Nov-15, Volume: 589 Topics: Administration, Cutaneous; Animals; Carcinoma, Basal Cell; Drug Delivery Systems; Imiquimod; Needles; Polymers; Skin Neoplasms; Swine	2020
Conservative treatment of lentigo maligna with topical imiquimod 5% cream: a case report. Dermatology online journal, 2020, Jul-15, Volume: 26, Issue:7 Topics: Administration, Topical; Aged, 80 and over; Antineoplastic Agents; Conservative Treatment; Drug Administration Schedule; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Nausea; Skin Neoplasms; Vomiting	2020
Immunocryosurgery for basal cell carcinoma: impact on circulating CD4 European journal of dermatology : EJD, 2020, Oct-01, Volume: 30, Issue:5 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Humans; Imiquimod; Interferon-alpha; Interleukin-10; Lymphocyte Count; Male; Middle Aged; Skin Neoplasms; T-Lymphocytes, Regulatory; Tumor Necrosis Factor-alpha	2020
Topical treatment of equine sarcoids with imiquimod 5% cream or Sanguinaria canadensis and zinc chloride - an open prospective study. Veterinary dermatology, 2020, Volume: 31, Issue:6 Topics: Animals; Chlorides; Horse Diseases; Horses; Imiquimod; Prospective Studies; Sanguinaria; Skin Neoplasms; Zinc Compounds	2020
Real-life data on basal cell carcinoma treatment: Insights on clinicians' therapeutic choices from an institutional hospital registry. Dermatologic therapy, 2020, Volume: 33, Issue:6 Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Hospitals; Humans; Imiquimod; Registries; Skin Neoplasms	2020
In lieu of penectomy: complete resolution of penile melanoma in situ with topical imiquimod and tretinoin. International journal of dermatology, 2021, Volume: 60, Issue:8 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Melanoma; Skin Neoplasms; Tretinoin	2021
Uncommon preputial localization of Langerhans cell histiocytosis. Pediatric dermatology, 2021, Volume: 38, Issue:2 Topics: Adolescent; Histiocytosis, Langerhans-Cell; Humans; Imiquimod; Male; Mometasone Furoate; Remission, Spontaneous; Skin Neoplasms	2021
Ingenol Mebutate and the Treatment of Actinic Keratosis. Journal of drugs in dermatology : JDD, 2021, 01-01, Volume: 20, Issue:1 Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Clinical Trials as Topic; Diterpenes; Fluorouracil; Humans; Imiquimod; Incidence; Keratosis, Actinic; Patient Preference; Photochemotherapy; Photosensitizing Agents; Risk Assessment; Skin Neoplasms; Treatment Outcome	2021
Perianal Paget's Disease. Diseases of the colon and rectum, 2021, Volume: 64, Issue:5 Topics: Administration, Cutaneous; Aged; Anal Canal; Antineoplastic Agents; Female; Humans; Imiquimod; Mohs Surgery; Paget Disease, Extramammary; Photochemotherapy; Radiotherapy; Skin Neoplasms	2021
A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers. Journal of drugs in dermatology : JDD, 2021, 03-01, Volume: 20, Issue:3 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cost-Benefit Analysis; Cryotherapy; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Tretinoin	2021
Topical Imiquimod for Lentigo Maligna: Survival Analysis of 103 Cases With 17 Years Follow-up. Journal of drugs in dermatology : JDD, 2021, 03-01, Volume: 20, Issue:3 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratolytic Agents; Male; Middle Aged; Neoplasm Recurrence, Local; Nicotinic Acids; Prospective Studies; Retrospective Studies; Skin Neoplasms; Time Factors	2021
Tumor Clearance and Immune Cell Recruitment in UV-Induced Murine Squamous Cell Carcinoma Exposed to Ablative Fractional Laser and Imiquimod Treatment. Lasers in surgery and medicine, 2021, Volume: 53, Issue:9 Topics: Animals; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Imiquimod; Lasers; Mice; Skin Neoplasms; Ultraviolet Rays	2021
Dermoscopic Features of Giant Molluscum Contagiosum in a Patient with Acquired Immunodeficiency Syndrome. Acta dermatovenerologica Croatica : ADC, 2020, Volume: 28, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adult; Child, Preschool; Female; Humans; Imiquimod; Melanoma; Molluscum Contagiosum; Skin Neoplasms	2020
Real-world experience of off-label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna. The British journal of dermatology, 2021, Volume: 185, Issue:3 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Off-Label Use; Skin Neoplasms	2021
Recurrence of a Basal Cell Carcinoma in a Vitiligo-like Area After Imiquimod Treatment. Actas dermo-sifiliograficas, 2021, Volume: 112 Suppl 1 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome; Vitiligo	2021
Treatment of Cutaneous Squamous Cell Carcinoma In Situ With Curettage Followed by Topical Imiquimod 5% Cream. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2021, 05-01, Volume: 47, Issue:5 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Curettage; Female; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms; Surveys and Questionnaires	2021
Novel Treatment of In-Transit Metastatic Melanoma With Shave Excision, Electrodesiccation and Curettage, and Topical Imiquimod 5% Cream. Journal of drugs in dermatology : JDD, 2021, May-01, Volume: 20, Issue:5 Topics: Aged, 80 and over; Chemotherapy, Adjuvant; Combined Modality Therapy; Curettage; Electrocoagulation; Humans; Imiquimod; Male; Melanoma; Skin Cream; Skin Neoplasms	2021
Topical imiquimod as neoadjuvant therapy before Mohs micrographic surgery for basal cell carcinoma in the head and neck region: findings from a large retrospective study. The British journal of dermatology, 2021, Volume: 185, Issue:4 Topics: Carcinoma, Basal Cell; Humans; Imiquimod; Mohs Surgery; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2021
Clinical and histologic features associated with lentigo maligna clearance after imiquimod treatment. The Journal of dermatological treatment, 2022, Volume: 33, Issue:4 Topics: Adjuvants, Immunologic; Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Margins of Excision; Skin Neoplasms; Treatment Outcome	2022
Long-term efficacy and safety of imiquimod 5% and fluorouracil 1% creams in medical monotherapy of complex eyelid basal cell carcinomas. European journal of ophthalmology, 2022, Volume: 32, Issue:4 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelids; Fluorouracil; Humans; Imiquimod; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2022
The combined effect of CO Journal of cosmetic dermatology, 2022, Volume: 21, Issue:5 Topics: Antineoplastic Agents; Carbon Dioxide; Carcinoma, Basal Cell; Diclofenac; Female; Humans; Imiquimod; Lasers, Gas; Male; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome	2022
Patient preferences for curettage followed by imiquimod 5% cream vs. surgical excision for the treatment of non-facial nodular basal cell carcinoma: a discrete choice experiment. Journal of the European Academy of Dermatology and Venereology : JEADV, 2022, Volume: 36, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Curettage; Humans; Imiquimod; Patient Preference; Skin Neoplasms; Treatment Outcome	2022
Immunological Overkilling Followed by Cellular Replenishment: A Novel 2-Step Treatment for Halo Congenital Melanocytic Nevus. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2021, 10-01, Volume: 47, Issue:10 Topics: Biopsy; Child; Combined Modality Therapy; Female; Forehead; Humans; Imiquimod; Keratinocytes; Melanocytes; Nevus, Halo; Nevus, Pigmented; Skin Cream; Skin Neoplasms; Transplantation, Autologous	2021
Long-Term Outcomes of Melanoma In Situ Treated With Topical 5% Imiquimod Cream: A Retrospective Review. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2017, Volume: 43, Issue:8 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Follow-Up Studies; Humans; Imiquimod; Male; Melanoma; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2017
Imiquimod treatment for lentigo maligna: LIMIT-1 trial. The British journal of dermatology, 2017, Volume: 177, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Lentigo; Skin Neoplasms	2017
Complete resolution of mycosis fungoides tumors with imiquimod 5% cream: a case series. The Journal of dermatological treatment, 2017, Volume: 28, Issue:6 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Etanercept; Female; Follow-Up Studies; Humans; Imiquimod; Immunosuppressive Agents; Male; Mycosis Fungoides; Remission Induction; Skin Cream; Skin Neoplasms; Ultraviolet Rays	2017
Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection. Journal of dermatological science, 2017, Volume: 87, Issue:3 Topics: Administration, Cutaneous; Aminoquinolines; Animals; Cell Movement; Disease Models, Animal; Emulsions; Epitopes; Flow Cytometry; Humans; Imiquimod; Langerhans Cells; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Major Histocompatibility Complex; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88; Signal Transduction; Skin; Skin Neoplasms; T-Lymphocytes, Cytotoxic; Toll-Like Receptor 7; Vaccination	2017
Combined immunotherapy: CTLA-4 blockade potentiates anti-tumor response induced by transcutaneous immunization. Journal of dermatological science, 2017, Volume: 87, Issue:3 Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antineoplastic Agents, Immunological; CTLA-4 Antigen; Drug Synergism; Flow Cytometry; Humans; Imiquimod; Immunologic Memory; Immunotherapy; Melanoma, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Ovalbumin; Peptide Fragments; Skin Neoplasms; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Toll-Like Receptor 7; Xenograft Model Antitumor Assays	2017
Multiple Basal Cell Carcinoma Arising in a Verrucous Epidermal Naevus: Clinical, Histological and Therapeutic Observations. Acta dermato-venereologica, 2018, 01-12, Volume: 98, Issue:1 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cryotherapy; Diterpenes; Female; Gels; Humans; Imiquimod; Neoplasms, Multiple Primary; Nevus, Sebaceous of Jadassohn; Skin Neoplasms; Treatment Outcome	2018
9-Phenanthrol enhances the generation of an CD8 Journal of dermatological science, 2017, Volume: 87, Issue:3 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Animals; Calcium; Cell Degranulation; Cell Movement; Dendritic Cells; Humans; Imiquimod; Immunity, Innate; Mast Cells; Melanoma; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phenanthrenes; Protein Kinase Inhibitors; Skin; Skin Neoplasms; T-Lymphocytes, Cytotoxic; TRPM Cation Channels; Vaccination; Xenograft Model Antitumor Assays	2017
Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments. PloS one, 2017, Volume: 12, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cytokines; Female; Humans; Imiquimod; Interleukin-23; Male; Middle Aged; Photochemotherapy; Real-Time Polymerase Chain Reaction; RNA, Messenger; Skin Neoplasms; Th17 Cells	2017
Topical Imiquimod for Melanoma In Situ? A Word of Caveat. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2018, Volume: 44, Issue:4 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Melanoma; Skin Neoplasms	2018
Acquired progressive lymphangioma: Case report with partial response to imiquimod 5% cream. Pediatric dermatology, 2017, Volume: 34, Issue:6 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Child, Preschool; Diagnosis, Differential; Female; Humans; Imiquimod; Lymphangioma; Sarcoma, Kaposi; Skin; Skin Neoplasms	2017
Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2018, Volume: 44, Issue:1 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Skin Cream; Skin Neoplasms; Time Factors	2018
Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma. The Journal of investigative dermatology, 2018, Volume: 138, Issue:3 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Ointments; Photochemotherapy; Skin Neoplasms	2018
Lymphoedema in patients with lentigo maligna treated with imiquimod: a long-term adverse effect. The British journal of dermatology, 2018, Volume: 178, Issue:6 Topics: Aged; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Lymphedema; Skin Neoplasms	2018
Successful treatment of giant invasive cutaneous squamous cell carcinoma by plum-blossom needle assisted photodynamic therapy sequential with imiquimod: Case experience. Photodiagnosis and photodynamic therapy, 2018, Volume: 21 Topics: Aged, 80 and over; Aminoquinolines; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Imiquimod; Male; Needles; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2018
T Cells Dominate the Local Immune Response Induced by Intralesional IL-2 in Combination with Imiquimod and Retinoid for In-Transit Metastatic Melanoma. The Journal of investigative dermatology, 2018, Volume: 138, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Female; Follow-Up Studies; Humans; Imiquimod; Injections, Intralesional; Interleukin-2; Male; Melanoma; Middle Aged; Retinoids; Skin Neoplasms; T-Lymphocytes; Treatment Outcome	2018
Guidelines of care for the management of basal cell carcinoma. Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:3 Topics: Administration, Cutaneous; Aminoquinolines; Anilides; Antineoplastic Agents; Carcinoma, Basal Cell; Dermatologic Surgical Procedures; Early Detection of Cancer; Humans; Imiquimod; Neoplasm Grading; Neoplasm Staging; Neoplasms, Second Primary; Photochemotherapy; Photosensitizing Agents; Pyridines; Radiotherapy; Skin Neoplasms; United States	2018
Reversed actinic damage in two children with xeroderma pigmentosum treated with topical imiquimod. Journal of the European Academy of Dermatology and Venereology : JEADV, 2018, Volume: 32, Issue:7 Topics: Administration, Cutaneous; Antineoplastic Agents; Carcinoma, Basal Cell; Child, Preschool; Eyelid Neoplasms; Humans; Imiquimod; Male; Nose Neoplasms; Skin Neoplasms; Xeroderma Pigmentosum	2018
Comparing Topical Treatments for Basal Cell Carcinoma. The Journal of investigative dermatology, 2018, Volume: 138, Issue:3 Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2018
Commentary on "Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma". Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2019, Volume: 45, Issue:1 Topics: Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Follow-Up Studies; Humans; Imiquimod; Skin Neoplasms	2019
Selective hemangioma cell dysfunction and apoptosis triggered by in vitro treatment with imiquimod. Toxicology letters, 2018, May-15, Volume: 288 Topics: Aminoquinolines; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Survival; Cellular Senescence; Cytoskeleton; Endothelial Cells; Hemangioma; Humans; Imiquimod; Melanoma, Experimental; Mice; Skin Neoplasms; Stress Fibers	2018
Variation in the diagnosis and clinical management of lentigo maligna across Europe: a survey study among European Association of Dermatologists and Venereologists members. Journal of the European Academy of Dermatology and Venereology : JEADV, 2018, Volume: 32, Issue:9 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Cryotherapy; Dermatologic Surgical Procedures; Dermatology; Dermoscopy; Europe; Female; Health Care Surveys; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Patient Preference; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiotherapy; Skin Neoplasms; Watchful Waiting	2018
Immunocryosurgery as monotherapy for lentigo maligna or combined with surgical excision for lentigo maligna melanoma. The Journal of dermatology, 2018, Volume: 45, Issue:5 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Biopsy; Combined Modality Therapy; Cryosurgery; Dermatologic Surgical Procedures; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunotherapy; Melanoma; Skin; Skin Cream; Skin Neoplasms	2018
Comparison of Melanocyte Density Counts in Topical Imiquimod-Treated Skin Surrounding Lentigo Maligna vs Control Biopsy Specimens. JAMA dermatology, 2018, 04-01, Volume: 154, Issue:4 Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Biopsy; Cell Count; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Melanocytes; Skin; Skin Neoplasms	2018
Laser immunotherapy for cutaneous squamous cell carcinoma with optimal thermal effects to enhance tumour immunogenicity. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2018, Volume: 34, Issue:8 Topics: Adjuvants, Immunologic; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Combined Modality Therapy; Female; HMGB1 Protein; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Imiquimod; Immunotherapy; Laser Therapy; Mice; Middle Aged; Phototherapy; Skin Neoplasms	2018
Complete response of extramammary Paget's disease with imiquimod and PDT: Report of two cases. Photodermatology, photoimmunology & photomedicine, 2018, Volume: 34, Issue:4 Topics: Female; Humans; Imiquimod; Male; Middle Aged; Paget Disease, Extramammary; Photochemotherapy; Skin Neoplasms	2018
Reply to: "Cutaneous squamous cell carcinoma progression during imiquimod treatment". Journal of the American Academy of Dermatology, 2018, Volume: 79, Issue:1 Topics: Administration, Cutaneous; Aminoquinolines; Carcinoma, Squamous Cell; Disease Progression; Humans; Imiquimod; Skin Neoplasms	2018
In vivo evaluation of antitumoral and antiangiogenic effect of imiquimod-loaded polymeric nanoparticles. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 103 Topics: Aminoquinolines; Angiogenesis Inhibitors; Animals; Chick Embryo; Chorioallantoic Membrane; Drug Carriers; Drug Liberation; Imiquimod; In Vitro Techniques; Male; Mice; Nanoparticles; Papilloma; Particle Size; Skin Neoplasms; Surface Properties	2018
Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged Excision. JAMA dermatology, 2018, 08-01, Volume: 154, Issue:8 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Nicotinic Acids; Off-Label Use; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2018
Lentigo Maligna-Challenges, Observations, Imiquimod, Confocal Microscopy, and Personalized Treatment. JAMA dermatology, 2018, 08-01, Volume: 154, Issue:8 Topics: Aminoquinolines; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Microscopy, Confocal; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Off-Label Use; Skin Neoplasms	2018
Cutaneous squamous cell carcinoma progression during imiquimod treatment. Journal of the American Academy of Dermatology, 2018, Volume: 79, Issue:1 Topics: Administration, Cutaneous; Aminoquinolines; Carcinoma, Squamous Cell; Disease Progression; Humans; Imiquimod; Skin Neoplasms	2018
Cells to Surgery Quiz: July 2018. The Journal of investigative dermatology, 2018, Volume: 138, Issue:7 Topics: Administration, Cutaneous; Aminolevulinic Acid; Antineoplastic Agents; Carcinoma, Basal Cell; Disease-Free Survival; Drug Eruptions; Equivalence Trials as Topic; Face; Fluorouracil; Humans; Imiquimod; Male; Photochemotherapy; Photosensitizing Agents; Skin Cream; Skin Neoplasms; Treatment Outcome	2018
Response of basal cell carcinoma to imiquimod was associated with the Gli1 : Gli3 expression ratio. The British journal of dermatology, 2018, Volume: 179, Issue:6 Topics: Administration, Cutaneous; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Nerve Tissue Proteins; Skin; Skin Cream; Skin Neoplasms; Treatment Outcome; Zinc Finger Protein GLI1; Zinc Finger Protein Gli3	2018
Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma. Photodiagnosis and photodynamic therapy, 2018, Volume: 23 Topics: Aged; Aminolevulinic Acid; Animals; Apoptosis; Carcinoma, Squamous Cell; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Imiquimod; Inflammation Mediators; Male; Mice; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; T-Lymphocytes	2018
Successful treatment of multifocal pigmented basal cell carcinomas with the application of topical 5% imiquimod cream. Dermatologic therapy, 2018, Volume: 31, Issue:5 Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Carcinoma, Basal Cell; Head and Neck Neoplasms; Humans; Imiquimod; Male; Neoplasms, Multiple Primary; Scalp; Skin Cream; Skin Neoplasms	2018
Recurrence Patterns after Primary Excision of Invasive Melanoma with Melanoma The American surgeon, 2018, Aug-01, Volume: 84, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Male; Margins of Excision; Melanoma; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms	2018
Epidermal mast cells in Bowenoid papulosis during topical imiquimod therapy. The Journal of dermatology, 2019, Volume: 46, Issue:4 Topics: Administration, Cutaneous; Aged; Biopsy; Bowen's Disease; Epidermis; Glucocorticoids; Humans; Imiquimod; Male; Mast Cells; Psoriasis; Scrotum; Skin Neoplasms; Treatment Outcome	2019
Immunocryosurgery for non-superficial basal cell carcinomas ≤ 20 mm in maximal diameter: Five-year follow-up. Journal of geriatric oncology, 2019, Volume: 10, Issue:3 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Disease-Free Survival; Follow-Up Studies; Humans; Imiquimod; Middle Aged; Prospective Studies; Skin Neoplasms	2019
[Riesgo de recurrencia y de nuevas neoplasias cutáneas malignas en sujetos mexicanos con carcinoma basocelular]. Cirugia y cirujanos, 2018, Volume: 86, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Electrocoagulation; Female; Humans; Imiquimod; Male; Margins of Excision; Middle Aged; Mohs Surgery; Neoplasms, Second Primary; Recurrence; Retrospective Studies; Risk; Skin Neoplasms; Young Adult	2018
Serial excision and imiquimod for lentigo maligna melanoma: a proposal for a combined treatment. Italian journal of dermatology and venereology, 2021, Volume: 156, Issue:Suppl. 1 t Topics: Combined Modality Therapy; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Melanoma; Skin Neoplasms	2021
Imiquimod 5% cream in occlusion, for the treatment of lentigo maligna: A new scheme of short cycles and the need for clinical trials. Dermatologic therapy, 2019, Volume: 32, Issue:1 Topics: Administration, Cutaneous; Aged, 80 and over; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin Neoplasms; Time Factors; Treatment Outcome	2019
Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study. Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:4 Topics: Administration, Cutaneous; Aged; California; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Comparative Effectiveness Research; Female; Fluorouracil; Humans; Imiquimod; Intention to Treat Analysis; Keratinocytes; Keratosis, Actinic; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Risk Factors; Skin Neoplasms	2019
Sequential treatment of daylight photodynamic therapy and imiquimod 5% cream for the treatment of superficial basal cell carcinoma on sun exposed areas. Dermatologic therapy, 2019, Volume: 32, Issue:2 Topics: Aged; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Photochemotherapy; Skin Neoplasms; Sunlight; Treatment Outcome	2019
Confocal Microscopy and Lentigo Maligna: An in vivo Pilot Study for the Assessment of Response to Imiquimod Therapy. Dermatology (Basel, Switzerland), 2019, Volume: 235, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Contraindications, Procedure; Dermatologic Surgical Procedures; Dermoscopy; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Microscopy, Confocal; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Skin Neoplasms; Treatment Outcome	2019
Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study. Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:4 Topics: Aged; Aminolevulinic Acid; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basal Cell; Equivalence Trials as Topic; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Failure	2019
Multiple Lesions in Irradiated Skin. JAMA oncology, 2019, May-01, Volume: 5, Issue:5 Topics: Adult; Anilides; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Male; Neoplasms, Radiation-Induced; Pyridines; Skin; Skin Neoplasms	2019
Long-term outcomes of imiquimod-treated lentigo maligna. Clinical and experimental dermatology, 2019, Volume: 44, Issue:6 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Biopsy; Dose-Response Relationship, Drug; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Inflammation; Male; Middle Aged; Pigmentation; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2019
Topical Application of a Dual ABC Transporter Substrate and NF-κB Inhibitor Blocks Multiple Sources of Cutaneous Inflammation in Mouse Skin. The Journal of investigative dermatology, 2019, Volume: 139, Issue:7 Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Humans; Imiquimod; Inflammation; Keratinocytes; Mice; NF-kappa B; Nicotinic Acids; Nitriles; Piperidines; Pyrrolidines; Skin; Skin Neoplasms	2019
[Eruptive epidermoid cysts after imiquimod treatment of recurrent basal cell carcinoma : A case report]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2019, Volume: 70, Issue:5 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Epidermal Cyst; Female; Humans; Imiquimod; Skin Neoplasms; Treatment Outcome	2019
Insight into imiquimod skin permeation and increased delivery using microneedle pre-treatment. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2019, Volume: 139 Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Carcinoma, Basal Cell; Imiquimod; Models, Animal; Needles; Permeability; Skin; Skin Absorption; Skin Cream; Skin Neoplasms; Swine	2019
Topical Combination of Fluorouracil and Calcipotriene as a Palliative Therapy for Refractory Extramammary Paget Disease. JAMA dermatology, 2019, May-01, Volume: 155, Issue:5 Topics: Administration, Topical; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Female; Fluorouracil; Humans; Imiquimod; Middle Aged; Paget Disease, Extramammary; Palliative Care; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2019
Recalcitrant extragenital giant condyloma acuminatum: A need for combination therapy. Dermatologic therapy, 2019, Volume: 32, Issue:3 Topics: Adult; Axilla; Buschke-Lowenstein Tumor; Combined Modality Therapy; Cryotherapy; Humans; Imiquimod; Immunotherapy; Male; Podophyllotoxin; Skin Neoplasms; Treatment Outcome	2019
An Algorithm for the Management of Residual Head and Neck Melanoma In Situ Using Topical Imiquimod: A Pilot Study. Annals of plastic surgery, 2019, Volume: 82, Issue:4S Suppl 3 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Agents; Female; Head and Neck Neoplasms; Humans; Imiquimod; Male; Melanoma; Middle Aged; Neoplasm, Residual; Pilot Projects; Retrospective Studies; Skin Neoplasms	2019
Lymphoplasmacytic plaque effectively treated with imiquimod. Italian journal of dermatology and venereology, 2021, Volume: 156, Issue:Suppl. 1 t Topics: Aminoquinolines; Humans; Imiquimod; Plaque, Atherosclerotic; Skin Abnormalities; Skin Neoplasms	2021
Complete Resolution of Primary Cutaneous Anaplastic Large Cell Lymphoma With Topical Imiquimod Journal of drugs in dermatology : JDD, 2019, May-01, Volume: 18, Issue:5 Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Diagnosis, Differential; Female; Forehead; Humans; Imiquimod; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Skin Neoplasms	2019
Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment. Acta dermato-venereologica, 2019, Sep-01, Volume: 99, Issue:10 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Off-Label Use; Remission Induction; Retrospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome; Young Adult	2019
Long-term outcomes of imiquimod-treated lentigo maligna: add on cryosurgery to induce inflammation and increase efficacy? Clinical and experimental dermatology, 2020, Volume: 45, Issue:2 Topics: Cryosurgery; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Inflammation; Melanoma; Skin Neoplasms	2020
Aldara activates TLR7-independent immune defence. Nature communications, 2013, Volume: 4 Topics: Aminoquinolines; Animals; Apoptosis; Carcinoma, Basal Cell; Cell Proliferation; Cells, Cultured; Cytokines; Epidermis; Gene Expression Regulation; Humans; Imiquimod; Immunity; Inflammasomes; Interferon Type I; Keratinocytes; Keratosis, Actinic; Mice; Models, Immunological; Neutrophil Infiltration; RNA, Messenger; Skin Neoplasms; Toll-Like Receptor 7; Up-Regulation	2013
Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study. Clinical and experimental dermatology, 2013, Volume: 38, Issue:8 Topics: Administration, Topical; Adrenergic beta-Antagonists; Aminoquinolines; Antineoplastic Agents; Female; Hemangioma; Humans; Imiquimod; Infant; Male; Retrospective Studies; Skin Neoplasms; Timolol	2013
Thickness of superficial basal cell carcinoma (sBCC) predicts imiquimod efficacy: a proposal for a thickness-based definition of sBCC. The British journal of dermatology, 2013, Volume: 169, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Failure; Treatment Outcome	2013
Treating basal-cell carcinoma in a real life setting. The Lancet. Oncology, 2013, Volume: 14, Issue:7 Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Imiquimod; Male; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2013
Neuropsychiatric symptoms associated with topical imiquimod therapy: report of 2 cases. JAMA dermatology, 2013, Volume: 149, Issue:4 Topics: Adjuvants, Immunologic; Administration, Topical; Aged, 80 and over; Aminoquinolines; Bipolar Disorder; Delirium; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neuropsychological Tests; Skin Neoplasms	2013
Office-based treatment of basal cell carcinoma with immunocryosurgery: feasibility and efficacy. Acta dermatovenerologica Alpina, Pannonica, et Adriatica, 2013, Volume: 22, Issue:2 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Ambulatory Care; Aminoquinolines; Carcinoma, Basal Cell; Cohort Studies; Cryosurgery; Feasibility Studies; Female; Follow-Up Studies; Greece; Humans; Imiquimod; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Office Visits; Risk Assessment; Skin Neoplasms; Treatment Outcome	2013
Key Opinion Leader (KOL) Consensus for actinic keratosis management in Italy: the AKTUAL Workshop. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2013, Volume: 148, Issue:5 Topics: Aminoquinolines; Carcinoma, Squamous Cell; Case Management; Clinical Trials as Topic; Cryosurgery; Diagnosis, Differential; Diclofenac; Disease Management; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Italy; Keratosis, Actinic; Laser Therapy; Neoplasms, Radiation-Induced; Photochemotherapy; Practice Guidelines as Topic; Skin Neoplasms; Sunscreening Agents; United Kingdom; United States; Watchful Waiting	2013
Effective treatment of metastatic renal cell carcinoma with topical imiquimod therapy. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2014, Volume: 12, Issue:2 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Imiquimod; Kidney Neoplasms; Male; Middle Aged; Skin Neoplasms; Treatment Outcome	2014
Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma. The British journal of dermatology, 2014, Volume: 170, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Dermoscopy; Humans; Imiquimod; Male; Middle Aged; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2014
British Association of Dermatologists' guidelines for the management of squamous cell carcinoma in situ (Bowen's disease) 2014. The British journal of dermatology, 2014, Volume: 170, Issue:2 Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Bowen's Disease; Cautery; Combined Modality Therapy; Costs and Cost Analysis; Cryotherapy; Curettage; Fluorouracil; Forecasting; Humans; Imiquimod; Laser Therapy; Male; Mohs Surgery; Nail Diseases; Penile Neoplasms; Photochemotherapy; Skin Neoplasms	2014
Development of novel topical drug delivery system containing cisplatin and imiquimod for dual therapy in cutaneous epithelial malignancy. Journal of liposome research, 2014, Volume: 24, Issue:2 Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Drug Delivery Systems; Humans; Imiquimod; Mice; Microscopy, Fluorescence; Rats, Wistar; Skin Neoplasms	2014
Evidence-based treatment for low-risk basal cell carcinoma. The Lancet. Oncology, 2014, Volume: 15, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Skin Neoplasms	2014
Imiquimod in the treatment of breast cancer skin metastasis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Mar-10, Volume: 32, Issue:8 Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Disease Progression; Fatal Outcome; Female; Humans; Imiquimod; Pain; Skin Neoplasms; Treatment Outcome	2014
Severe cutaneous and neurologic toxicity in melanoma patients during vemurafenib administration following anti-PD-1 therapy. Cancer immunology research, 2013, Volume: 1, Issue:6 Topics: Adult; Aminoquinolines; Anaphylaxis; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Drug Eruptions; Female; Guillain-Barre Syndrome; Humans; Imiquimod; Indoles; Melanoma; Middle Aged; Nivolumab; Programmed Cell Death 1 Receptor; Skin Neoplasms; Sulfonamides; Vemurafenib	2013
[In-transit metastasis in melanoma: Efficacy of topical imiquimod combined with carbon dioxide laser or with electrocautery]. Annales de dermatologie et de venereologie, 2014, Volume: 141, Issue:2 Topics: Administration, Cutaneous; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Disease Progression; Electrocoagulation; Facial Neoplasms; Fatal Outcome; Humans; Imiquimod; Interferon-alpha; Laser Therapy; Lasers, Gas; Leg; Lymphatic Metastasis; Male; Melanoma; Palliative Care; Remission Induction; Sentinel Lymph Node Biopsy; Skin Neoplasms	2014
[Psychiatric disorders associated with use of imiquimod]. Annales de dermatologie et de venereologie, 2014, Volume: 141, Issue:2 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Dementia; Depression; Female; Humans; Imiquimod; Immunologic Factors; Male; Mental Disorders; Middle Aged; Psychomotor Agitation; Skin Neoplasms; Sleep Initiation and Maintenance Disorders	2014
Lichen planopilaris after imiquimod 5% cream for multiple BCC in basal cell naevus syndrome. The Australasian journal of dermatology, 2015, Volume: 56, Issue:4 Topics: Alopecia; Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Drug Eruptions; Female; Head and Neck Neoplasms; Humans; Imiquimod; Lichen Planus; Middle Aged; Scalp; Skin Cream; Skin Neoplasms	2015
Giant Basal cell carcinoma. Journal of special operations medicine : a peer reviewed journal for SOF medical professionals, 2014,Spring, Volume: 14, Issue:1 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Early Detection of Cancer; Humans; Imiquimod; Laser Therapy; Male; Military Personnel; Mohs Surgery; Skin Neoplasms; Sunburn; Sunlight; Sunscreening Agents	2014
Complete remission of two patients with recurrent and wide spread extramammary Paget disease obtained from 5-aminolevulinic acid-based photodynamic therapy and imiquimod combination treatment. Photodiagnosis and photodynamic therapy, 2014, Volume: 11, Issue:3 Topics: Aged; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Drug Therapy, Combination; Genital Neoplasms, Male; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Photosensitizing Agents; Remission Induction; Skin Neoplasms; Treatment Outcome	2014
In vivo reflectance confocal microscopy to monitor the response of lentigo maligna to imiquimod. Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:1 Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Aminoquinolines; Dermoscopy; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Microscopy, Confocal; Middle Aged; Off-Label Use; Prospective Studies; Skin Neoplasms	2014
Treatment of various types of basal cell carcinoma with topical 5% imiquimod in the elderly who refused surgical intervention: a case series. The Journal of dermatological treatment, 2015, Volume: 26, Issue:2 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cryotherapy; Cytokines; Female; Humans; Imiquimod; Male; Skin Neoplasms	2015
Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization. The Journal of investigative dermatology, 2014, Volume: 134, Issue:10 Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dendritic Cells; Disease Models, Animal; Down-Regulation; Fibroblast Growth Factors; Humans; Imiquimod; Interleukin-8; Melanoma; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Middle Aged; Neovascularization, Pathologic; Ribonuclease, Pancreatic; Skin Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2014
In transit recurrence of Merkel cell carcinoma associated with polyarthritis effectively treated with immunocryosurgery. Acta dermato-venereologica, 2014, Volume: 94, Issue:6 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Arthritis; Carcinoma, Merkel Cell; Cryosurgery; Drug Administration Schedule; Female; Humans; Imiquimod; Immunotherapy; Neoplasm Recurrence, Local; Paraneoplastic Syndromes; Remission Induction; Skin Neoplasms; Treatment Outcome	2014
Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2014, Volume: 149, Issue:2 Topics: Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Attitude of Health Personnel; Carcinoma in Situ; Carcinoma, Squamous Cell; Cryotherapy; Curettage; Dermatology; Dermoscopy; Diclofenac; Disease Management; Guideline Adherence; Humans; Imiquimod; Italy; Keratosis, Actinic; Laser Therapy; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Photochemotherapy; Photosensitivity Disorders; Physicians; Practice Guidelines as Topic; Practice Patterns, Physicians'; Skin Neoplasms; Sunlight; Surveys and Questionnaires	2014
Visualization and treatment of subclinical actinic keratoses with topical imiquimod 5% cream: an observational study. BioMed research international, 2014, Volume: 2014 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Skin Cream; Skin Neoplasms; Treatment Outcome	2014
Dramatic clearance of HIV-associated bowenoid papulosis using combined oral acitretin and topical 5% imiquimod. Journal of drugs in dermatology : JDD, 2014, Volume: 13, Issue:8 Topics: Acitretin; Administration, Cutaneous; Administration, Oral; Adult; Aminoquinolines; Anal Canal; Antineoplastic Agents; Bowen's Disease; Drug Therapy, Combination; HIV Infections; Humans; Imiquimod; Keratolytic Agents; Male; Skin Neoplasms	2014
Use of imiquimod for residual acral melanoma. BMJ case reports, 2014, Aug-21, Volume: 2014 Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Follow-Up Studies; Foot Diseases; Humans; Imiquimod; Male; Melanoma; Melanoma, Cutaneous Malignant; Skin Cream; Skin Neoplasms; Treatment Outcome	2014
Acral lentiginous melanoma treated with topical imiquimod cream: possible cooperation between drug and tumour cells. Clinical and experimental dermatology, 2015, Volume: 40, Issue:1 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Foot; Humans; Imiquimod; Melanoma; Skin Neoplasms; Treatment Outcome	2015
Imiquimod 5% cream as an adjuvant pre-operative treatment for basal cell carcinoma of the periocular area. Orbit (Amsterdam, Netherlands), 2014, Volume: 33, Issue:6 Topics: Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid Neoplasms; Female; Humans; Imiquimod; Male; Middle Aged; Pilot Projects; Prospective Studies; Skin Cream; Skin Neoplasms	2014
Successful treatment of genital Bowen's disease with imiquimod 5% cream. International journal of STD & AIDS, 2015, Volume: 26, Issue:10 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms; Treatment Outcome	2015
Human papillomavirus-related verrucous carcinoma in a renal transplant patient after long-term immunosuppression: a case report. Transplantation proceedings, 2014, Volume: 46, Issue:8 Topics: Adult; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents; Carcinoma, Verrucous; Foot Diseases; Humans; Imiquimod; Immunocompromised Host; Immunosuppression Therapy; Kidney Transplantation; Male; Papillomavirus Infections; Skin Neoplasms	2014
Combination therapy for perianal squamous cell carcinoma in situ with imiquimod and photodynamic therapy. Cutis, 2014, Volume: 94, Issue:5 Topics: Aminolevulinic Acid; Aminoquinolines; Anal Canal; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Dissection; Female; Humans; Imiquimod; Middle Aged; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Postoperative Complications; Skin Neoplasms; Treatment Outcome	2014
Eruptive keratoacanthomas as a complication of fractionated CO2 laser resurfacing and combination therapy with imiquimod and intralesional methotrexate. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2015, Volume: 41, Issue:1 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Imiquimod; Injections, Intralesional; Keratoacanthoma; Lasers, Gas; Methotrexate; Rejuvenation; Skin Neoplasms	2015
Buschke-Lowenstein tumor. The American journal of the medical sciences, 2015, Volume: 349, Issue:1 Topics: Adjuvants, Immunologic; Adolescent; Aminoquinolines; Buschke-Lowenstein Tumor; HIV Infections; Humans; Imiquimod; Male; Skin Neoplasms	2015
Field cancerization: from molecular basis to selective field-directed management of actinic keratosis. Current problems in dermatology, 2015, Volume: 46 Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Skin Neoplasms	2015
Using topical imiquimod for the management of positive in situ margins after melanoma resection. Cancer medicine, 2015, Volume: 4, Issue:4 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Imiquimod; Male; Melanoma; Middle Aged; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2015
Imiquimod induces sustained remission of actinic damage: a case report spanning one decade of observation. Cutis, 2015, Volume: 95, Issue:2 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Skin Neoplasms	2015
Imiquimod-induced AMPK activation causes translation attenuation and apoptosis but not autophagy. Journal of dermatological science, 2015, Volume: 78, Issue:2 Topics: Adenosine Triphosphate; Aminoquinolines; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Down-Regulation; Enzyme Activation; Gene Silencing; Humans; Imiquimod; Melanoma; Myeloid Cell Leukemia Sequence 1 Protein; Myeloid Differentiation Factor 88; Phosphorylation; Protein Biosynthesis; Protein Serine-Threonine Kinases; Signal Transduction; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8	2015
Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type. Journal of the American Academy of Dermatology, 2015, Volume: 72, Issue:6 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma in Situ; Chemotherapy, Adjuvant; Cohort Studies; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Melanoma; Neoplasm Invasiveness; Neoplasm Staging; Retrospective Studies; Risk Assessment; Skin Cream; Skin Neoplasms; Survival Rate; Treatment Outcome	2015
Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU). Journal of the American Academy of Dermatology, 2015, Volume: 73, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Skin Neoplasms; Treatment Failure; Tumor Burden	2015
100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series. Journal of the American Academy of Dermatology, 2015, Volume: 73, Issue:4 Topics: Administration, Topical; Aminoquinolines; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imiquimod; Injections, Intralesional; Interleukin-2; Male; Melanoma; Melanoma, Cutaneous Malignant; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Retinoids; Retrospective Studies; Risk Assessment; Skin Neoplasms; Treatment Outcome	2015
Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics. International journal of dermatology, 2016, Volume: 55, Issue:3 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cross-Sectional Studies; Cryotherapy; Denmark; Dermatology; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Outpatient Clinics, Hospital; Photochemotherapy; Photosensitizing Agents; Practice Patterns, Physicians'; Private Practice; Sex Factors; Skin Neoplasms	2016
Non-melanoma skin cancer: to Mohs or not to Mohs? Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2015, Volume: 150, Issue:5 Topics: Adult; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Follow-Up Studies; Humans; Imiquimod; Male; Microsurgery; Skin Neoplasms	2015
Co-encapsulation of imiquimod and copaiba oil in novel nanostructured systems: promising formulations against skin carcinoma. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2015, Nov-15, Volume: 79 Topics: Aminoquinolines; Animals; Balsams; Cell Line; Female; Humans; Imiquimod; Keratinocytes; Nanocapsules; Particle Size; Skin; Skin Neoplasms; Swine	2015
Diagnosis of Amelanotic Lentigo Maligna by Using In vivo Reflectance Confocal Microscopy. Acta dermato-venereologica, 2016, Volume: 96, Issue:3 Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Cell Proliferation; Epidermis; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Melanocytes; Melanoma, Amelanotic; Microscopy, Confocal; Predictive Value of Tests; Skin Neoplasms; Treatment Outcome	2016
TLR7 Gln11Leu single nucleotide polymorphism and response to treatment with imiquimod in patients with basal cell carcinoma: a pilot study. Pharmacogenomics, 2015, Volume: 16, Issue:17 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Resistance, Neoplasm; Female; Glutamine; Humans; Imiquimod; Leucine; Male; Pilot Projects; Polymorphism, Single Nucleotide; Skin Neoplasms; Toll-Like Receptor 7; Treatment Outcome	2015
Cryosurgery during Imiquimod (Immunocryosurgery) for Periocular Basal Cell Carcinomas: An Efficacious Minimally Invasive Treatment Alternative. Dermatology (Basel, Switzerland), 2016, Volume: 232, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Child; Combined Modality Therapy; Cryosurgery; Facial Neoplasms; Feasibility Studies; Female; Humans; Imiquimod; Male; Middle Aged; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Young Adult	2016
Five-year recurrence rate of lentigo maligna after treatment with imiquimod. The British journal of dermatology, 2016, Volume: 174, Issue:1 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms	2016
A two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod: excellent cosmesis, but frequent recurrences on the nose. The British journal of dermatology, 2016, Volume: 174, Issue:5 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Facial Neoplasms; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Laser Therapy; Leg; Male; Neoplasm Recurrence, Local; Nose Neoplasms; Skin Neoplasms; Treatment Outcome	2016
Local cryosurgery and imiquimod: A successful combination for the treatment of locoregional cutaneous metastasis of melanoma: A case series. The Journal of dermatology, 2016, Volume: 43, Issue:5 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Cryosurgery; Female; Humans; Imiquimod; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Skin Neoplasms	2016
Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol. An experimental hairless mouse study. Journal of photochemistry and photobiology. B, Biology, 2016, Volume: 154 Topics: Aminolevulinic Acid; Aminoquinolines; Animals; Calcitriol; Carcinoma, Squamous Cell; Female; Fluorouracil; Imiquimod; Mice; Mice, Hairless; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Skin Neoplasms; Ultraviolet Rays	2016
Imiquimod activates p53-dependent apoptosis in a human basal cell carcinoma cell line. Journal of dermatological science, 2016, Volume: 81, Issue:3 Topics: Active Transport, Cell Nucleus; Aminoquinolines; Antineoplastic Agents; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Autophagy; Carcinoma, Basal Cell; Cell Line, Tumor; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Imiquimod; Mutation; Phosphorylation; Reactive Oxygen Species; RNA Interference; Signal Transduction; Skin Neoplasms; Time Factors; Transfection; Tumor Suppressor Protein p53	2016
Immunomodulatory Effectiveness of Fish Oil and omega-3 Fatty Acids in Human Non-melanoma Skin Carcinoma Cells. Journal of oleo science, 2016, Volume: 65, Issue:3 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Drug Combinations; Fatty Acids, Omega-3; Fish Oils; Humans; Imiquimod; Immunosuppressive Agents; Interleukin-10; Interleukin-6; Skin Neoplasms; Tumor Necrosis Factor-alpha	2016
Treatment of Imiquimod Resistant Epidermodysplasia Verruciformis With Ingenol Mebutate. Journal of drugs in dermatology : JDD, 2016, Volume: 15, Issue:3 Topics: Acitretin; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Drug Resistance; Epidermodysplasia Verruciformis; Female; Gels; Humans; Imiquimod; Keratolytic Agents; Rare Diseases; Skin Neoplasms; Treatment Outcome; Tretinoin	2016
Safety and efficacy of a novel short occlusive regimen of imiquimod for selected non-melanotic skin lesions in renal transplant patients. Internal medicine journal, 2016, Volume: 46, Issue:3 Topics: Adult; Aged; Aminoquinolines; Antineoplastic Agents; Australia; Female; Humans; Imiquimod; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome	2016
Rhabdomyolysis and capillary leak syndrome in a patient treated with topical imiquimod. International journal of dermatology, 2016, Volume: 55, Issue:9 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Capillary Leak Syndrome; Carcinoma, Basal Cell; Humans; Imiquimod; Male; Rhabdomyolysis; Skin Neoplasms	2016
Successful treatment of multiple vemurafenib-induced keratoacanthomas by topical application of imiquimod cream: Confirmation of clinical clearance by dermoscopy. The Journal of dermatological treatment, 2016, Volume: 27, Issue:5 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Drug Eruptions; Female; Humans; Imiquimod; Indoles; Keratoacanthoma; Melanoma; Skin Neoplasms; Sulfonamides; Treatment Outcome; Vemurafenib	2016
Clinical and histological resolution of invasive squamous cell carcinoma by topical imiquimod 3.75%: a case report. European journal of dermatology : EJD, 2016, Aug-01, Volume: 26, Issue:4 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Imiquimod; Male; Neoplasm Invasiveness; Scalp; Skin Neoplasms	2016
Treatment of in-transit and metastatic melanoma in two patients treated with ipilimumab and topical imiquimod. Melanoma research, 2016, Volume: 26, Issue:4 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Humans; Imiquimod; Ipilimumab; Male; Melanoma; Middle Aged; Skin Neoplasms	2016
Case of Japanese Hermansky-Pudlak syndrome patient with deeply invasive squamous cell carcinoma and multiple lesions of actinic keratosis on the face and neck. The Journal of dermatology, 2017, Volume: 44, Issue:2 Topics: Administration, Cutaneous; Adult; Carcinoma, Squamous Cell; Face; Hermanski-Pudlak Syndrome; Humans; Imiquimod; Japan; Keratosis, Actinic; Male; Membrane Proteins; Neck; Skin; Skin Neoplasms; Sunlight; Tomography, X-Ray Computed; Treatment Outcome	2017
Dermoscopic Ulceration is a Predictor of Basal Cell Carcinoma Response to Imiquimod: A Retrospective Study. Acta dermato-venereologica, 2017, 01-04, Volume: 97, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Dermoscopy; Female; Humans; Imiquimod; Male; Retrospective Studies; Skin Neoplasms	2017
Immunocryosurgery - an effective combinational modality for Bowen's disease. Dermatologic therapy, 2016, Volume: 29, Issue:5 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Chemotherapy, Adjuvant; Cryosurgery; Drug Administration Schedule; Female; Greece; Humans; Imiquimod; Immunotherapy; Male; Middle Aged; Retrospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome	2016
Solid nanoemulsion as antigen and immunopotentiator carrier for transcutaneous immunization. Cellular immunology, 2016, Volume: 308 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Drug Delivery Systems; Humans; Imiquimod; Immunization; Langerhans Cells; Mice; Mice, Inbred C57BL; Nanostructures; Oils; Precancerous Conditions; Skin Neoplasms; Vaccination	2016
Treatment of Bowen Disease With Photodynamic Therapy and the Advantages of Sequential Topical Imiquimod. Actas dermo-sifiliograficas, 2017, Volume: 108, Issue:2 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Drug Administration Schedule; Female; Humans; Imiquimod; Male; Photochemotherapy; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2017
Topical 5% imiquimod eliminated human papillomavirus 16-associated Bowen's disease. The Journal of dermatology, 2017, Volume: 44, Issue:3 Topics: Administration, Topical; Adult; Antineoplastic Agents; Biopsy; Bowen's Disease; Fingers; Human papillomavirus 16; Humans; Imiquimod; Male; Papillomavirus Infections; Skin Neoplasms	2017
Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases. Cancer immunology, immunotherapy : CII, 2016, Volume: 65, Issue:10 Topics: Administration, Topical; Aged; Aminoquinolines; Antigens, Neoplasm; Antineoplastic Agents; Cancer Vaccines; Cell Movement; Cells, Cultured; Combined Modality Therapy; Cytokines; Enzyme-Linked Immunospot Assay; Female; Humans; Imiquimod; Lymphocytes, Tumor-Infiltrating; Male; Melanoma; Middle Aged; Neoplasm Staging; Peptide Fragments; Skin Neoplasms; T-Lymphocytes; Toll-Like Receptor 7; Transcriptome; Vaccines, Subunit	2016
Pretreatment with topical glucocorticosteroids to enhance the antitumour efficacy of imiquimod: long-term follow-up in Bowen disease. The British journal of dermatology, 2017, Volume: 176, Issue:4 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Clobetasol; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Forkhead Transcription Factors; Glucocorticoids; Humans; Imiquimod; Ointments; Skin Neoplasms; T-Lymphocytes, Regulatory; Treatment Outcome	2017
Novel Fish Oil-based Bigel System for Controlled Drug Delivery and its Influence on Immunomodulatory Activity of Imiquimod Against Skin Cancer. Pharmaceutical research, 2017, Volume: 34, Issue:1 Topics: Aminoquinolines; Animals; Cell Line; Delayed-Action Preparations; Drug Delivery Systems; Female; Fish Oils; Humans; Hydrogels; Imiquimod; Immunologic Factors; Inflammation; Interleukin-10; Interleukin-6; Mice; Skin; Skin Neoplasms; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2017
[Eruptive epidermoid cysts during topical imiquimod treatment]. Annales de dermatologie et de venereologie, 2017, Volume: 144, Issue:3 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Diagnosis, Differential; Eyebrows; Humans; Imiquimod; Keratosis; Male; Pruritus; Skin Neoplasms	2017
Hearing loss in association with topical imiquimod use for squamous cell carcinoma in situ (Bowen disease). The Australasian journal of dermatology, 2016, Volume: 57, Issue:4 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Female; Hearing Loss, Sensorineural; Humans; Imiquimod; Skin Neoplasms	2016
The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines. PloS one, 2016, Volume: 11, Issue:12 Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Apoptosis; Cell Line, Tumor; Facial Neoplasms; Humans; Imiquimod; Marsupialia; Skin Neoplasms	2016
Topical imiquimod clears invasive melanoma. Cutis, 2016, Volume: 98, Issue:5 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Head and Neck Neoplasms; Humans; Imiquimod; Male; Melanoma; Scalp; Skin Neoplasms	2016
Diagnosis and management of lentigo maligna: an observational study comparing 2005 with 2014 data in one institution. Clinical and experimental dermatology, 2017, Volume: 42, Issue:3 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Female; Hospitals, University; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Incidence; Male; Middle Aged; Radiotherapy; Retrospective Studies; Skin Neoplasms; Surgical Procedures, Operative; Watchful Waiting	2017
Subungual Melanoma In Situ Treated With Imiquimod 5% Cream After Conservative Surgery Recurrence. Journal of drugs in dermatology : JDD, 2017, Mar-01, Volume: 16, Issue:3 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Humans; Imiquimod; Male; Melanoma; Nails; Neoplasm Recurrence, Local; Skin Cream; Skin Neoplasms; Toes	2017
Definitive surgical treatment of 24 skin cancers not cured by prior imiquimod therapy: a case series. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2008, Volume: 34, Issue:9 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Male; Melanoma; Middle Aged; Mohs Surgery; Skin Neoplasms; Treatment Outcome	2008
Sequential treatment of giant basal cell carcinomas. Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2009, Volume: 62, Issue:10 Topics: Administration, Topical; Aged; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2009
Imiquimod for restoring local immunity in a renal transplant patient with persistent keratoacanthoma. Dermatology online journal, 2008, Mar-15, Volume: 14, Issue:3 Topics: Adjuvants, Immunologic; Aminoquinolines; Humans; Imiquimod; Immunocompromised Host; Keratoacanthoma; Kidney Transplantation; Male; Middle Aged; Skin; Skin Neoplasms	2008
Vasodilatory adverse events associated with topical imiquimod 5 percent cream. Dermatology online journal, 2008, Apr-15, Volume: 14, Issue:4 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Angioedema; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Skin; Skin Neoplasms; Urticaria	2008
Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject. Clinical therapeutics, 2008, Volume: 30, Issue:7 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Hydroxyurea; Hyperpigmentation; Imiquimod; Male; Myeloproliferative Disorders; Nail Diseases; Skin Neoplasms	2008
Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream. Dermatology online journal, 2008, Feb-28, Volume: 14, Issue:2 Topics: Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Humans; Imiquimod; Male; Ointments; Photochemotherapy; Photosensitizing Agents; Remission Induction; Skin Neoplasms	2008
Lentigo maligna managed with topical imiquimod and dermoscopy: report of two cases. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2008, Volume: 34, Issue:11 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Dermoscopy; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Skin Neoplasms	2008
Topical imiquimod therapy for lentigo maligna. Annals of plastic surgery, 2008, Volume: 61, Issue:4 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Skin Neoplasms	2008
Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face. The Journal of dermatological treatment, 2009, Volume: 20, Issue:2 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy, Needle; Carcinoma, Basal Cell; Dermoscopy; Dose-Response Relationship, Drug; Drug Administration Schedule; Face; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Risk Assessment; Sampling Studies; Skin Neoplasms; Treatment Outcome	2009
Imiquimod treatment associated with a reduction in new skin cancer formation. Clinical and experimental dermatology, 2009, Volume: 34, Issue:1 Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Carcinoma, Basal Cell; Combined Modality Therapy; Humans; Imiquimod; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Skin Neoplasms	2009
Videodermatoscopy of lentigo maligna treated with imiquimod. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:11 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Dermoscopy; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Nose; Skin; Skin Neoplasms	2008
Eruptive keratoacanthoma following topical imiquimod for in situ squamous cell carcinoma of the skin in a renal transplant recipient. Journal of the American Academy of Dermatology, 2008, Volume: 59, Issue:5 Suppl Topics: Aged, 80 and over; Aminoquinolines; Bowen's Disease; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratoacanthoma; Keratosis, Actinic; Kidney Transplantation; Skin Neoplasms	2008
Density of dendritic cells around basal cell carcinomas is related to tumor size, anatomical site and stromal characteristics, and might be responsible for the response to topical therapy. International journal of dermatology, 2008, Volume: 47, Issue:12 Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cell Count; Facial Neoplasms; Female; Humans; Imiquimod; Langerhans Cells; Male; Middle Aged; Skin Neoplasms	2008
Coexisting perianal squamous cell carcinoma, Bowen's disease, and condylomata acuminata treated with topical imiquimod 5%. International journal of dermatology, 2008, Volume: 47, Issue:12 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Anus Diseases; Anus Neoplasms; Bowen's Disease; Carcinoma, Squamous Cell; Condylomata Acuminata; Female; Humans; Imiquimod; Immunologic Factors; Middle Aged; Neoplasms, Multiple Primary; Skin Neoplasms	2008
Use of imiquimod 5% cream (Aldara) in cats with multicentric squamous cell carcinoma in situ: 12 cases (2002-2005). Veterinary and comparative oncology, 2008, Volume: 6, Issue:1 Topics: Aminoquinolines; Animals; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Cat Diseases; Cats; Female; Imiquimod; Kaplan-Meier Estimate; Male; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome	2008
Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNalpha-2b and topical imiquimod 5% cream. International journal of dermatology, 2009, Volume: 48, Issue:2 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Therapy, Combination; Female; Humans; Imiquimod; Interferon alpha-2; Interferon-alpha; Middle Aged; Nose Neoplasms; Recombinant Proteins; Skin Neoplasms	2009
Topical treatment of bowenoid papulosis of the penis with imiquimod. Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:8 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Humans; Imiquimod; Male; Penis; Skin Neoplasms; Treatment Outcome; Young Adult	2009
Long-term follow-up of a hemifacial lentigo maligna treated using 5% imiquimod. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2009, Volume: 35, Issue:2 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Disease-Free Survival; Drug Administration Schedule; Facial Neoplasms; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Remission Induction; Skin Neoplasms	2009
Imiquimod and lentigo maligna: a search for prognostic features in a clinicopathological study with long-term follow-up. The British journal of dermatology, 2009, Volume: 160, Issue:5 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Prognosis; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2009
Complete remission of cutaneous and subcutaneous melanoma metastases of the scalp with imiquimod therapy. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2009, Volume: 7, Issue:6 Topics: Aminoquinolines; Antineoplastic Agents; Head and Neck Neoplasms; Humans; Imiquimod; Male; Melanoma; Middle Aged; Remission Induction; Scalp; Skin Neoplasms; Treatment Outcome	2009
Progress of multiple cutaneous and subcutaneous melanoma metastases of the face during imiquimod treatment. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2009, Volume: 7, Issue:6 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Fatal Outcome; Humans; Imiquimod; Male; Melanoma; Skin Neoplasms; Treatment Failure	2009
The use of imiquimod to minimize the surgical defect when excising invasive malignant melanoma surrounded by extensive melanoma in situ, lentiginous type. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2009, Volume: 35, Issue:5 Topics: Adjuvants, Immunologic; Aged, 80 and over; Aminoquinolines; Cheek; Female; Follow-Up Studies; Humans; Imiquimod; Male; Melanoma; Middle Aged; Neoplasm Invasiveness; Scalp; Skin Neoplasms; Wound Healing	2009
Dermatoses of the nipple. Canadian journal of surgery. Journal canadien de chirurgie, 2009, Volume: 52, Issue:2 Topics: Adenoma; Aminoquinolines; Antineoplastic Agents; Breast Diseases; Epidermal Cyst; Female; Fibroma; Humans; Imiquimod; Molluscum Contagiosum; Nevus, Blue; Nipples; Paget's Disease, Mammary; Retrospective Studies; Skin Neoplasms	2009
[Diagnosis and treatment of non-melanoma skin neoplasm]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Biopsy; Imiquimod; Melanoma; Neoplasm Staging; Photochemotherapy; Prognosis; Skin Neoplasms	2009
Combination of cryosurgery and topical imiquimod: does timing matter for successful immunocryosurgery? Cryobiology, 2009, Volume: 59, Issue:1 Topics: Administration, Topical; Aminoquinolines; Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Combined Modality Therapy; Cryosurgery; Dendritic Cells; Humans; Imiquimod; Immunosuppression Therapy; Immunotherapy; Lentigo; Skin Neoplasms; Time Factors; Toll-Like Receptors	2009
Pemphigus-like lesions induced by imiquimod. Clinical and experimental dermatology, 2009, Volume: 34, Issue:5 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Eruptions; Female; Humans; Imiquimod; Middle Aged; Pemphigus; Skin Neoplasms	2009
Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2009, Volume: 35, Issue:8 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Skin Neoplasms	2009
Multiple basal cell carcinomas after radiation treatment: successful treatment with topical imiquimod. Clinical and experimental dermatology, 2010, Volume: 35, Issue:2 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Neoplasms, Radiation-Induced; Skin Neoplasms; Treatment Outcome	2010
The role of imiquimod in treating infantile haemangiomas: cause for concern? Clinical and experimental dermatology, 2009, Volume: 34, Issue:7 Topics: Aminoquinolines; Antineoplastic Agents; Female; Hemangioma; Humans; Imiquimod; Infant; Skin Neoplasms	2009
Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin. The Journal of investigative dermatology, 2009, Volume: 129, Issue:11 Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Biopsy; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Cell Division; Granzymes; Humans; Imiquimod; In Vitro Techniques; Interferon-gamma; Interleukin-10; Lymphocyte Activation; Perforin; Pore Forming Cytotoxic Proteins; Signal Transduction; Skin Neoplasms; Transforming Growth Factor beta	2009
A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption. Journal of the American Academy of Dermatology, 2009, Volume: 61, Issue:1 Topics: Ambulatory Surgical Procedures; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cheek; Cost-Benefit Analysis; Curettage; Frozen Sections; Humans; Imiquimod; Mohs Surgery; Plastic Surgery Procedures; Skin Neoplasms	2009
Immunocryosurgery for basal cell carcinoma: results of a pilot, prospective, open-label study of cryosurgery during continued imiquimod application. Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:12 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Feasibility Studies; Female; Humans; Imiquimod; Male; Pilot Projects; Prospective Studies; Skin Neoplasms	2009
Imiquimod-induced vitiligo after treatment of nodular basal cell carcinoma. Journal of cutaneous pathology, 2009, Volume: 36, Issue:8 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Male; Melanocytes; Skin; Skin Neoplasms; Time Factors; Vitiligo	2009
Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis. Journal of cutaneous pathology, 2010, Volume: 37, Issue:1 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Dermis; Female; Head and Neck Neoplasms; Humans; Imiquimod; Melanoma; Middle Aged; Skin Neoplasms; Subcutaneous Tissue; Treatment Outcome	2010
Superficial basal cell carcinoma treated with imiquimod 5% topical cream for a 4-week period: a case series. Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:7 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms	2009
Using the body's immune system to fight disease: practical immune enhancement. Summary. Postgraduate medicine, 2002, Volume: 112, Issue:6 Suppl Us Topics: Aminoquinolines; Humans; Imiquimod; Immunity; Immunologic Factors; Skin Neoplasms	2002
Combination therapy with imiquimod, 5-fluorouracil, and tazarotene in the treatment of extensive radiation-induced Bowen's disease of the hands. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2010, Volume: 36, Issue:5 Topics: Aminoquinolines; Antineoplastic Agents; Biopsy; Bowen's Disease; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Therapy, Combination; Fluorouracil; Follow-Up Studies; Hand; Humans; Imiquimod; Male; Middle Aged; Neoplasms, Radiation-Induced; Nicotinic Acids; Skin Neoplasms	2010
Successful treatment of three cases of primary extramammary Paget's disease of the vulva with Imiquimod--proposal of a therapeutic schedule. Journal of the European Academy of Dermatology and Venereology : JEADV, 2010, Volume: 24, Issue:4 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Imiquimod; Middle Aged; Paget Disease, Extramammary; Remission Induction; Skin Neoplasms; Vulvar Neoplasms	2010
Treatment of cutaneous tumors with topical 5% imiquimod cream. Clinics (Sao Paulo, Brazil), 2009, Volume: 64, Issue:10 Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Brazil; Child; Female; Humans; Imiquimod; Male; Middle Aged; Recurrence; Retrospective Studies; Skin Neoplasms; Young Adult	2009
Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2010, Jan-31, Volume: 39, Issue:1-3 Topics: Aminoquinolines; Animals; Antineoplastic Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Imidazoles; Imiquimod; Injections, Intraperitoneal; Injections, Intravenous; Male; Melanoma; Mice; Mice, Nude; Nitrosourea Compounds; Organophosphorus Compounds; Quinoxalines; Rats; Skin Neoplasms; Xenograft Model Antitumor Assays	2010
Use of reflectance confocal microscopy to monitor response of lentigo maligna to nonsurgical treatment. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2010, Volume: 36, Issue:2 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Cryosurgery; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Microscopy, Confocal; Middle Aged; Neoplasm Invasiveness; Skin Neoplasms; Treatment Outcome	2010
Perineal extramammary Paget disease responsive to topical imiquimod. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2010, Volume: 8, Issue:1 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Paget Disease, Extramammary; Perineum; Skin Neoplasms; Treatment Outcome	2010
[Topical imiquimod as palliative therapy for extensive lentigo maligna on the cheek]. Annales de dermatologie et de venereologie, 2010, Volume: 137, Issue:2 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Cheek; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Palliative Care; Skin Neoplasms	2010
[Clinical remission of classic Kaposi sarcoma with topical 5% imiquimod]. Actas dermo-sifiliograficas, 2010, Volume: 101, Issue:2 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Curettage; Electrocoagulation; Foot Diseases; Humans; Imiquimod; Male; Penile Neoplasms; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms	2010
Successful treatment of cutaneous hemangioma of infancy with topical imiquimod 5%: a report of 3 cases. Ear, nose, & throat journal, 2010, Volume: 89, Issue:3 Topics: Aminoquinolines; Antineoplastic Agents; Hemangioma; Humans; Imiquimod; Infant; Male; Skin Neoplasms	2010
Bone invasion by squamous cell carcinoma in situ (Bowen's disease) of the finger during treatment with imiquimod 5% cream: case report. The Journal of hand surgery, 2010, Volume: 35, Issue:6 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Squamous Cell; Finger Joint; Fingers; Humans; Imiquimod; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Radiography; Skin Neoplasms	2010
When imiquimod fails. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2010, Volume: 36, Issue:5 Topics: Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Follow-Up Studies; Humans; Imiquimod; Leg; Male; Middle Aged; Mohs Surgery; Skin Neoplasms; Skin Transplantation; Time Factors; Treatment Failure	2010
The use of imiquimod in the treatment of periocular tumours. Orbit (Amsterdam, Netherlands), 2010, Volume: 29, Issue:2 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Eyelid Neoplasms; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2010
Letter: Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular basal cell carcinomas before Mohs micrographic surgery: a randomized, double-blind, vehicle-controlled study. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2010, Volume: 36, Issue:3 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Mohs Surgery; Neoadjuvant Therapy; Nose Neoplasms; Skin Neoplasms	2010
Imiquimod simultaneously induces autophagy and apoptosis in human basal cell carcinoma cells. The British journal of dermatology, 2010, Volume: 163, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Basal Cell; Caspase Inhibitors; Caspases; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Imiquimod; Skin Neoplasms; Tumor Cells, Cultured	2010
A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities. Journal of the European Academy of Dermatology and Venereology : JEADV, 2010, Volume: 24, Issue:12 Topics: Aminolevulinic Acid; Aminoquinolines; Bowen's Disease; Carcinoma, Basal Cell; Cost-Benefit Analysis; Humans; Imiquimod; Photochemotherapy; Skin Neoplasms	2010
Imiquimod cream 5% for the treatment of arsenic-induced cutaneous neoplasms. Cutis, 2010, Volume: 85, Issue:4 Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Arsenic; Carcinoma, Squamous Cell; Follow-Up Studies; Humans; Imiquimod; Keratosis; Male; Neoplasm Recurrence, Local; Psoriasis; Skin Neoplasms	2010
Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG. PloS one, 2010, May-13, Volume: 5, Issue:5 Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; CD8-Positive T-Lymphocytes; Cell Proliferation; Dinucleoside Phosphates; Hydroquinones; Imiquimod; Immunoglobulin G; Immunotherapy; Injections, Subcutaneous; Killer Cells, Natural; Leukocyte Count; Lymphocyte Activation; Lymphocyte Depletion; Melanoma; Mice; Mice, Inbred C57BL; Pigmentation; Skin Neoplasms	2010
Current management of actinic keratoses. Skin therapy letter, 2010, Volume: 15, Issue:5 Topics: Administration, Cutaneous; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Squamous Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Skin Neoplasms	2010
[Imiquimod cream. A cream to use with precaution]. Revue de l'infirmiere, 2010, Issue:161 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Condylomata Acuminata; Drug Eruptions; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Skin Neoplasms; Treatment Outcome	2010
Imiquimod for the treatment of classical Kaposi's sarcoma. Acta dermato-venereologica, 2010, Volume: 90, Issue:4 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Male; Ointments; Sarcoma, Kaposi; Skin Neoplasms; Toes; Treatment Outcome	2010
Topical imiquimod for periocular lentigo maligna. Ophthalmology, 2010, Volume: 117, Issue:12 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Eyelid Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Retrospective Studies; Skin Neoplasms	2010
Treatment of lentigo maligna with imiquimod cream: a long-term follow-up study of 10 patients. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2010, Volume: 36, Issue:6 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Facial Neoplasms; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Prospective Studies; Skin Neoplasms; Treatment Outcome	2010
Periocular lentigo maligna treated with imiquimod. The Journal of dermatological treatment, 2011, Volume: 22, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Eye Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome	2011
Nonsyndromic multiple basal cell carcinomas successfully treated with imiquimod 5% cream. Cutaneous and ocular toxicology, 2010, Volume: 29, Issue:4 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms; Treatment Outcome	2010
Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010, Volume: 26, Issue:4 Topics: Acrylic Resins; Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cryotherapy; Eyelid Neoplasms; Eyelids; Female; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Skin Neoplasms; Treatment Outcome	2010
Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2010, Volume: 36, Issue:10 Topics: Algorithms; Aminoquinolines; Biopsy; Carcinoma in Situ; Carcinoma, Squamous Cell; Cryosurgery; Curettage; Dermatology; Diagnosis, Differential; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Mohs Surgery; Photochemotherapy; Precancerous Conditions; Reproducibility of Results; Skin Neoplasms; Terminology as Topic; United States	2010
The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions. The British journal of ophthalmology, 2011, Volume: 95, Issue:12 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Conjunctivitis; Erythema; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2011
UV exposure boosts transcutaneous immunization and improves tumor immunity: cytotoxic T-cell priming through the skin. The Journal of investigative dermatology, 2011, Volume: 131, Issue:1 Topics: Aminoquinolines; Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Imiquimod; Immune Tolerance; Immunologic Memory; Langerhans Cells; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Skin; Skin Neoplasms; T-Lymphocytes, Cytotoxic; Toll-Like Receptor 7; Ultraviolet Rays	2011
Cryosurgery during imiquimod cream treatment ("immunocryosurgery") for Bowen's disease of the skin: a case series. Acta dermato-venereologica, 2010, Volume: 90, Issue:5 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Chemotherapy, Adjuvant; Cryosurgery; Drug Administration Schedule; Female; Greece; Humans; Imiquimod; Male; Middle Aged; Ointments; Skin Neoplasms; Time Factors; Treatment Outcome	2010
Reversible relapse of pemphigus foliaceus triggered by topical imiquimod suggests that Toll-like receptor 7 inhibitors may be useful treatments for pemphigus. Clinical and experimental dermatology, 2011, Volume: 36, Issue:1 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Middle Aged; Pemphigus; Skin Neoplasms; Toll-Like Receptor 7; Treatment Outcome	2011
Failed treatment of amelanotic lentigo maligna with imiquimod followed by pigment production. Archives of dermatology, 2010, Volume: 146, Issue:9 Topics: Administration, Topical; Aminoquinolines; Biopsy, Needle; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunohistochemistry; Melanoma, Amelanotic; Middle Aged; Neoplasm Recurrence, Local; Nose; Risk Assessment; Skin Neoplasms; Treatment Outcome	2010
Long-term outcome after treatment with 5% topical imiquimod cream in patients with basal cell carcinoma of the eyelids. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2011, Volume: 249, Issue:1 Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid Neoplasms; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Prospective Studies; Skin Neoplasms; Treatment Outcome	2011
Mild clinical phenotype of Kindler syndrome associated with late diagnosis and skin cancer. Dermatology (Basel, Switzerland), 2010, Volume: 221, Issue:4 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Basement Membrane; Blister; Carcinoma, Basal Cell; Cryosurgery; Delayed Diagnosis; Epidermolysis Bullosa; Female; Fluorouracil; Homozygote; Humans; Imiquimod; Male; Membrane Proteins; Middle Aged; Mutation; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Periodontal Diseases; Photosensitivity Disorders; Skin Neoplasms	2010
Immunocryosurgery for patients with therapeutically challenging basal cell carcinomas: report of two representative cases. The Journal of dermatological treatment, 2012, Volume: 23, Issue:1 Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Carcinoma, Basal Cell; Cryosurgery; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms	2012
[Surgical vs nonsurgical treatment of basal cell carcinoma]. Actas dermo-sifiliograficas, 2010, Volume: 101, Issue:8 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryosurgery; Fluorouracil; Follow-Up Studies; Hedgehog Proteins; Humans; Imiquimod; Interferons; Laser Therapy; Mohs Surgery; Neoplasm Recurrence, Local; Photochemotherapy; Phytotherapy; Plant Preparations; Risk Factors; Semecarpus; Skin Neoplasms; Treatment Outcome	2010
Kaposi's sarcoma after repeated surgical procedures in an immunocompetent patient: the lymphatic hypothesis. Dermatology (Basel, Switzerland), 2010, Volume: 221, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Biopsy; Dupuytren Contracture; Herpesvirus 8, Human; Humans; Imiquimod; Immunocompetence; Lymphatic System; Male; Middle Aged; Sarcoma, Kaposi; Skin Neoplasms; Treatment Outcome	2010
Lentiginous melanoma in situ treatment with topical imiquimod: need for individualized regimens. Archives of dermatology, 2010, Volume: 146, Issue:11 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Female; Humans; Imiquimod; Male; Melanoma; Skin Neoplasms	2010
Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil. Dermatology online journal, 2010, Dec-15, Volume: 16, Issue:12 Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antimetabolites; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Immunologic Factors; Leg; Male; Porokeratosis; Precancerous Conditions; Remission Induction; Skin Neoplasms	2010
Complete basal cell carcinoma remission with imiquimod in a patient with nevoid basal cell carcinoma syndrome and associated basal cell carcinoma of the scalp and invasive ductal breast cancer. Journal of the American Academy of Dermatology, 2011, Volume: 64, Issue:3 Topics: Aminoquinolines; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Carcinoma, Ductal, Breast; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Imiquimod; Middle Aged; Patched Receptors; Receptors, Cell Surface; Scalp; Skin Neoplasms	2011
Eruptive Kaposi sarcoma: an unusual presentation in an HIV-negative patient. Cutis, 2011, Volume: 87, Issue:1 Topics: Aged; Aminoquinolines; Antineoplastic Agents; CD4 Lymphocyte Count; Cryotherapy; Humans; Imiquimod; Italy; Lymphopenia; Male; Sarcoma, Kaposi; Skin Neoplasms	2011
Eruptive keratoacanthoma and squamous cell carcinoma complicating imiquimod therapy: response to oral acitretin. The Australasian journal of dermatology, 2011, Volume: 52, Issue:1 Topics: Acitretin; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratoacanthoma; Keratolytic Agents; Skin Neoplasms; Treatment Outcome	2011
Effectiveness and satisfaction with imiquimod for the treatment of superficial basal cell carcinoma in daily dermatological practice. Journal of the European Academy of Dermatology and Venereology : JEADV, 2011, Volume: 25, Issue:11 Topics: Aged; Aminoquinolines; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Skin Neoplasms	2011
Regression of internal melanoma metastases following application of topical imiquimod to overlying skin. Journal of drugs in dermatology : JDD, 2011, Volume: 10, Issue:3 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Disease Progression; Humans; Imiquimod; Male; Melanoma; Middle Aged; Neoplasm Staging; Skin Neoplasms	2011
Comparing ablative fractionated resurfacing, photodynamic therapy, and topical imiquimod in the treatment of trichoblastomas of Brooke-Spiegler Syndrome: a case study. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2011, Volume: 37, Issue:7 Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Adenoid Cystic; Carcinoma, Skin Appendage; Combined Modality Therapy; Humans; Imiquimod; Lasers, Solid-State; Male; Middle Aged; Neoplastic Syndromes, Hereditary; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2011
What's new in the treatment of actinic keratoses? Cutis, 2011, Volume: 87, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Diterpenes; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Skin Neoplasms	2011
Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream. Melanoma research, 2011, Volume: 21, Issue:3 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Humans; Imiquimod; Injections, Intralesional; Interleukin-2; Male; Melanoma; Middle Aged; Retinoids; Skin Neoplasms	2011
Lupus erythematosus-like reaction in imiquimod-treated skin: a report of 2 cases. The American Journal of dermatopathology, 2011, Volume: 33, Issue:5 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Dermatitis; Diagnosis, Differential; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis, Actinic; Lupus Erythematosus, Systemic; Male; Skin Neoplasms	2011
Treatment of giant Bowen's disease with sequential use of photodynamic therapy and imiquimod cream. Photodermatology, photoimmunology & photomedicine, 2011, Volume: 27, Issue:3 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Head and Neck Neoplasms; Humans; Imiquimod; Male; Photochemotherapy; Remission Induction; Skin Neoplasms	2011
Successful treatment of multiple keratoacanthoma with topical imiquimod and low-dose acitretin. The Journal of dermatology, 2011, Volume: 38, Issue:4 Topics: Acitretin; Administration, Oral; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratoacanthoma; Keratolytic Agents; Skin Neoplasms	2011
Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer. Acta dermato-venereologica, 2011, Volume: 91, Issue:4 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Humans; Imiquimod; Immunologic Factors; Keratosis, Actinic; Lymphatic System; Male; Ointments; Skin Neoplasms; Treatment Outcome	2011
Re-inventing intratumoral immunotherapy for melanoma. Immunotherapy, 2011, Volume: 3, Issue:5 Topics: Aminoquinolines; Antineoplastic Agents; BCG Vaccine; Cytokines; Humans; Imiquimod; Immunotherapy; Injections, Intralesional; Melanoma; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome	2011
[Oral acitretin and topical imiquimod as neoadjuvant treatment for giant basal cell carcinoma]. Actas dermo-sifiliograficas, 2012, Volume: 103, Issue:2 Topics: Acitretin; Administration, Cutaneous; Administration, Oral; Aged; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Combined Modality Therapy; Facial Neoplasms; Female; Humans; Imiquimod; Neoadjuvant Therapy; Psoriasis; Remission Induction; Skin Neoplasms; Skin Ulcer; Thoracic Neoplasms	2012
[Descriptive analysis of cutaneous recurrence patterns in patients with melanoma]. Actas dermo-sifiliograficas, 2011, Volume: 102, Issue:10 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Female; Humans; Imiquimod; Kaplan-Meier Estimate; Lymph Node Excision; Male; Melanoma; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prognosis; Skin Neoplasms; Skin Ulcer	2011
Failure of extensive extramammary Paget disease of the inguinal area to clear with imiquimod cream, 5%: possible progression to invasive disease during therapy. Archives of dermatology, 2011, Volume: 147, Issue:6 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Emollients; Groin; Humans; Imiquimod; Male; Paget Disease, Extramammary; Skin Neoplasms; Treatment Failure	2011
Achromic superficial spreading melanoma accidentally treated with imiquimod. Acta dermato-venereologica, 2012, Volume: 92, Issue:1 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Diagnostic Errors; Female; Humans; Imiquimod; Medication Errors; Melanoma, Amelanotic; Skin Neoplasms	2012
A pilot study of clinical efficacy of imiquimod and cryotherapy for the treatment of basal cell carcinoma with incomplete response to imiquimod. Journal of the European Academy of Dermatology and Venereology : JEADV, 2012, Volume: 26, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryotherapy; Female; Humans; Imiquimod; Male; Middle Aged; Pilot Projects; Skin Neoplasms	2012
Imiquimod-induced TLR7 signaling enhances repair of DNA damage induced by ultraviolet light in bone marrow-derived cells. Journal of immunology (Baltimore, Md. : 1950), 2011, Aug-15, Volume: 187, Issue:4 Topics: Aminoquinolines; Animals; Antineoplastic Agents; Bone Marrow Cells; Cell Line; DNA Damage; DNA Repair; Female; Gene Expression Regulation, Neoplastic; Imiquimod; Membrane Glycoproteins; Mice; Mice, Knockout; Myeloid Differentiation Factor 88; Pyrimidine Dimers; Signal Transduction; Skin Neoplasms; Toll-Like Receptor 7; Ultraviolet Rays; Xeroderma Pigmentosum Group A Protein	2011
Topical imiquimod in the treatment of two cutaneous melanocytomas in a dog. Veterinary dermatology, 2012, Volume: 23, Issue:2 Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Agents; Dog Diseases; Dogs; Female; Imiquimod; Melanoma; Skin Neoplasms	2012
Extramammary Paget disease: failure to respond to topical imiquimod 5%. Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:3 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Genital Neoplasms, Male; Humans; Imiquimod; Male; Paget Disease, Extramammary; Scrotum; Skin Neoplasms; Treatment Failure	2011
Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:5 Topics: Aminoquinolines; Antineoplastic Agents; Asymptomatic Diseases; Cryotherapy; Diagnostic Imaging; Evidence-Based Medicine; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Lymphatic Metastasis; Melanoma; Nail Diseases; Neoplasm Grading; Neoplasm Staging; Sentinel Lymph Node Biopsy; Skin Neoplasms	2011
Cutaneous mucinous carcinoma arising in extramammary Paget disease of the perineum. The American Journal of dermatopathology, 2011, Volume: 33, Issue:7 Topics: Adenocarcinoma, Mucinous; Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Neoplasms, Multiple Primary; Paget Disease, Extramammary; Perineum; Skin Neoplasms; Vulvar Neoplasms	2011
Conservative management of extramammary paget disease with imiquimod. Journal of lower genital tract disease, 2012, Volume: 16, Issue:1 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Skin Neoplasms; Treatment Outcome; Vulva; Vulvar Neoplasms	2012
Ulcerated infantile hemangioma treated with imiquimod. Dermatology online journal, 2011, Sep-15, Volume: 17, Issue:9 Topics: Aminoquinolines; Antineoplastic Agents; Buttocks; Hemangioma; Humans; Imiquimod; Infant; Male; Skin Neoplasms; Ulcer	2011
Amelanotic lentigo maligna managed with topical imiquimod. The Journal of dermatology, 2012, Volume: 39, Issue:5 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Melanoma, Amelanotic; Skin Neoplasms	2012
Aesthetic evaluation after non-invasive treatment for superficial basal cell carcinoma. Journal of the European Academy of Dermatology and Venereology : JEADV, 2013, Volume: 27, Issue:5 Topics: Adult; Aged; Aminoquinolines; Carcinoma, Basal Cell; Esthetics; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Reproducibility of Results; Skin Neoplasms	2013
Cryoimmunotherapy: superficial basal cell cancer and squamous cell carcinoma in situ treated with liquid nitrogen followed by imiquimod. Archives of dermatology, 2011, Volume: 147, Issue:11 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cryotherapy; Female; Follow-Up Studies; Humans; Imiquimod; Immunotherapy; Male; Nitrogen; Retrospective Studies; Skin Neoplasms	2011
Large facial basal cell carcinoma treated with multimodal combination therapy. Cutis, 2011, Volume: 88, Issue:4 Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Combined Modality Therapy; Facial Neoplasms; Follow-Up Studies; Humans; Imiquimod; Male; Mohs Surgery; Skin Neoplasms; Treatment Outcome	2011
Persistent erythematous lesion of the vulva: a diagnostic and treatment challenge. Journal of drugs in dermatology : JDD, 2012, Volume: 11, Issue:1 Topics: Administration, Topical; Aminoquinolines; Bowen's Disease; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms; Treatment Outcome; Vulva	2012
Solar cheilosis: an ominous precursor part II. Therapeutic perspectives. Journal of the American Academy of Dermatology, 2012, Volume: 66, Issue:2 Topics: Administration, Topical; Aminoquinolines; Biopsy; Carcinoma, Squamous Cell; Cheilitis; Combined Modality Therapy; Diagnosis, Differential; Diclofenac; Female; Fluorouracil; Humans; Imiquimod; Lip Neoplasms; Male; Middle Aged; Precancerous Conditions; Skin Neoplasms; Sunlight	2012
Treatment of multifocal Bowen's disease in immunocompromised women with surgery and topical imiquimod. Obstetrics and gynecology, 2012, Volume: 119, Issue:2 Pt 2 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Female; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Skin Neoplasms; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vulvar Neoplasms	2012
[Clinical application of imiquimod for the treatment of infantile hemangiomas]. Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery, 2011, Volume: 27, Issue:6 Topics: Aminoquinolines; Female; Hemangioma; Humans; Imiquimod; Infant; Male; Skin Neoplasms; Treatment Outcome	2011
Topical treatment of cutaneous Kaposi sarcoma with imiquimod 5% in renal-transplant recipients: a clinicopathological observation. Clinical and experimental dermatology, 2012, Volume: 37, Issue:6 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Antigens, CD; Antineoplastic Agents; Female; Humans; Imiquimod; Immunohistochemistry; Kidney Transplantation; Male; Middle Aged; Sarcoma, Kaposi; Skin Neoplasms	2012
Mcl-1 determines the imiquimod-induced apoptosis but not imiquimod-induced autophagy in skin cancer cells. Journal of dermatological science, 2012, Volume: 65, Issue:3 Topics: Aminoquinolines; Apoptosis; Autophagy; bcl-X Protein; Biomarkers, Tumor; Carcinoma, Basal Cell; Cell Line, Tumor; Down-Regulation; Humans; Imiquimod; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Skin Neoplasms; Up-Regulation	2012
Melanoma in situ treated successfully using imiquimod after nonclearance with surgery: review of the literature. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2012, Volume: 38, Issue:6 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Facial Neoplasms; Follow-Up Studies; Humans; Imiquimod; Male; Melanoma; Mohs Surgery; Skin Neoplasms	2012
Imiquimod attenuates the growth of UVB-induced SCC in mice through Th1/Th17 cells. Molecular carcinogenesis, 2013, Volume: 52, Issue:10 Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Cell Transformation, Neoplastic; Cytokines; Dendritic Cells; Epidermis; Imiquimod; Immunoenzyme Techniques; Keratinocytes; Mice; Mice, Transgenic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin Neoplasms; STAT3 Transcription Factor; Th1 Cells; Th17 Cells; Ultraviolet Rays	2013
Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream. International journal of dermatology, 2012, Volume: 51, Issue:4 Topics: Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2012
Incipient retinal vein occlusion following immunotherapy of periorbital basal cell carcinoma. The Australasian journal of dermatology, 2012, Volume: 53, Issue:2 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Middle Aged; Retinal Vein Occlusion; Skin Neoplasms	2012
Conventional surgery compared with slow Mohs micrographic surgery in the treatment of lentigo maligna: a retrospective study of 62 cases. Actas dermo-sifiliograficas, 2012, Volume: 103, Issue:7 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Mohs Surgery; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm, Residual; Paraffin Embedding; Reoperation; Retrospective Studies; Skin Neoplasms; Skin Pigmentation; Treatment Outcome	2012
Human papillomavirus type 73 associated with multiple cutaneous squamous cell carcinomas in an immunosuppressed patient. International journal of dermatology, 2012, Volume: 51, Issue:6 Topics: Adult; Aminoquinolines; Amputation, Surgical; Antineoplastic Agents; Carcinoma, Squamous Cell; DNA, Viral; Fingers; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Lip Neoplasms; Male; Mohs Surgery; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Skin Neoplasms	2012
The use of dermatoscopy to monitor therapeutic response of Bowen disease: a dermatoscopic pathological study. The British journal of dermatology, 2012, Volume: 167, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Dermoscopy; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Prospective Studies; Skin Neoplasms; Treatment Outcome	2012
Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases. Journal of the American Academy of Dermatology, 2012, Volume: 67, Issue:2 Topics: Aged, 80 and over; Aminoquinolines; Anti-Infective Agents, Local; Antineoplastic Agents; Chemoradiotherapy; Drug Therapy, Combination; Gentian Violet; Humans; Imiquimod; Male; Melanoma; Skin Neoplasms	2012
Treatment of lymphangioma circumscriptum with topical imiquimod 5% cream. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2012, Volume: 38, Issue:9 Topics: Administration, Cutaneous; Adolescent; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Lymphangioma; Male; Skin Neoplasms	2012
Topical imiquimod treatment of cutaneous vascular disorders in pediatric patients: clinical evaluation on the efficacy and safety. Journal of Zhejiang University. Science. B, 2012, Volume: 13, Issue:9 Topics: Administration, Topical; Aminoquinolines; Child, Preschool; Dermatologic Agents; Female; Granuloma, Pyogenic; Hemangioma; Humans; Imiquimod; Infant; Male; Port-Wine Stain; Retrospective Studies; Skin Diseases, Vascular; Skin Neoplasms; Treatment Outcome	2012
Bowen's disease in a renal transplant recipient treated with a single application of topical imiquimod: severe adverse skin reaction with favourable clinical outcome. Acta bio-medica : Atenei Parmensis, 2012, Volume: 83, Issue:1 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Female; Humans; Imiquimod; Kidney Transplantation; Skin; Skin Neoplasms; Treatment Outcome	2012
Bowen's disease of the digit successfully treated with immunocryosurgery. International journal of dermatology, 2013, Volume: 52, Issue:4 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Combined Modality Therapy; Cryosurgery; Fingers; Humans; Imiquimod; Male; Skin Neoplasms	2013
Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Dec-15, Volume: 18, Issue:24 Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chemoradiotherapy; Cyclophosphamide; Cytokines; Dose Fractionation, Radiation; Drug Synergism; Histocompatibility Antigens Class I; Humans; Imiquimod; Immunologic Memory; Injections, Intraperitoneal; Intercellular Adhesion Molecule-1; Lymph Nodes; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Neoplasm Recurrence, Local; Neoplasm Transplantation; Skin Neoplasms; T-Lymphocytes; Toll-Like Receptor 7; Tumor Burden	2012
Breast cancer treatment with imiquimod: applying an old lotion to a new disease. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Dec-15, Volume: 18, Issue:24 Topics: Aminoquinolines; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Imiquimod; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Skin Neoplasms; Toll-Like Receptor 7	2012
[Item 149--Epithelial and melanotic skin tumors: human papillomavirus (HPV) tumors]. Annales de dermatologie et de venereologie, 2012, Volume: 139, Issue:11 Suppl Topics: Adult; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Child; Combined Modality Therapy; Condylomata Acuminata; Cryosurgery; Cryotherapy; Female; Gammapapillomavirus; Humans; Imiquimod; Immunocompromised Host; Laser Therapy; Lasers, Gas; Male; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Pregnancy Complications, Neoplastic; Risk; Skin Neoplasms; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaccination; Warts	2012
A novel two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod. The British journal of dermatology, 2013, Volume: 168, Issue:6 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Laser Therapy; Male; Middle Aged; Skin Neoplasms; Treatment Outcome	2013
Treatment of nodular basal cell carcinoma with cryotherapy and reduced protocol of imiquimod. Cutis, 2012, Volume: 90, Issue:5 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryotherapy; Facial Neoplasms; Humans; Imiquimod; Male; Nose; Skin Neoplasms	2012
Letter: Immunocryotherapy for difficult-to-treat basal cell carcinoma of the eyelid. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:1 Pt 1 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Eyelid Neoplasms; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms	2013
Giant basal cell carcinoma. Improvement and vitiligo-like hypopigmentation after intermittent treatment with 5% imiquimod. Acta dermatovenerologica Croatica : ADC, 2012, Volume: 20, Issue:4 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Head and Neck Neoplasms; Humans; Imiquimod; Scalp; Skin Neoplasms; Vitiligo	2012
Arbor cutis: hyperkeratotic plaque secondary to the use of imiquimod for the treatment of squamous cell carcinoma in situ. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:4 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Eruptions; Female; Forearm; Humans; Imiquimod; Keratosis; Skin Neoplasms	2013
Clearance of invasive melanoma with topical imiquimod. Journal of drugs in dermatology : JDD, 2013, Volume: 12, Issue:1 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Female; Frail Elderly; Humans; Imiquimod; Inflammation; Melanoma; Neoplasm Invasiveness; Skin; Skin Neoplasms	2013
Topical imiquimod eradicates skin metastases of malignant melanoma but fails to prevent rapid lymphogenous metastatic spread. The British journal of dermatology, 2002, Volume: 147, Issue:3 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Lymphatic Metastasis; Male; Melanoma; Skin Neoplasms	2002
Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma. Dermatology (Basel, Switzerland), 2002, Volume: 205, Issue:2 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Injections, Intralesional; Interleukin-2; Male; Melanoma; Skin Neoplasms	2002
Treatment of stage IA cutaneous T-Cell lymphoma with topical application of the immune response modifier imiquimod. Archives of dermatology, 2002, Volume: 138, Issue:9 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Biopsy, Needle; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Lymphoma, T-Cell, Cutaneous; Middle Aged; Neoplasm Staging; Skin Neoplasms; Treatment Outcome	2002
Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report. The Journal of dermatological treatment, 2002, Volume: 13, Issue:3 Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Skin Neoplasms	2002
An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream. Journal of the American Academy of Dermatology, 2002, Volume: 47, Issue:4 Suppl Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Skin Neoplasms	2002
Topical imiquimod for Bowenoid papulosis in an HIV-positive woman. Acta dermato-venereologica, 2002, Volume: 82, Issue:3 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Female; HIV Seropositivity; Humans; Imiquimod; Skin Neoplasms	2002
Cream to be tested as skin cancer care. Expert review of anticancer therapy, 2002, Volume: 2, Issue:6 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Australia; Carcinoma, Basal Cell; Clinical Trials as Topic; Humans; Imiquimod; Skin Neoplasms; United Kingdom; United States	2002
Catching skin cancer early. New treatments aim to keep keratoses from developing into invasive cancer. Health news (Waltham, Mass.), 2002, Volume: 8, Issue:12 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Humans; Imiquimod; Keratosis; Photochemotherapy; Precancerous Conditions; Risk Factors; Skin Neoplasms	2002
Successful treatment of basal cell carcinoma on the face with imiquimod 5% cream. Acta dermato-venereologica, 2002, Volume: 82, Issue:6 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms; Treatment Outcome	2002
Noninvasive imaging, treatment, and microscopic confirmation of clearance of basal cell carcinoma. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2003, Volume: 29, Issue:3 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Humans; Imiquimod; Male; Microscopy, Confocal; Middle Aged; Skin Neoplasms	2003
Is imiquimod effective and safe for actinic keratosis? The Journal of family practice, 2003, Volume: 52, Issue:3 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Evidence-Based Medicine; Humans; Imiquimod; Keratosis; Photosensitivity Disorders; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Safety; Skin Neoplasms	2003
Topical imiquimod in the treatment of metastatic melanoma to skin. Archives of dermatology, 2003, Volume: 139, Issue:3 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dacarbazine; Female; Humans; Imiquimod; Interferon alpha-2; Interferon-alpha; Knee; Leg; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Recombinant Proteins; Scalp; Skin Neoplasms; Treatment Outcome	2003
[Recurrent Bowen's disease of the nail: treatment by topical imiquimod (Aldara)]. Annales de dermatologie et de venereologie, 2003, Volume: 130, Issue:2 Pt 1 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Bowen's Disease; Female; Humans; Imiquimod; Nail Diseases; Recurrence; Skin Neoplasms; Treatment Outcome	2003
Management of cutaneous locoregional recurrences of melanoma: a new therapeutic perspective with imiquimod. Dermatology (Basel, Switzerland), 2003, Volume: 206, Issue:3 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Melanoma; Neoplasm Recurrence, Local; Skin Neoplasms	2003
Bowenoid papulosis successfully treated with imiquimod. Journal of the European Academy of Dermatology and Venereology : JEADV, 2003, Volume: 17, Issue:3 Topics: Aged; Aminoquinolines; Anal Canal; Antineoplastic Agents; Bowen's Disease; Diagnosis, Differential; Female; Humans; Imiquimod; Skin Neoplasms	2003
Treatment of Bowen's disease and basal cell carcinoma of the nose with imiquimod 5% cream. The Australasian journal of dermatology, 2003, Volume: 44, Issue:2 Topics: Administration, Topical; Aminoquinolines; Biopsy, Needle; Bowen's Disease; Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Middle Aged; Skin Neoplasms; Treatment Outcome	2003
Nudging epidermal field cancerogenesis by imiquimod. Dermatology (Basel, Switzerland), 2003, Volume: 206, Issue:4 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Humans; Imiquimod; Keratinocytes; Middle Aged; Neoplasms, Multiple Primary; Skin; Skin Neoplasms; Treatment Outcome	2003
Prolonged imiquimod treatment and graft-versus-host reaction: histological mimicry in the skin infiltration pattern of the monocyte-macrophage-dendrocyte lineage. Dermatology (Basel, Switzerland), 2003, Volume: 206, Issue:4 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Dendritic Cells; Graft vs Host Reaction; Humans; Imiquimod; Immunohistochemistry; Macrophages; Middle Aged; Monocytes; Skin; Skin Neoplasms; Tumor Necrosis Factor-alpha	2003
Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides. Dermatology (Basel, Switzerland), 2003, Volume: 207, Issue:1 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Follow-Up Studies; Humans; Imiquimod; Male; Mycosis Fungoides; PUVA Therapy; Risk Assessment; Skin Neoplasms; Treatment Outcome	2003
Treatment of verrucous carcinoma with imiquimod and CO2 laser ablation. Dermatology (Basel, Switzerland), 2003, Volume: 207, Issue:1 Topics: Aged; Aged, 80 and over; Aminoquinolines; Biopsy, Needle; Carbon Dioxide; Carcinoma, Verrucous; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Laser Therapy; Neoplasm Staging; Risk Assessment; Skin Neoplasms; Treatment Outcome	2003
Imiquimod to treat different cancers of the epidermis. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2003, Volume: 29, Issue:8 Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Humans; Imiquimod; Keratosis; Male; Neoplasms, Basal Cell; Skin Neoplasms	2003
Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream. Archives of dermatology, 2003, Volume: 139, Issue:7 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Skin Neoplasms	2003
Extensive lentigo maligna clearing with topical imiquimod. Archives of dermatology, 2003, Volume: 139, Issue:7 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms	2003
Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease. Archives of dermatology, 2003, Volume: 139, Issue:7 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Melanoma; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Skin Neoplasms	2003
New and emerging treatments for nonmelanomas and actinic keratoses. Journal of drugs in dermatology : JDD, 2003, Volume: 2, Issue:4 Topics: Adjuvants, Immunologic; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diclofenac; Humans; Imiquimod; Keratosis; Photochemotherapy; Skin Neoplasms	2003
[Topical immunomodulators in dermatology]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:7 Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Asthma; Autoimmune Diseases; Bowen's Disease; Child; Cyclopropanes; Dermatitis, Atopic; Dinitrochlorobenzene; Female; Follow-Up Studies; Herpes Simplex; Humans; Imidazoles; Imiquimod; Immunity, Cellular; Immunocompromised Host; Immunoglobulin A; Immunosuppressive Agents; Lichen Sclerosus et Atrophicus; Male; Molluscum Contagiosum; Papillomavirus Infections; Precancerous Conditions; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Time Factors; Warts	2003
Imiquimod: a topically applied link between innate and acquired immunity. Archives of dermatology, 2003, Volume: 139, Issue:10 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Immunity, Active; Immunity, Innate; Skin Neoplasms	2003
Topical treatment of lentigo maligna melanoma with imiquimod 5% cream. Dermatology (Basel, Switzerland), 2003, Volume: 207, Issue:3 Topics: Administration, Topical; Aged; Aminoquinolines; Dose-Response Relationship, Drug; Drug Administration Schedule; Facial Neoplasms; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Ointments; Skin Neoplasms; Treatment Outcome	2003
Treatment of Bowen's disease and erythroplasia of Queyrat. The British journal of dermatology, 2003, Volume: 149 Suppl 66 Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Bowen's Disease; Erythroplasia; Humans; Imiquimod; Male; Middle Aged; Penile Neoplasms; Skin Neoplasms; Treatment Outcome	2003
Imiquimod in basal cell carcinoma: how does it work? The British journal of dermatology, 2003, Volume: 149 Suppl 66 Topics: Adjuvants, Immunologic; Aminoquinolines; Apoptosis; Carcinoma, Basal Cell; Cytokines; Dendritic Cells; Gene Expression; Humans; Imiquimod; Immunotherapy, Active; Skin Neoplasms	2003
Excellent response of basal cell carcinomas and pigmentary changes in xeroderma pigmentosum to imiquimod 5% cream. The British journal of dermatology, 2003, Volume: 149, Issue:4 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Skin Neoplasms; Xeroderma Pigmentosum	2003
Treatment of Bowen's disease using a cycle regimen of imiquimod 5% cream. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Imiquimod; Middle Aged; Ointments; Skin Neoplasms; Treatment Outcome	2003
The use of imiquimod 5% cream for the treatment of basal cell carcinoma as observed in Gorlin's syndrome. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Male; Middle Aged; Ointments; Skin Neoplasms; Treatment Outcome	2003
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Ointments; Skin Neoplasms; Treatment Outcome	2003
Imiquimod-responsive basal cell carcinomas and factor XIIIa-enriched dendrocytes. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Carcinoma, Basal Cell; Dendritic Cells; Facial Neoplasms; Factor XIIIa; Humans; Imiquimod; Immunohistochemistry; Middle Aged; Skin Neoplasms	2003
The treatment of basal skin carcinomas in two sisters with xeroderma pigmentosum. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Administration, Topical; Adolescent; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Skin Neoplasms; Treatment Outcome; Xeroderma Pigmentosum	2003
Successful treatment of extramammary Paget's disease of the scrotum with imiquimod 5% cream. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy; Genital Neoplasms, Male; Humans; Imiquimod; Male; Paget Disease, Extramammary; Scrotum; Skin Neoplasms; Treatment Outcome	2003
[Cutaneous epithelial tumors. Molecular biology and pathogenesis-based therapy]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:12 Topics: Adjuvants, Immunologic; Alleles; Aminoquinolines; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cerebellar Neoplasms; Disease Models, Animal; Genes, Tumor Suppressor; Hedgehog Proteins; Humans; Imiquimod; Medulloblastoma; Membrane Proteins; Mice; Mutation; Patched Receptors; Patched-1 Receptor; Receptors, Cell Surface; Signal Transduction; Skin Neoplasms; Trans-Activators; Transcription Factors; Tumor Cells, Cultured; Veratrum Alkaloids	2003
Two cases of squamous cell carcinoma treated with topical imiquimod 5%. Journal of the European Academy of Dermatology and Venereology : JEADV, 2004, Volume: 18, Issue:1 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Skin Neoplasms	2004
Imiquimod for the treatment of Bowen's disease and invasive squamous cell carcinoma. Journal of drugs in dermatology : JDD, 2003, Volume: 2, Issue:6 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Female; Humans; Imiquimod; Leg; Male; Nose; Shoulder; Skin Neoplasms; Treatment Outcome	2003
Topical imiquimod immunotherapy in the management of lentigo maligna. Clinical and experimental dermatology, 2004, Volume: 29, Issue:1 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunotherapy; Male; Skin Neoplasms; Treatment Outcome	2004
Locoregional cutaneous metastases of malignant melanoma and their management. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2004, Volume: 30, Issue:2 Pt 2 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Lymphatic Metastasis; Male; Melanoma; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Skin Neoplasms; Treatment Outcome	2004
Psoriasis induced by topical imiquimod. The Australasian journal of dermatology, 2004, Volume: 45, Issue:1 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Interferon Inducers; Middle Aged; Psoriasis; Skin; Skin Neoplasms	2004
[Imiquimod, pegylated interferon-alpha-2b and interleukin-2 in the treatment of cutaneous melanoma metastases]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2004, Volume: 55, Issue:2 Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Antineoplastic Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imiquimod; Injections, Intralesional; Interferon alpha-2; Interferon Inducers; Interferon-alpha; Interleukin-2; Melanoma; Neoplasm Metastasis; Recombinant Proteins; Skin Neoplasms; Time Factors	2004
Successful treatment of invasive squamous cell carcinoma using topical imiquimod. Archives of dermatology, 2004, Volume: 140, Issue:4 Topics: Administration, Topical; Aged; Aminoquinolines; Biopsy, Needle; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Face; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Male; Neoplasm Invasiveness; Risk Assessment; Skin Neoplasms; Treatment Outcome	2004
Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy. Journal of the American Academy of Dermatology, 2004, Volume: 50, Issue:5 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Ointments; Skin Neoplasms	2004
In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases. The British journal of dermatology, 2004, Volume: 150, Issue:4 Topics: Administration, Topical; Aged; Aminoquinolines; Angiogenesis Inhibitors; Antineoplastic Agents; Female; Gene Expression Regulation; Humans; Imiquimod; Interferon-alpha; Kisspeptins; Matrix Metalloproteinases; Melanoma; Neovascularization, Pathologic; Proteins; Skin Neoplasms; Tissue Inhibitor of Metalloproteinase-1; Tumor Suppressor Proteins; Vascular Endothelial Growth Factors	2004
Imiquimod (Aldara) for actinic keratoses. The Medical letter on drugs and therapeutics, 2004, May-24, Volume: 46, Issue:1183 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Drug Administration Schedule; Humans; Imiquimod; Keratosis; Photosensitivity Disorders; Skin Neoplasms	2004
Invasive squamous cell carcinoma treated with imiquimod 5% cream. Acta dermato-venereologica, 2004, Volume: 84, Issue:3 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Imiquimod; Leg; Male; Neoplasm Invasiveness; Ointments; Skin Neoplasms; Treatment Outcome	2004
Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome. The Journal of dermatological treatment, 2004, Volume: 15, Issue:2 Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Face; Humans; Imiquimod; Male; Skin Neoplasms; Treatment Outcome	2004
Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (Aldara). The British journal of dermatology, 2004, Volume: 150, Issue:6 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Cytokines; Follow-Up Studies; Humans; Imiquimod; Interferon-gamma; Ki-1 Antigen; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Skin Neoplasms	2004
Localized pemphigus foliaceus induced by topical imiquimod treatment. Archives of dermatology, 2004, Volume: 140, Issue:7 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diagnosis, Differential; Drug Eruptions; Face; Facial Dermatoses; Female; Humans; Imiquimod; Middle Aged; Pemphigus; Skin Neoplasms	2004
A pilot study of treatment of lentigo maligna with 5% imiquimod cream. The British journal of dermatology, 2004, Volume: 151, Issue:2 Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Pilot Projects; Skin Neoplasms; Treatment Outcome	2004
Angioedema associated with imiquimod. Journal of the American Academy of Dermatology, 2004, Volume: 51, Issue:3 Topics: Aminoquinolines; Angioedema; Antineoplastic Agents; Bowen's Disease; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms; Skin Ulcer	2004
Topical imidazoquinoline therapy of cutaneous squamous cell carcinoma polarizes lymphoid and monocyte/macrophage populations to a Th1 and M1 cytokine pattern. Clinical and experimental dermatology, 2004, Volume: 29, Issue:5 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Agents; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Cytokines; Female; Humans; Imiquimod; Immunohistochemistry; Leukocytes, Mononuclear; Macrophages; Male; Middle Aged; Skin Neoplasms	2004
Use of in vivo confocal microscopy in malignant melanoma: an aid in diagnosis and assessment of surgical and nonsurgical therapeutic approaches. Archives of dermatology, 2004, Volume: 140, Issue:9 Topics: Aminoquinolines; Biopsy, Needle; Facial Neoplasms; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Male; Melanoma; Microscopy, Confocal; Middle Aged; Mohs Surgery; Neoplasm Staging; Risk Assessment; Sampling Studies; Sensitivity and Specificity; Skin; Skin Neoplasms; Treatment Outcome	2004
Topical imiquimod treatment of lentigo maligna: clinical and histologic evaluation. Journal of the American Academy of Dermatology, 2004, Volume: 51, Issue:4 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Drug Administration Schedule; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Skin; Skin Neoplasms; Treatment Outcome	2004
Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod. The British journal of dermatology, 2004, Volume: 151, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Skin Neoplasms; T-Lymphocyte Subsets	2004
Bowenoid papulosis in a patient with AIDS treated with imiquimod: case report. Acta dermatovenerologica Croatica : ADC, 2004, Volume: 12, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Humans; Imiquimod; Male; Middle Aged; Papillomavirus Infections; Penis; Scrotum; Skin Neoplasms	2004
Gene expression in actinic keratoses: pharmacological modulation by imiquimod. The British journal of dermatology, 2004, Volume: 151, Issue:6 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Apoptosis; Cell Adhesion Molecules; Cytokines; Gene Expression Regulation; Genes, p53; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Membrane Glycoproteins; Middle Aged; Neoplasms, Radiation-Induced; Precancerous Conditions; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptors	2004
Successful treatment of persistent melanoma in situ with 5% imiquimod cream. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2004, Volume: 30, Issue:12 Pt 2 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Imiquimod; Melanoma; Neck; Skin Neoplasms	2004
A patient with xeroderma pigmentosum treated with imiquimod 5% cream. Journal of the American Academy of Dermatology, 2005, Volume: 52, Issue:1 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Male; Skin Neoplasms; Xeroderma Pigmentosum	2005
Use of imiquimod for treating skin cancer. Journal of the American Academy of Dermatology, 2005, Volume: 52, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Skin Neoplasms	2005
Imiquimod is a strong inhibitor of tumor cell-induced angiogenesis. International journal of dermatology, 2005, Volume: 44, Issue:1 Topics: Adjuvants, Immunologic; Aminoquinolines; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bowen's Disease; Cell Line, Tumor; Disease Models, Animal; Humans; Imiquimod; Interferon-alpha; Interleukin-18; Keratinocytes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neovascularization, Pathologic; Papillomaviridae; Papillomavirus Infections; Sarcoma; Skin Neoplasms; Tumor Necrosis Factor-alpha	2005
Imiquimod in the treatment of extensive recurrent lentigo maligna. Journal of the American Academy of Dermatology, 2005, Volume: 52, Issue:2 Suppl 1 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Neoplasm Recurrence, Local; Skin Neoplasms	2005
Treatment of cutaneous metastatic melanoma with imiquimod 5% cream and the pulsed-dye laser. The British journal of dermatology, 2005, Volume: 152, Issue:2 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Humans; Imiquimod; Laser Therapy; Male; Melanoma; Skin Neoplasms	2005
Minimizing surgery in skin cancer treatment. A new test looks for cancer in the lymph nodes during melanoma surgery, while a topical cream helps people with another form of skin cancer avoid the knife. Health news (Waltham, Mass.), 2005, Volume: 11, Issue:2 Topics: Adjuvants, Immunologic; Aminoquinolines; Antibodies, Neoplasm; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Basal Cell; Humans; Imiquimod; Lymphatic Metastasis; Melanoma; Skin Neoplasms	2005
Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod. Journal of cutaneous pathology, 2005, Volume: 32, Issue:4 Topics: Adjuvants, Immunologic; Aminoquinolines; Breast Neoplasms; Carcinoma, Basal Cell; Chemotaxis, Leukocyte; Female; Humans; Imiquimod; Interferon Type I; Lymphocytes; Melanoma; Membrane Glycoproteins; Receptors, Cell Surface; Receptors, Chemokine; Receptors, CXCR3; Signal Transduction; Skin; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptors	2005
Infiltrative squamous cell carcinoma on the scalp after treatment with 5% imiquimod cream. Journal of the American Academy of Dermatology, 2005, Volume: 52, Issue:4 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Carcinoma, Squamous Cell; Dosage Forms; Head and Neck Neoplasms; Humans; Imiquimod; Male; Scalp; Skin Neoplasms	2005
[Treatment of paraungual HPV73-positive Bowen disease with imiquimod cream]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2006, Volume: 57, Issue:4 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Drug Administration Schedule; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Nail Diseases; Occlusive Dressings; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Skin; Skin Neoplasms	2006
Imiquimod: an effective alternative for the treatment of invasive cutaneous squamous cell carcinoma. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2005, Volume: 31, Issue:3 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Imiquimod; Keratinocytes; Male; Skin Neoplasms	2005
Imiquimod 5% cream: a new treatment for Bowen's disease. International journal of tissue reactions, 2005, Volume: 27, Issue:1 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Antiviral Agents; Biopsy; Bowen's Disease; Carcinoma, Squamous Cell; Epidermis; Female; Humans; Imiquimod; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Skin Neoplasms; Time Factors; Treatment Outcome	2005
Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream. International journal of dermatology, 2005, Volume: 44, Issue:5 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Facial Neoplasms; Female; Humans; Imiquimod; Male; Melanoma; Skin Neoplasms; Treatment Outcome	2005
Can you tell me more about topical treatments for skin cancer? Mayo Clinic women's healthsource, 2005, Volume: 9, Issue:6 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Fluorouracil; Humans; Imiquimod; Skin Neoplasms	2005
Imiquimod and squamous cell cancer. Archives of dermatology, 2005, Volume: 141, Issue:6 Topics: Aminoquinolines; Biopsy, Needle; Bowen's Disease; Carcinoma, Squamous Cell; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Precancerous Conditions; Risk Assessment; Skin Neoplasms; Treatment Outcome	2005
Regression of lymphomatous skin deposits in a chronic lymphocytic leukemia patient treated with the Toll-like receptor-7/8 agonist, imiquimod. Leukemia & lymphoma, 2005, Volume: 46, Issue:6 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Disease Progression; Humans; Imiquimod; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Male; Signal Transduction; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8; Treatment Outcome	2005
Eruptive epidermoid cysts resulting from treatment with imiquimod. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2005, Volume: 31, Issue:7 Pt 1 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Dermatologic Agents; Female; Humans; Imiquimod; Retinoids; Skin Diseases; Skin Neoplasms; Treatment Outcome	2005
Imiquimod to treat basal cell and squamous cell carcinomas. American family physician, 2005, Jul-01, Volume: 72, Issue:1 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Drug Approval; Humans; Imiquimod; Patient Selection; Skin Neoplasms; United States; United States Food and Drug Administration	2005
Bowen disease of the eyelid successfully treated with imiquimod. Ophthalmic plastic and reconstructive surgery, 2005, Volume: 21, Issue:4 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Eyelid Neoplasms; Humans; Imiquimod; Male; Ointments; Skin Neoplasms	2005
Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment. Journal of the National Cancer Institute, 2005, Aug-03, Volume: 97, Issue:15 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Clinical Trials as Topic; Dendritic Cells; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Imiquimod; Immunohistochemistry; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Microscopy, Confocal; Plasma Cells; Polymerase Chain Reaction; Skin Neoplasms	2005
Topical imiquimod to treat recurrent breast cancer. Breast cancer research and treatment, 2005, Volume: 94, Issue:1 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Imiquimod; Skin Neoplasms	2005
Successful treatment of penile Bowen's disease with 5% imiquimod cream. International journal of STD & AIDS, 2005, Volume: 16, Issue:9 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Squamous Cell; Humans; Imiquimod; Male; Penile Diseases; Skin Neoplasms; Treatment Outcome	2005
Therapy of cutaneous squamous cell carcinoma in two retirement home residents. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2005, Volume: 3, Issue:9 Topics: Adjuvants, Immunologic; Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Hand Dermatoses; Homes for the Aged; Humans; Imiquimod; Skin Neoplasms; Surgical Flaps; Treatment Outcome	2005
[Topical immunomodulator against skin cancer. Does the cream replace the knife? (interview by Dr. Judith Neumaier)]. MMW Fortschritte der Medizin, 2005, Sep-15, Volume: 147, Issue:37 Topics: Aminoquinolines; Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Humans; Imiquimod; Immunologic Factors; Ointments; Skin; Skin Neoplasms; Treatment Outcome	2005
A preliminary study of imiquimod treatment in variants of basal cell carcinoma. The American surgeon, 2005, Volume: 71, Issue:8 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Biopsy; Carcinoma, Basal Cell; Humans; Imiquimod; Pilot Projects; Polymerase Chain Reaction; Skin; Skin Neoplasms; Treatment Outcome	2005
[Imiquimod treatment of lentigo maligna to dermoscopic and histologic clearance]. Ugeskrift for laeger, 2005, Sep-26, Volume: 167, Issue:39 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Cheek; Dermoscopy; Facial Neoplasms; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Ointments; Skin Neoplasms	2005
[How I treat ... lentigo maligna by topical imiquimod]. Revue medicale de Liege, 2005, Volume: 60, Issue:9 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Skin Neoplasms	2005
[Imiquimod--a substance with a broad working spectrum]. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2004, Volume: 2, Issue:10 Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Dermatologic Agents; Focal Epithelial Hyperplasia; Imiquimod; Papillomavirus Infections; Skin Neoplasms	2004
Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2003, Volume: 1, Issue:10 Topics: Adult; Aged; Aminoquinolines; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Humans; Imiquimod; Immunosuppressive Agents; Interferons; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Prednisone; PUVA Therapy; Remission Induction; Skin; Skin Neoplasms; Tacrolimus; Tetrahydronaphthalenes; Time Factors; Treatment Outcome; Vincristine	2003
Image in clinical medicine. Lentigo maligna. The New England journal of medicine, 2005, Nov-17, Volume: 353, Issue:20 Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Face; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Ointments; Skin Neoplasms	2005
[Treatment of Bowen's disease of the penis with imiquimod 5% cream]. Actas urologicas espanolas, 2005, Volume: 29, Issue:8 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Bowen's Disease; Humans; Imiquimod; Male; Penile Neoplasms; Skin Neoplasms; Treatment Outcome	2005
Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas. Clinical and experimental dermatology, 2006, Volume: 31, Issue:1 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Eruptions; Female; Humans; Imiquimod; Middle Aged; Psoriasis; Skin Neoplasms	2006
Aggressive undifferentiated squamous cell carcinoma in an immunosuppressed patient after kidney transplantation. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2005, Volume: 3, Issue:1 Topics: Acitretin; Adjuvants, Immunologic; Administration, Oral; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Counseling; Cyclosporine; Follow-Up Studies; Humans; Imiquimod; Immunocompromised Host; Immunosuppressive Agents; Keratolytic Agents; Keratosis; Kidney Transplantation; Male; Middle Aged; Ointments; Skin; Skin Neoplasms; Sunscreening Agents; Time Factors	2005
Treatment of an extensive superficial basal cell carcinoma of the face with imiquimod 5% cream. International journal of tissue reactions, 2005, Volume: 27, Issue:3 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Carcinoma, Basal Cell; Drug Administration Schedule; Face; Follow-Up Studies; Humans; Imiquimod; Male; Skin Neoplasms; Time Factors; Treatment Outcome	2005
A man with a pigmented growth on his chest. The Journal of family practice, 2006, Volume: 55, Issue:1 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Diagnosis, Differential; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Skin Neoplasms	2006
Disseminated porokeratosis palmaris and plantaris treated with imiquimod cream to prevent malignancy. Acta dermato-venereologica, 2005, Volume: 85, Issue:6 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Humans; Imiquimod; Male; Middle Aged; Ointments; Porokeratosis; Skin; Skin Neoplasms	2005
To the editor: incompletely excised basal cell carcinoma treated with 5% imiquimod cream. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2005, Volume: 31, Issue:11 Pt 1 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms	2005
Successful treatment of vulvar Bowen's disease with topical imiquimod 5% cream. International journal of dermatology, 2006, Volume: 45, Issue:2 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Female; Humans; Imiquimod; Skin Neoplasms; Vulvar Neoplasms	2006
Treatment of multiple lesions of Bowen's disease and squamous cell carcinoma with topical imiquimod. The Journal of dermatology, 2005, Volume: 32, Issue:12 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy, Needle; Bowen's Disease; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Male; Neoplasm Staging; Risk Assessment; Skin Neoplasms; Treatment Outcome	2005
[Perianal Bowen's disease treated with imiquimod]. Actas dermo-sifiliograficas, 2005, Volume: 96, Issue:7 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Bowen's Disease; Humans; Imiquimod; Male; Skin Neoplasms	2005
[Imiquimod for the treatment of skin metastases of melanoma]. Actas dermo-sifiliograficas, 2005, Volume: 96, Issue:8 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Melanoma; Skin Neoplasms	2005
[Lentigo maligna treated with 5% imiquimod cream]. Actas dermo-sifiliograficas, 2005, Volume: 96, Issue:10 Topics: Aminoquinolines; Antineoplastic Agents; Dosage Forms; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Remission Induction; Skin Neoplasms	2005
Lentigo maligna and radiotherapy. The New England journal of medicine, 2006, Mar-23, Volume: 354, Issue:12 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin Neoplasms	2006
Apparent response of cutaneous Merkel cell tumor to topical imiquimod. Cutis, 2006, Volume: 77, Issue:2 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Merkel Cell; Forehead; Humans; Imiquimod; Skin Neoplasms	2006
Usefulness of dermoscopy to monitor clinical efficacy of imiquimod treatment for lentigo maligna. Archives of dermatology, 2006, Volume: 142, Issue:4 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Cheek; Dermoscopy; Disease Progression; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin Neoplasms	2006
Treatment of precancerous and cancerous lesions of chronic arsenicism with 5% imiquimod cream. Archives of dermatology, 2006, Volume: 142, Issue:4 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Arsenic; Arsenic Poisoning; Chronic Disease; Forearm; Humans; Imiquimod; Keratosis; Male; Precancerous Conditions; Skin Neoplasms; Water Pollutants, Chemical	2006
Topical therapy with imiquimod for eyelid lesion. Clinical & experimental ophthalmology, 2006, Volume: 34, Issue:2 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Eyelid Neoplasms; Humans; Imiquimod; Male; Skin Neoplasms	2006
Treatment of verrucous carcinoma with topical imiquimod. Journal of the American Academy of Dermatology, 2006, Volume: 54, Issue:5 Suppl Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Carcinoma, Verrucous; Female; Foot Diseases; Hallux; Humans; Imiquimod; Male; Ointments; Skin Neoplasms; Treatment Outcome	2006
Treatment of limited extent extramammary Paget's disease with 5 percent imiquimod cream. Dermatology online journal, 2006, Jan-27, Volume: 12, Issue:1 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Imiquimod; Paget Disease, Extramammary; Skin Neoplasms; Thigh; Treatment Outcome	2006
Treatment of invasive squamous cell carcinoma with 5-percent imiquimod cream. Dermatology online journal, 2006, Mar-30, Volume: 12, Issue:3 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Imiquimod; Neoplasm Invasiveness; Ointments; Skin Neoplasms; Treatment Outcome	2006
[Imiquimod in treatment of palpebral mycosis fungoides]. Archivos de la Sociedad Espanola de Oftalmologia, 2006, Volume: 81, Issue:4 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Eyelid Neoplasms; Eyelids; Humans; Imiquimod; Male; Mycosis Fungoides; Ophthalmologic Surgical Procedures; Skin Neoplasms; Treatment Outcome	2006
Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases. Journal of drugs in dermatology : JDD, 2006, Volume: 5, Issue:5 Topics: Administration, Topical; Aged; Aminoquinolines; Biopsy, Needle; Carcinoma, Basal Cell; Chemotherapy, Adjuvant; Emollients; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Male; Middle Aged; Mohs Surgery; Neoplasm Staging; Risk Assessment; Skin Neoplasms; Treatment Outcome	2006
TOLLing away in Brazil. Nature immunology, 2006, Volume: 7, Issue:7 Topics: Adaptor Proteins, Signal Transducing; Aminoquinolines; Animals; Antineoplastic Agents; Antiprotozoal Agents; Brazil; Carcinoma, Basal Cell; Condylomata Acuminata; Diaminopimelic Acid; Drosophila melanogaster; Drosophila Proteins; Gene Expression Regulation; Gram-Negative Bacteria; Humans; Imiquimod; Immunity, Innate; Infections; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Melanoma; Mice; Models, Immunological; Molecular Structure; Peptidoglycan; Protozoan Infections; Radiation Chimera; RNA Helicases; Signal Transduction; Skin Diseases; Skin Neoplasms; Substrate Specificity; Toll-Like Receptor 7; Toll-Like Receptors	2006
[Multifocal penile intraepithelial neoplasia--targeted treatment with imiquimod]. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2006, Volume: 4, Issue:7 Topics: Administration, Topical; Aged; Aminoquinolines; Carcinoma; Dermatologic Agents; Drug Delivery Systems; Humans; Imiquimod; Male; Penile Neoplasms; Skin Neoplasms; Treatment Outcome	2006
Treatment of mammary and extramammary Paget's skin disease with topical imiquimod. The Journal of dermatological treatment, 2006, Volume: 17, Issue:3 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Diagnosis, Differential; Female; Groin; Humans; Imiquimod; Paget Disease, Extramammary; Paget's Disease, Mammary; Skin Neoplasms	2006
A case of epidermodysplasia verruciformis associated with squamous cell carcinoma and Bowen's disease: a therapeutic challenge. The Journal of dermatological treatment, 2006, Volume: 17, Issue:3 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Squamous Cell; Diagnosis, Differential; Drug Therapy, Combination; Epidermodysplasia Verruciformis; Humans; Imiquimod; Interferons; Male; Middle Aged; Scalp; Skin Neoplasms	2006
Limited extent AIDS-related cutaneous Kaposi's sarcoma responsive to imiquimod 5% cream. International journal of dermatology, 2006, Volume: 45, Issue:7 Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; HIV Infections; Humans; Imiquimod; Male; Sarcoma, Kaposi; Skin Neoplasms; Treatment Outcome	2006
Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study. The Australasian journal of dermatology, 2006, Volume: 47, Issue:3 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Facial Neoplasms; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Mucous Membrane; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2006
Invasive squamous cell carcinoma after treatment of carcinoma in situ with 5% imiquimod cream. The Australasian journal of dermatology, 2006, Volume: 47, Issue:3 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Head and Neck Neoplasms; Humans; Imiquimod; Leg; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Second Primary; Scalp; Skin Neoplasms; Treatment Outcome	2006
Multiple keratoacanthomas as an untoward response to imiquimod therapy for actinic keratoses. Acta dermato-venereologica, 2006, Volume: 86, Issue:4 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Squamous Cell; Humans; Imiquimod; Keratoacanthoma; Keratosis; Male; Middle Aged; Skin Neoplasms; Ultraviolet Rays	2006
Complete remission of multiple satellite and in-transit melanoma metastases after sequential treatment with isolated limb perfusion and topical imiquimod. The British journal of dermatology, 2006, Volume: 155, Issue:2 Topics: Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Fatal Outcome; Female; Humans; Imiquimod; Melanoma; Middle Aged; Remission Induction; Skin Neoplasms	2006
Hundreds of basal cell carcinomas in a Gorlin-Goltz syndrome patient cured with imiquimod 5% cream. Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:7 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Humans; Imiquimod; Male; Middle Aged; Ointments; Skin Neoplasms	2006
[Application of imiquimod and resiquimod in dermatology]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2006, Volume: 28, Issue:3 Topics: Adjuvants, Immunologic; Aminoquinolines; Antineoplastic Agents; Condylomata Acuminata; Humans; Imidazoles; Imiquimod; Skin Neoplasms	2006
Resolution of tinea pedis with imiquimod cream 5% in a patient with nodular basal cell carcinoma. Cutis, 2006, Volume: 78, Issue:1 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Male; Skin Neoplasms; Tinea Pedis; Toes	2006
Treatment of mycosis fungoides with imiquimod 5% cream. Clinical and experimental dermatology, 2006, Volume: 31, Issue:6 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Interferon Inducers; Male; Mycosis Fungoides; Skin Neoplasms	2006
Atypical lymphocytic reaction with epidermotropism and lymphocytic vasculopathic reaction (lymphocytic vasculitis) after treatment with imiquimod. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:5 Suppl Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Lymphocytes; Skin Diseases; Skin Neoplasms; Vasculitis	2006
Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:6 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Squamous Cell; Cytokines; Drug Evaluation; Drug Synergism; Fingers; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Ointments; Prodrugs; Remission Induction; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8	2006
In situ photoimmunotherapy: a tumour-directed treatment for melanoma. The British journal of dermatology, 2006, Volume: 155, Issue:6 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Female; Humans; Imiquimod; Infrared Rays; Laser Therapy; Lung Neoplasms; Male; Melanoma; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Toll-Like Receptors; Treatment Outcome	2006
Topical imiquimod: effectiveness in intraepithelial melanoma of oral mucosa. The Lancet. Oncology, 2006, Volume: 7, Issue:12 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Melanoma; Mouth Mucosa; Mouth Neoplasms; Skin Neoplasms	2006
Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study. Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:1 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Child, Preschool; Drug Eruptions; Facial Neoplasms; Female; Head and Neck Neoplasms; Hemangioma; Humans; Imiquimod; Infant; Infant, Newborn; Interferon Inducers; Male; Ointments; Remission Induction; Retrospective Studies; Severity of Illness Index; Skin Neoplasms; Treatment Outcome	2007
Recurrent invasive basal cell carcinoma after radiation and imiquimod: a case report. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:1 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Humans; Imiquimod; Male; Nasal Cavity; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Nose Neoplasms; Skin Neoplasms	2007
Cost-effectiveness of treatment of superficial basal cell carcinoma: surgical excision vs. imiquimod 5% cream. The British journal of dermatology, 2007, Volume: 156, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cost-Benefit Analysis; Humans; Imiquimod; Mohs Surgery; Skin Neoplasms	2007
Basal cell carcinoma. Dermatology nursing, 2006, Volume: 18, Issue:6 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Causality; Cryosurgery; Curettage; Diagnosis, Differential; Electrosurgery; Female; Fluorouracil; Humans; Imiquimod; Information Services; Interferon alpha-2; Interferon-alpha; Internet; Leg; Mohs Surgery; Nurse's Role; Patient Education as Topic; Recombinant Proteins; Skin Care; Skin Neoplasms	2006
Solitary plaque mycosis fungoides on the penis responding to topical imiquimod therapy. The British journal of dermatology, 2007, Volume: 156, Issue:3 Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Male; Mycosis Fungoides; Penile Neoplasms; Skin Neoplasms	2007
Multiple scrotal epidermolytic acanthomas successfully treated with topical imiquimod. The Journal of dermatology, 2007, Volume: 34, Issue:4 Topics: Acanthoma; Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Male; Middle Aged; Scrotum; Skin Neoplasms	2007
Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod. Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:5 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Epidermodysplasia Verruciformis; Humans; Imiquimod; Male; Membrane Proteins; Mutation; Skin Neoplasms	2007
Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions. The Journal of investigative dermatology, 2007, Volume: 127, Issue:7 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Animals; Antigens, Neoplasm; Combined Modality Therapy; Cryosurgery; Female; Imiquimod; Immunity; Interferon Inducers; Interferon-gamma; Melanoma, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Skin Neoplasms; Toll-Like Receptor 7; Vitiligo	2007
Lentigo maligna (melanoma in situ) treated with imiquimod cream 5%: 12 case reports. Cutis, 2007, Volume: 79, Issue:2 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Ointments; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2007
Treatment of Bowen's disease with topical 5% imiquimod cream: retrospective study. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:4 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Female; Humans; Imiquimod; Male; Middle Aged; Ointments; Skin Neoplasms	2007
Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:5 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Diagnosis, Differential; Forehead; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms	2007
Basal cell carcinoma: treatment with imiquimod. International journal of dermatology, 2007, Volume: 46, Issue:5 Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Aminoquinolines; Biopsy; Carcinoma, Basal Cell; Erythema; Female; Humans; Imiquimod; Male; Middle Aged; Skin; Skin Neoplasms; Spain; Time Factors; Treatment Outcome	2007
Treating actinic keratoses with imiquimod. Australian family physician, 2007, Volume: 36, Issue:5 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Squamous Cell; Cryotherapy; Facial Dermatoses; Humans; Imiquimod; Keratosis; Male; Middle Aged; Photosensitivity Disorders; Scalp Dermatoses; Skin Neoplasms	2007
Nature of inflammatory infiltrate in superficial cutaneous malignancies during topical imiquimod treatment. The American Journal of dermatopathology, 2007, Volume: 29, Issue:3 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Biomarkers, Tumor; Bowen's Disease; Carcinoma in Situ; Carcinoma, Basal Cell; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Inflammation; Keratosis; Male; Melanoma; Middle Aged; Skin Neoplasms	2007
A therapeutic approach to perianal extramammary Paget's disease: topical imiquimod can be useful to prevent or defer surgery. Medical science monitor : international medical journal of experimental and clinical research, 2007, Volume: 13, Issue:6 Topics: Administration, Topical; Aged; Aminoquinolines; Anal Canal; Antineoplastic Agents; Humans; Imiquimod; Male; Paget Disease, Extramammary; Skin Neoplasms	2007
Successful treatment of primary cutaneous follicle centre lymphoma with topical 5% imiquimod. The British journal of dermatology, 2007, Volume: 157, Issue:3 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Skin Neoplasms; Treatment Outcome	2007
Combined treatment with intratumoral injection of dendritic cells and topical application of imiquimod for murine melanoma. Clinical and experimental dermatology, 2007, Volume: 32, Issue:5 Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Agents; Combined Modality Therapy; Dendritic Cells; Female; Imiquimod; Immunotherapy, Adoptive; Injections, Intralesional; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Skin Neoplasms	2007
Treatment of double ectopic extramammary Paget's disease of bilateral chest with imiquimod 5% cream. Journal of the European Academy of Dermatology and Venereology : JEADV, 2007, Volume: 21, Issue:7 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Male; Paget Disease, Extramammary; Skin Neoplasms; Thorax	2007
Lentigo maligna successfully treated with imiquimod. South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie, 2007, Volume: 45, Issue:2 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Cryotherapy; Forehead; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Reoperation; Skin Neoplasms; Treatment Outcome	2007
Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience. Cutis, 2007, Volume: 79, Issue:3 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Curettage; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome	2007
5% topical imiquimod tolerance in transplant recipients. Dermatology (Basel, Switzerland), 2007, Volume: 215, Issue:2 Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Drug Administration Schedule; Female; Humans; Imiquimod; Immunocompromised Host; Keratosis; Male; Middle Aged; Retrospective Studies; Skin; Skin Neoplasms; Transplantation; Treatment Outcome; Ultraviolet Rays; Warts	2007
Squamous cell carcinoma on the scalp following treatment with 5% imiquimod cream. Clinical and experimental dermatology, 2007, Volume: 32, Issue:5 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Imiquimod; Keratosis; Male; Radiodermatitis; Scalp; Skin Neoplasms	2007
Ocular effects of imiquimod with treatment of eyelid melanoma in situ. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:9 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Conjunctiva; Erythema; Eyelid Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin; Skin Neoplasms; Visual Acuity	2007
Treatment of locally metastatic melanoma: a novel approach. Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:8 Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Imiquimod; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nicotinic Acids; Skin Neoplasms; Treatment Outcome	2007
Induction of the members of Notch pathway in superficial basal cell carcinomas treated with imiquimod. Archives of dermatological research, 2007, Volume: 299, Issue:10 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Calcium-Binding Proteins; Carcinoma, Basal Cell; Gene Expression Profiling; Humans; Imiquimod; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Intracellular Signaling Peptides and Proteins; Jagged-1 Protein; Membrane Proteins; Polymerase Chain Reaction; Receptor, Notch1; Serrate-Jagged Proteins; Signal Transduction; Skin Neoplasms; Up-Regulation	2007
Letter: Changes in dermoscopic features in superficial basal cell carcinomas treated with imiquimod. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:11 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Dermoscopy; Drug Monitoring; Erythema; Female; Humans; Imiquimod; Immunologic Factors; Male; Middle Aged; Remission Induction; Skin Neoplasms; Skin Ulcer	2007
Treatment of lentigo maligna with imiquimod 5% cream. Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:10 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Skin Neoplasms	2007
The appearance of inflammatory papules in the skin surrounding areas treated with imiquimod cream for basal cell carcinoma. The British journal of dermatology, 2008, Volume: 158, Issue:2 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Back; Carcinoma, Basal Cell; Humans; Imiquimod; Male; Skin Diseases, Papulosquamous; Skin Neoplasms	2008
Imiquimod treatment of papilloma virus and DMBA /TPA-induced cutaneous skin cancer in Mastomys coucha: an unique animal model system useful for preclinical studies. The British journal of dermatology, 2007, Volume: 157 Suppl 2 Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoquinolines; Animals; Antineoplastic Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Imiquimod; Murinae; Papilloma; Papillomavirus Infections; Skin Neoplasms; Tetradecanoylphorbol Acetate; Treatment Outcome	2007
Residual basal cell carcinoma after treatment with imiquimod: a caution on assuming complete cure. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:12 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Neoplasm, Residual; Scalp; Skin Neoplasms; Treatment Failure	2007
Treatment of lentigo maligna with imiquimod before staged excision. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2008, Volume: 34, Issue:2 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Ointments; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2008
Nodular basal cell carcinoma: when in doubt, cut it out. Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:12 Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Mohs Surgery; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Failure	2007
EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase-dependent apoptosis in T-cell lymphomas and HTLV-I-associated adult T-cell leukemia/lymphoma. Blood, 2008, Apr-01, Volume: 111, Issue:7 Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; bcl-X Protein; Caspases; Cell Division; Cytochromes c; G2 Phase; Human T-lymphotropic virus 1; Humans; Imiquimod; Inflammation; Inhibitor of Apoptosis Proteins; Jurkat Cells; Leukemia-Lymphoma, Adult T-Cell; Lymphocyte Activation; Lymphoma, T-Cell; Membrane Potential, Mitochondrial; NF-kappa B; Quinoxalines; Skin Neoplasms; Tumor Suppressor Protein p53	2008
Vitiligo-like hypopigmentation with poliosis following treatment of superficial basal cell carcinoma with imiquimod. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2008, Volume: 34, Issue:6 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Hypopigmentation; Imiquimod; Male; Skin Neoplasms; Thorax	2008
Cryosurgery during topical imiquimod: a successful combination modality for lentigo maligna. International journal of dermatology, 2008, Volume: 47, Issue:5 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aminoquinolines; Combined Modality Therapy; Cryosurgery; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Skin Neoplasms	2008
Apparent clinical resolution of pinnal actinic keratoses and squamous cell carcinoma in a cat using topical imiquimod 5% cream. Journal of feline medicine and surgery, 2008, Volume: 10, Issue:6 Topics: Aminoquinolines; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cat Diseases; Cats; Ear Auricle; Female; Imiquimod; Skin Neoplasms; Treatment Outcome	2008
Involution of infantile haemangiomas after imiquimod 5% cream. Clinical and experimental dermatology, 2008, Volume: 33, Issue:4 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Child, Preschool; Female; Hemangioma; Humans; Imiquimod; Infant; Male; Remission Induction; Skin Neoplasms; Treatment Outcome	2008
Clearance of basal cell and superficial squamous cell carcinomas after imiquimod therapy. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Male; Middle Aged; Retrospective Studies; Skin Neoplasms	2008
Bowen's disease of the penis treated with topical imiquimod 5% cream. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:5 Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Male; Ointments; Penile Neoplasms; Skin Neoplasms	2008
Nonsurgical therapy holds promise for basal cell carcinoma. Oncology (Williston Park, N.Y.), 1999, Volume: 13, Issue:7 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Cytokines; Drug Administration Schedule; Humans; Imiquimod; Interferons; Ointments; Skin Neoplasms; Treatment Outcome	1999
Toward the biologic treatment of nonmelanoma skin cancer. Journal of the American Academy of Dermatology, 1999, Volume: 41, Issue:6 Topics: Adjuvants, Immunologic; Aminoquinolines; Humans; Imiquimod; Immunotherapy; Skin Neoplasms	1999
The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2000, Volume: 26, Issue:6 Topics: Adjuvants, Immunologic; Aminoquinolines; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Ointments; Skin Neoplasms	2000
Topical imiquimod treatment of a cutaneous melanoma metastasis. Journal of the American Academy of Dermatology, 2000, Volume: 43, Issue:3 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Female; Humans; Imiquimod; Melanoma; Middle Aged; Skin Neoplasms; Treatment Outcome	2000
Imiquimod: a novel treatment for lentigo maligna. The British journal of dermatology, 2000, Volume: 143, Issue:4 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Interferon Inducers; Male; Scalp; Skin Neoplasms	2000
Dermal dendritic cells in anogenital warty lesions unresponsive to an immune-response modifier. Journal of cutaneous pathology, 2001, Volume: 28, Issue:3 Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antigen-Presenting Cells; Bowen's Disease; Carcinoma, Basal Cell; Condylomata Acuminata; Dendritic Cells; Dermis; Humans; Imiquimod; Male; Skin Neoplasms; Treatment Failure	2001
Bowen's disease (squamous cell carcinoma in situ) in immunosuppressed patients treated with imiquimod 5% cream and a cox inhibitor, sulindac: potential applications for this combination of immunotherapy. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2001, Volume: 27, Issue:2 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Female; Humans; Imiquimod; Immunosuppression Therapy; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasms, Second Primary; Ointments; Skin Neoplasms; Sulindac	2001
New cream to treat skin cancer? [news]. Mayo Clinic health letter (English ed.), 2001, Volume: 19, Issue:3 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Ointments; Skin Neoplasms	2001
[Imiquimod: a new treatment possibility in bowenoid papulosis?]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2001, Volume: 52, Issue:2 Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Biopsy; Bowen's Disease; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Male; Ointments; Papillomaviridae; Papillomavirus Infections; Penile Diseases; Risk Factors; Sexual Partners; Sexually Transmitted Diseases, Viral; Skin; Skin Diseases, Papulosquamous; Skin Neoplasms; Time Factors; Tumor Virus Infections	2001
Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases. The British journal of dermatology, 2001, Volume: 144, Issue:5 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Follow-Up Studies; Humans; Imiquimod; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Precancerous Conditions; Recurrence; Scalp Dermatoses; Skin Neoplasms	2001
Topical imiquimod to treat intraepidermal carcinoma. Archives of dermatology, 2001, Volume: 137, Issue:6 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratosis; Male; Middle Aged; Nose; Photosensitivity Disorders; Precancerous Conditions; Skin Neoplasms; Thorax	2001
[Initial success with topical immunomodulators. A creme for skin cancer? (interview by Renate Jackle)]. MMW Fortschritte der Medizin, 2001, May-24, Volume: 143, Issue:21 Topics: Adjuvants, Immunologic; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Melanoma; Neoplasms, Radiation-Induced; Ointments; Radiodermatitis; Skin Neoplasms; Treatment Outcome	2001
Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2001, Volume: 27, Issue:6 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Imiquimod; Immunosuppressive Agents; Kidney Transplantation; Leg; Male; Middle Aged; Pilot Projects; Skin Neoplasms; Survivors; Treatment Outcome	2001
Topical imiquimod 5% cream in the treatment of Bowen's disease of the penis. Journal of the American Academy of Dermatology, 2002, Volume: 46, Issue:1 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Humans; Imiquimod; Male; Middle Aged; Penis; Skin Neoplasms	2002
Treatment of Bowen's disease of the penis with imiquimod. Journal of the American Academy of Dermatology, 2002, Volume: 46, Issue:3 Topics: Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Humans; Imiquimod; Male; Middle Aged; Penile Neoplasms; Skin Neoplasms	2002
Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream. Journal of the American Academy of Dermatology, 2002, Volume: 46, Issue:4 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Male; Ointments; Penile Neoplasms; Skin Neoplasms	2002
'Rub on' treatment for basal-cell carcinoma. The Lancet. Oncology, 2002, Volume: 3, Issue:4 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Ointments; Skin Neoplasms; Treatment Outcome	2002
Infantile hemangioma: clinical resolution with 5% imiquimod cream. Archives of dermatology, 2002, Volume: 138, Issue:7 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hemangioma, Capillary; Humans; Imiquimod; Male; Scalp; Skin Neoplasms	2002
Therapeutic response of a brother and sister with xeroderma pigmentosum to imiquimod 5% cream. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2002, Volume: 28, Issue:6 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Tolerance; Facial Neoplasms; Female; Humans; Imiquimod; Male; Ointments; Skin Neoplasms; Xeroderma Pigmentosum	2002
Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms. International journal of dermatology, 2002, Volume: 41 Suppl 1 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Bowen's Disease; Cicatrix; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis; Paget Disease, Extramammary; Photochemotherapy; Pruritus; Randomized Controlled Trials as Topic; Skin Neoplasms	2002
Imiquimod 5% cream: a new treatment option for basal cell carcinoma. International journal of dermatology, 2002, Volume: 41 Suppl 1 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; CD3 Complex; Cytokines; Dose-Response Relationship, Drug; Drug Eruptions; Humans; Imiquimod; Interferon-gamma; Interleukins; Neoplasms, Fibroepithelial; Receptors, Cell Surface; Skin Neoplasms; Th1 Cells; Tumor Necrosis Factor-alpha	2002
Successful treatment of anogenital Bowen's disease with the immunomodulator imiquimod, and monitoring of therapy by DNA image cytometry. The British journal of dermatology, 2002, Volume: 147, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Bowen's Disease; Condylomata Acuminata; DNA, Viral; Drug Monitoring; Female; Humans; Image Cytometry; Imiquimod; Interferon Inducers; Middle Aged; Papillomaviridae; Skin Neoplasms; Vaginal Neoplasms	2002